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THE EFFECTS OF CROSSLINKING ON THE STABILITY AND 
AUTOXIDATION RATE OF HUMAN HEMOGLOBIN A 
Human hemoglobin has been crosslinked and shown to 
stabilized by bis(3,5-dibromosalicyl) fumarate, 
dimethylpimelimidate, tris(/3-chloroethyl) amine and bis(/3-
chloroethyl) methylamine. Hemoglobin crosslinked by 
fumarate between the two Lys 82/3's (Walder et al. (1980) 1-.:._ 
Mol. Biol., 141:195) or Lys 99a's (Chatterjee et al. (1986) 
=-J_,._-=B_,i:...;o:;...:1-'.---"'C..::.h=--'e"'-=m_,_. , 2 6 1 : 9 9 2 9 ) p r o du c e s ma r k e d 1 y h i g he r 
transition temperature (Tm) of 57°C, while the Tm of Hb A 
is 41°C. The fumarate crosslinking reaction with 
deoxyhemoglobin yields a second major product with similar 
Tm (57°C). This second crosslinked hemoglobin appears to 
be crosslinked between the /3-subunits with one additional 
modification site. 
The Hb A-DMP gave a product with a Tm of 56°C. The 
oxy /382XLHb A or a99XLHb A was further treated with DMP to 
produce a double crosslinked hemoglobin, which has a Tm of 
60°C. Thus, the second crosslinking only slightly improved 
the stability by 3°C. The double crosslinked hemoglobins 
are stabilized by l9°C from Hb A compared to l6°C of single 
crosslinked hemoglobins. 
The hemoglobin crosslinked with tris(/3-chloroethyl) 
amine (Hiratsuka T., (1988) Biochemistry 2.]_:4110), has a Tm 
of 49.3°C, and that of hemoglobin treated with BCEA has the 
same stability as Hb A, 4l.3°C. 
The autoxidation of a99XLHb A is markedly faster 
than that of ,882XLHb A or Hb A. 
constant of autoxidation of these 
h-1, Hb A; 0.0269 h- 1 , ,882XLHb A; 
The first order rate 
hemoglobins are 0. 022 
and 0.0393 h-1, a99XLHb 
A. The faster rate of autoxidation of oxy a99XLHb A 
compared to oxy ,882XLHb A or Hb A was due to tertiary 
structure changes by the crosslink on the crosslinked 
hemoglobins. In a99XLHb A the crosslink holds the 
hemoglobin in the T conformation, and in ,882XLHb A, the R 
conformation. 
Cata lase and superoxide dismutase were able to 
retard the autoxidation of both Hb A and its crosslinked 
derivatives, a99XLHb A and ,882XLHb A by 2 fold. These 
results proclaim the importance of autoxidation rate and 
structural stability of crosslinked hemoglobins in the 
design of blood substitutes. 
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STATEMENT OF PURPOSE 
This research began with the hope of discovering a 
method to stabilize unstable hemoglobins and to develop a 
stabilized crosslinked normal hemoglobin which could be 
used as a blood substitute. The search for a hemoglobin-
based substitute is a logical approach to a complex 
problem. 
product 
Crosslinked hemoglobin is practically a natural 
and may minimize immunological risks. By 
crosslinking between the like subunits the hemoglobin 
molecule is locked in the tetramer form and is prevented 
from excretion through the glomeruli of the kidneys. 
Hence, its intravascular retention time in the body is 
increased. 
molecule, 
In introducing a crosslink into the hemoglobin 
there is a possibility that the crosslinked 
hemoglobin could be stabilized against heat, be resistant 
to oxidation, and have unaffected functional properties. 
However, the opposite possibilities must be considered. A 
thermally stabilized cross linked protein could be 
sterilized against unwanted factors by heating. The 
resistance to oxidation will unequivocally prolong the 
storage half-life of the modified protein. While the 
requirements of a successful blood substitute may go beyond 
these primary prerequisites, they are indispensable. 
The goal of this research is not the immediate 
creation of a blood substitute but does represent progress 
xx ii 
toliards its creation. This research proposes two basic 
tests. First, a number of crosslinking compounds will be 
rossl1.nk hemoglobin A The thermal stability of used to c . 
the crosslinked hemoglobins will be determined. Secondly, 
the autoxidation of these crosslinked hemoglobins will be 
evaluated. 
The study on thermal stability consists of three 
parts. Part A, the stability of fumarate /3-/3 and a-a 
crosslinked hemoglobin A will be compared. Part B, the 
stability of the single crosslinking of hemoglobin using 
bis(3,5-dibromosalicyl) fumarate, bis(/3-chloroethyl) amine, 
bis(f3-chloroethyl) methylamine, and dimethylpimelimidate 
will be measured and compared to that of hemoglobin A. 
Part C, the stability of the double crosslinked hemoglobins 
with dimethylpimelimidate will be compared. Cross linking 
within a subunit or between two subunits has the potential 
to lock the three dimensional or the quaternary structure 
of the protein in the conformation which the crosslinking 
took place. Hence, hypotheses that the single crosslink 
could stabilize the native structure of the protein from 
unmodified one, and the double crosslink could also further 
stabilize the single crosslinked protein, were developed. 
The study on the autoxidation of hemoglobin consists 
of two parts. Part A, the rate of autoxidation of fumarate 
crosslinked hemoglobin will be compared to hemoglobin A. 
Part B, the effect of catalase and superoxide dismutase or 
xxiii 
both on the autoxidation of uncrosslinked and crosslinked 
l obin A will be determined. hemog 
A hypothesis in the autoxidation mechanism of 
hemoglobin in which the T state is a step prior to 
oxidation is proposed. Such a mechanism is suggested from 
the autoxidation of /3-/3 and a-a crosslinked hemoglobin. 
Since the autoxidation of hemoglobin was proved to generate 
superoxide radical (02-·) and hydrogen peroxide (H202) (27-
29, 32, 34, 37), such anions generated in the reaction would 
be more damaging to the protein and accelerate the 
oxidation rate. The prevention of oxidative damage to 
hemoglobin could be achieved by enzymes and antioxidants 
(26,36,38,39). The proposal that such a protection by 
enzymes is realizable in the long term storage of 
crosslinked hemoglobin is tested by catalase and superoxide 
dismutase on the crosslinked hemoglobins, since these 
enzymes were known to scavenge H202 and 02-· (42-47). 
Other projects which are of significant importance 
to this research are the identification of the second 
unknown crosslinked product from the a cross linking 
reaction of Hb A with bis(3,5-dibromosalicyl) fumarate by 
amino acid analysis, and its thermal denaturation. A 
preliminary 19F NMR study in which the Cys 93/3 residue is 
labeled with 3-bromo-1,1,1-trifluoropropanone in order to 
probe the conformation of the native and the denatured 
state is included as an appendix. 
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CHAPTER I 
INTRODUCTION 
The introduction of this dissertation will elaborate 
briefly on the structural information of hemoglobin, the 
use of hemoglobin solution as a blood substitute, the 
modification and crosslinking of hemoglobin using chemical 
reagents and the changes in hemoglobin properties due to 
chemical crosslinking. A number of crosslinking compounds 
which are of interest or related to this research will also 
be discussed briefly. Finally, the research on which this 
dissertation is based will be elaborated in detail in the 
experimental, results and discussion chapters. 
HEMOGLOBIN A 
Hemoglobin is the oxygen carrying protein in the 
erythrocyte. Each erythrocyte is packed with 280 million 
molecules of hemoglobin. The roles of hemoglobin are to 
bind molecular oxygen to its heme irons in the lungs, 
deliver it to the various tissues throughout the body and 
transport carbon dioxide from the tissues back to the lungs 
to be exhaled (1). 
Work to determine the hemoglobin structure began 
around 1938 by Bernel et al. (2). It was not until 1960 
when the three dimensional structure of horse hemoglobin 
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was revealed by X-ray crystallography by Perutz et al. (3). 
A molecule of hemoglobin has four polypeptide chains, two a 
and two f3 chains. Each chain contains one heme with a 
molecular weight of 616 daltons. The a chain has 141 amino 
acids with a molecular weight of 15,126 daltons, and the f3 
chain, 146 amino acids and 15,867 daltons. A molecule of 
hemoglobin, therefore, has a molecular weight of 64,450 
daltons. The secondary and tertiary structures of the two 
types of chains are folded in a similar manner; the a chain 
has seven a-helices whereas the f:J chain has eight. The 
helices were named, starting with the N-terminus, A to H 
consecutively (1). 
The heme group is embedded in the globin chain, 
except for the two propianate groups which project out of 
the surface. The heme contained an iron atom at the center 
which plays an important role in ligand binding. The iron 
ion is coordinated to the four nitrogen atoms of the 
pyrrole rings of the heme. The fifth coordination site is 
coordinated to the proximal histidine F8, His 87a or His 
92f:J (4), and the sixth coordination site is the binding 
site for ligands (1). Oxygen can only bind to hemoglobin 
when the iron ion is in the +2 oxidation state. When 
oxygen is bound to hemoglobin, it is known as 
oxyhemoglobin, and the quaternary structure is described as 
a relaxed or R state. The state in which the iron ion 
remained in the +2 oxidation state, but there is not any 
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oxygen bound to it, is known as deoxyhemoglobin, and its 
quaternary structure is described by a tense or T state. 
When the iron ion is oxidized to Fe+3 ' it is called 
methemoglobin, and it is ligated to a water molecule. 
Other anions or ligands can bind to the +2 and +3 oxidation 
state of hemoglobin as well (1). 
The hemoglobin molecule acts in a cooperative manner 
in binding and releasing molecular oxygen, that is the 
binding or releasing of four oxygen molecules to or from 
the four subunits is not independent. The first oxygen 
attaches weakly to one of the heme; the second, third and 
fourth have increasing affinity in their order to the 
hemes. Likewise, the tendency to lose the first oxygen is 
with difficulty. 
comes off easier. 
With the first oxygen lost, the next one 
The interaction mechanisms during these 
transitions are well described (1). The cooperativity of 
oxygenation of hemoglobin was described by the Hill 
equation (5-7) 
Among the numerous small molecules which can bind to 
hemoglobin with physiological relevance were carbon 
dioxide, oxygen, 2,3-diphosphoglycerate (DPG), chloride ion 
and hydrogen ion. These molecules play a very important 
role in the oxygenation mechanism. A proton has a higher 
affinity for deoxyhemoglobin, hence at higher pH the oxygen 
affinity of hemoglobin is higher. This was known as the 
Bohr Effect (1). Carbon dioxide binds to the amino termini 
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of the deoxyhemoglobin molecule to form carbamates and is 
dissociated at the lungs to the less soluble C02 gas to be 
exhaled. DPG binds to deoxyhemoglobin at the amino termini 
of the two f:J chains at the central cavity of the four 
subunits. It is surrounded by eight positive charges, two 
of each, from the /3 amino terminus, His /32, Lys {:182, and 
His {:1143. This binding pushes the two /3 chains farther 
apart, which influences the release of oxygen and 
constrains the hemoglobin molecule in the T state (1). For 
complete references on the three dimensional structure, 
conformational changes, and interactions of amino acid 
residues within the hemoglobin molecule, one is referred to 
Perutz (5,6,8,9), Perutz et al. (10,11), Kendrew et al. 
(12), Heidner et al. (13), Ladner et al. (14), Padlan and 
Love (15,16), and Olsen (17). 
HEMOGLOBIN AS BLOOD SUBSTITUTES 
The development of hemoglobin solution as a blood 
substitute has intensified in recent years as better 
understanding of hemoglobin properties became known. Since 
hemoglobin in solution has the ability to bind oxygen, in 
theory it could be used in place of red blood cells (18). 
The value of hemoglobin as a blood substitute arose 
from four major drawbacks engrossed in whole blood: blood 
for transfusion is limited, blood type must be matched, 
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whole blood could carry infectious agents, and whole blood 
has a low storage half-life. A hemoglobin solution would 
have advantages over whole blood if some of the undesirable 
functional properties could be overcome. This would 
suggest the elimination of the need for cross-matching 
donor and recipient, minimizing any infectious viral 
agents, improving its half-life and stability (18). 
Cell-free hemoglobin in solution does not maintain a 
T state and has higher oxygen affinity than whole blood due 
to the absence of DPG. In solution, hemoglobin exists in 
equilibrium between tetrameric and dimeric forms (19). The 
dimer are readily excreted by the kidneys within 2-4 hours. 
Hemoglobin in solution exerts a colloidal oncotic pressure 
which limits it at lower concentration of 7 g/dL compared 
to intraerythrocytic concentration of hemoglobin at 30 g/dL 
(18). Hence, modification of hemoglobin is necessary for 
improving 
hemoglobin. 
these disadvantages inherent in cell-free 
The modification and crosslinking of hemoglobin with 
an external reagent manifests two major principles. The 
first principle is to achieve a molecular engineering which 
would produce an active stabilized protein. Recent 
interest was focussed in crosslinking and modifying the 
structure of Hb S to produce a modified protein which would 
be stable and resistant to polymerization when in the deoxy 
form (20-30). The second principle in modification of 
5 
hemoglobin is to develop a suitable hemoglobin derivative 
for clinical use as a blood substitute (26-32). 
The interest in using hemoglobin as blood substitute 
in recent years was focussed in modified hemoglobin 
products. 
hemoglobin 
The consideration in obtaining suitable 
currently solution as blood substitute is 
concentrated in improving its half-life, lowering its 
oxygen affinity to match that of whole blood, preventing 
autoxidation, defining the molecular changes chemically, 
assessing the degree of modification, improving the methods 
and procedures in modification, feasibility in 
pharmaceutical consideration, and assessing any adverse 
effects responded by the immune system to the modified 
hemoglobin (18). 
The prospect for overcoming the limitations inherent 
in cell-free hemoglobin engrosses two basic approaches: 
molecular modification of hemoglobin, and environment 
modification (18). Molecular modification involves the use 
of a modifying agent or cross 1 inking agent to react with 
hemoglobin either intermolecularly or intramolecularly to 
form dimeric or polymeric species. This approach has the 
potential to stabilize the hemoglobin molecule in the 
tetrameric form, possibly increasing the half-life, and 
preventing autoxidation. The environmental modification 
requires that hemoglobin be encapsulated within liposomes 
in the presence of DPG. This approach was investigated by 
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Chang (33), and Djordjevich and Miller (34). The present 
inV'estigation 
of hemoglobin. 
lies in the realm of molecular modification 
PERFLUOROCHEMICALS AS BLOOD REPLACEMENT 
Perfluorochemicals (PFC) are fluorinated 
hydrocarbons, in which most of the hydrogens are replaced 
by fluorines. Perfluorochemicals received a great deal of 
attention as a potential blood replacement (35). 
Perfluorochemicals are not antigenic. The emulsion of 
perfluorochemicals can dissolve oxygen up to 70% per unit 
volume (36,37), and their sizes are very small compared to 
the red blood cells and could pass through occluded blood 
vessels. 
Despite the enthusiasm in perfluorochemicals as 
blood replacement, the major failure was that when PFC's 
were given to patients they accumulate in the 1 i ve r and 
spleen to the point that these organs were not able to 
clear other foreign substances (38). The Food and Drug 
Administration has disapproved PFC's use for these reasons, 
and they are generally regarded as unsatisfactory blood 
replacement (39). 
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REAGENTS RECENTLY USED IN MODIFICATION AND CROSSLINKING OF 
HEMOGLOBINS 
The crosslinking of hemoglobin was shown by Bunn and 
Jandl in 1968, using bis(N-maleimidomethyl) ether (40). 
This hemoglobin derivative had high oxygen affinity (P50, 3 
mmHg). Subsequent work by Benesh et al. (31), using 
pyridoxal phosphate, obtained a modified hemoglobin which 
exhibited lower oxygen affinity (P50, 26-30 mmHg). 
Greenburg and Maffuid (41) showed that the dialdehyde of 
ATP (2'-o-[(R)-formyl- (adenine-9-yl) methyl]-3'-
triphosphate-3'-deoxy-(S)-glyceraldehyde could react with 
hemoglobin to yield a derivative with P50 of 11 mmHg (18). 
The modification of hemoglobin was investigated by 
several workers using various reagents to modify the 
structure of hemoglobin A, and hemoglobin S. Studies, upon 
which this research is based, were done with aspirin 
derivatives 
imidoesters 
(20-23), 
(45-48). 
nitrogen mustards 
The related aspirins 
(42-44), and 
were bis(o-
carboxyphenyl) succinate (25), acetyl-3,5-dibromosalicylic 
acid (24), mono-3,5-dibromosalicyl fumarate (49), bis(3,5-
dibromosalicyl) succinate, glutarate, adipate, and fumarate 
(26-30); and the imidoesters were dimethylpimelimidate 
(DMP) (46,48,50), dimethylsuberate (DMS) (46), and dimethyl 
adipate (DMA) (45,47). Others which were of interest were 
4,4'-diisothiocyanostilbene-2,2'-disulfonate (DIDS) (19)' 
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and 1
'
5-difluoro-2,4-dinitro benzene (51). The nitrogen 
mustards were tris(,8-chloroethyl) amine (TCEA) (43), and 
bis ( .B- chloroe thyl) me thylamine ( BCEA) ( 42, 44) . BCEA was 
known to react with hemoglobin (42 ,44), and TCEA has been 
used to crosslink three subunits of adenosine-
triphosphatase (ATP-ase) (43). 
The crosslinking of hemoglobin with imidoesters 
(DMA, DMS, DMP) (45-48) resulted in intrasubunits as well 
as intersubunits crosslinking. It was demonstrated that 
the imidoesters crosslinked hemoglobin in both the oxy and 
met forms to give intersubunit crosslinked species of 
molecular weight equivalent to dimers, trimers, and 
tetramers (45-48). The dimer species obtained were 
predominant compared to the trimers and tetramers. 
Polymeric species were formed as well if the reagent 
concentration was much higher than hemoglobin (48). Random 
crosslinking of the hemoglobin molecule by imidoesters 
occurred, and hence, a heterogeneous species was obtained. 
Such a heterogeneous species was difficult to purify to 
homogeneity (45-48). The amidinated hemoglobin had 
increased oxygen affinity (47). 
The crosslinking loci for several reagents which are 
of interest and directly related to this research are 
tabulated in Table 1. The use of crosslinking to effect 
the hemoglobin properties remained of interest, and 
abundant opportunity to be explored. 
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Table 1: 
The known loci of crosslinking 
hemoglobin with various crosslinking 
this research. 
and modification 
compounds related 
Reagents 
BBSF 
Aspirins 
PLP 
NFPLP 
PLS 
DPL 
PPP 
DMP 
TCEA 
BCEA 
DIDS 
DMA 
State of Hb 
in Reaction 
Crosslink and/or 
modified loci 
Oxy 
Deoxy 
Oxy 
Deoxy 
Deoxy 
Oxy 
Oxy 
Deoxy 
Oxy 
Oxy 
Oxy 
Oxy 
Deoxy 
met/oxy 
Lys 82fi1 to Lys 82fi2 29 
Lys 99a1 to Lys 99a2 28 
Lys 59fi, Lys 144fi, Lys 90a 22 
P N-termini 92 
fil N-terminus to Lys 82fi2 92 
a N-termini 92 
a N-termini 92 
fi1 N-terminus to Lys 82fi2 32 
c-Amino lysine residues 92 
Lysine and cysteine residues 43 
Lysine and cysteine residues 
suggested: His 2fi, His 97fi, 
His 143fi, His 146fi 44 
modified at Lys 82fi's 19 
Pl N-terminus to fi2 N-terminus 19 
c-Amino lysine residues 
known: Lys 7a1 to Lys lla1 
Lys 82fi1 to Lys 82fi2 47 
in 
to 
Abbreviations: BBSF bis(3,5-dibromosalicyl) fumarate, 
PLP pyridoxal-5'- phosphate, NFPLP 2-nor-2-formyl 
pyridoxal-5'-phosphate, PLS pyridoxal-5'-sulfate, DPL-
5' -deoxypyridoxal, PPP - bis-pyridoxal polyphosphate, DMP-
dimethylpimelimidate, TCEA tris(fi-chloroethyl) amine, 
BCEA bis(fi-chloroethyl) methylamine, DIDS 4,4'-
di iso thiocyanos ti lbene -2, 2' -disulfonate, DMA-
dimethyladipimidate. 
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PYRIDOXAL PHOSPHATES CROSSLINKING OF HEMOGLOBIN 
Pyridoxal phosphate and a number of its derivative 
compounds had been used to crosslink hemoglobin (31,32,92). 
The reaction of pyridoxal-5'-phosphate (PLP) with 
hemoglobin under deoxy conditions resulted in modification 
of the f3 chains at the N-terminal amino groups and in 
decreased oxygen affinity. A second derivative, 2-nor-2-
formyl pyridoxal-5'-phosphate (NFPLP), crosslinked deoxy 
hemoglobin between the N-terminus of /31 and the lysine 82/32 
(31,92). Other pyridoxal derivatives such as, pyridoxal 
5' -sulfate (PLS), pyridoxal-5' -methyl phosphate (PMP), 
pyridoxal-5'-phosphate monomethyl ether (PME), and 5'-deoxy 
pyridoxal (DPL) were known to modify the a chains at the N-
termini under oxy condition (31,92), and these hemoglobin 
derivatives had increased oxygen affinity. The negative 
charge from the phosphate group of the pyridoxal compounds 
has an electrostatic interaction with the positive charges 
from the amino acid residues in the DPG cleft, and this 
effect stabilized the T state which mimics closely the 
effect of DPG on hemoglobin (92). 
Recently, a new class of bis-pyridoxal polyphosphate 
compounds were developed to crosslink deoxyhemoglobin (32). 
The crosslinking site was found between the amino terminus 
of a f3 chain and the lysine 82 of the other f3 chain, as in 
the case for NFPLP crosslinking (32). The yield of 
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crosslinked hemoglobin varied with different derivative 
compounds. These crosslinked hemoglobins had decreased 
affinity for oxygen and still retained cooperativity (32). 
Two pyridoxalated crosslinked hemoglobins which are 
of interest were the polymeric species double crosslinked 
by glutaraldehyde (18) and bis(3,5-dibromosalicyl) fumarate 
(BBSF) (18). In reacting glutaraldehyde to pyridoxalated 
hemoglobin crosslinked with pyridoxal-5'-phosphate (PLP) 
produced several polymeric species of molecular weight up 
to 96,000 daltons (18). The polymerized pyridoxalated 
hemoglobin still retained a cooperative mechanism in 
binding oxygen and had lower oxygen affinity compared to 
unmodified hemoglobin, its pSO value was 32 mmHg while that 
of whole blood was 29 mmHg. At a given concentration, this 
polymerized pyridoxalated hemoglobin exerted a lower 
osmotic pressure compared to unmodified hemoglobin (18). 
In view of the oxygen binding properties of pyridoxalated 
crosslinked hemoglobins which exhibited low oxygen binding, 
the goal of using these crosslinked hemoglobins as blood 
substitute is realizable. 
ACETYLATION OF HEMOGLOBIN WITH ASPIRIN 
In 1963 Klotz and Tam discovered that aspirin could 
be used to acetylate Hb S (20). Subsequent reaction with 
hemoglobin using aspirin was further studied to investigate 
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the anti-sickling and oxygen binding properties (21). This 
investigation further proved the acetylation of hemoglobin 
with aspirin. The acetylation sites were thought to be 
either at the N-termini of the a chains as in the case of 
cyanate (52) and at the €-amino group of lysyl residues as 
those in serum albumin (53). 
A more detailed study of acetylation of hemoglobin 
by aspirin was done by Shamsuddin et al. (22). These 
investigators discovered that aspirin acetylated hemoglobin 
randomly, but at least three main sites were the loci where 
the majority of acetyl groups attached. These were the Lys 
59fi, Lys 144fi, and Lys 90a. This study led to the 
suggestion of the development of other acyl salicylate 
derivatives as potential anti-sickling agents. The 
investigation by Shamsuddin et al. (22) proved that aspirin 
slightly prevents gelling of hemoglobin S. The work by 
Klotz and Tam (20), and Bridges et al. (23) indicated a 
slight increase in oxygen affinity for the modified 
hemoglobin. The modification of hemoglobin by aspirin led 
to a number of acyl compounds which proved to be more 
potent in the crosslinking of hemoglobin. 
ACETYLATION OF HEMOGLOBIN WITH ASPIRIN DERIVATIVES 
Walder et al. (24) used acetyl-3,5-dibromosalicylic 
acid to acetylate Hb S and found essentially the same 
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effect as the work previously done by Klotz and Tam (20), 
shamsuddin et al. (22), and Bridges et al. (23), except the 
incorporation of acetyl groups into hemoglobin was more 
effective, that is the percent of modification increased 
significantly at a given molar ratio of reaction compared 
to aspirin. 
Zaugg et 
compound 
salicylic 
from 
acid. 
al. (25) synthesized a bifunctional 
aspirin, using succinyl chloride and 
This reagent, succinyl 
found to crosslink hemoglobin up to 50% 
disalicylate, was 
and yielded only 
dimeric and monomeric species. This indicated that the 
crosslinking may be intramolecular and selective at a 
specific site on the hemoglobin molecule. 
The interest in diaspirin compounds as crosslinkers 
intensified. During 1979 and 1980 Walder et al. (29,30) 
developed a series of di ester compounds, namely the 
derivatives of aspirin: bis(3,5-dibromosalicyl) fumarate, 
succinate, glutarate and adipate. These reagents were 
first used to crosslink oxyhemoglobin between the Lys 82P1 
and Lys 8 2Pz. The structure, oxygen binding properties, 
and solubility of the p crosslinked hemoglobins A (p82XLHb 
A) and S (P82XLHb S) were examined (27). In the absence of 
DPG the p82XLHb A had oxygen affinity slightly higher than 
or the same as the uncrosslinked Hb A. The presence of DPG 
did not affect the oxygen affinity of the p82XLHb A. 
However, in the presence of DPG the oxygen affinity of Hb A 
14 
(P50• 12.2 mmHg) was much less than that of the p82XLHb A 
(P 50 , 3.3 mmHg) (29). 
The examination of the structure of the crosslinked 
hemoglobin revealed that there was no overall structural 
changes. However, local perturbation occurred around the 
crosslink in the DPG binding cavity. This perturbation 
caused the P F helix, the ~ EF corner, His 143p and the p 
amino termini to move s 1 i gh t ly toward the center of the 
cavity ( 2 9) This finding became an important 
consideration in blocking sickling in Hb S. 
When reacted with deoxyhemoglobin bis(3,5-
dibromosalicyl) fumarate had the ability to crosslink 
selectively between the a chains between Lys 9901 and Lys 
9902 (28). The Hb A derivative crosslinked between the a 
chains (o99XLHb A) had oxygen affinity lower than the 
uncrosslinked Hb A and similar to that of the whole blood. 
Under closely matched physiological condition the P50 of 
a99XLHb A was 29 mmHg compared to 12 mmHg for Hb A (26), 
and 29 mmHg for whole blood (18). Despite the presence of 
the crosslink in the hemoglobin, both a and p crosslinked 
hemoglobins remained highly cooperative in binding oxygen 
(27-29). The P50 value and the Hill coefficient in 0.05 M 
Bis-Tris, 0.1 M NaCl, pH 7.0 at 25°C for hemoglobin 
derivatives were reported as in Table 2. 
By crosslinking between the two Lys 82P's in Hb S 
the solubility of deoxy Hb S was increased (27). The 
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solubility of deoxy a9 9XLHb s apparently arose from the 
turbation of the Val-6p acceptor site which constituted per 
the residues Phe-85P and Leu-88p at the start of the F 
helix. By small displacement of the F he 1 ix tow a rd the 
central cavity these residues were dragged along. Hence, 
they were less accessible to interact with Val-6 at the 
surf ace tetramer. By increasing the length of the 
crosslink span from four carbons to five and six carbons 
progressively reduced the magnitude of the perturbation, 
and consequently, the solubility of deoxy a99XLHb s 
decreased approaching that of uncrosslinked Hb S (27). 
Kikugawa (54) had used bis(3,5-dibromosalicyl) 
fumarate to crosslink asymmetrical hybrid hemoglobins 
between the P chains in hemolysate containing Hb A and S, 
and Hb S and Hb York (Hb Y) (54). The stability by 
mechanical shaking of both symmetrical crosslinked Hb A 
(p82XLHb A) and crosslinked Hb York (P82XLHb Y) improved 
slightly over the uncrosslinked hemoglobins A and York, and 
both the asymmetrical hybrid crosslinked Hb AS (82P1A 
82pzS XLHb) and crosslinked Hb YS 
improved over both the uncrosslinked Hb S and symmetrical 
crosslinked Hb S (p82XLHb S). However, the symmetrical 
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Table 2: 
The Hill coefficient (n) and Pso (mmHg) values of Hb A 
and crosslinked Hb A in O.OS M Bis-Tris, 0.1 M NaCl, pH 7, 
at 2S °C. 
H..emo glob in !:so !:so'# 
Hb A 4.0 11.8 2.7 a 
p82XLHb A 2.8 2.8 2.3 b 
a99XLHb A 13.9 29.0 2.6 c 
Whole blood 29.0 d 
Hb S 4.2 10.0 2.9 e 
p82XLHb S 2.S 2.6 2.S f 
Hb A-DMA 0.36 3.7 1.8 g 
* -No DPG present; # -DPG present in 2 mM; a, b, e and f-
from Kikugawa (S4); c -from Chatterjee (28); d -from Bolin 
(18), g -from Pennathur-Das (47). 
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crosslinked Hb S had the same mechanical stability as the 
ro sslinked Hb S (54). unc 
By intramolecular crosslinking between either the a1 
and a 2 or the P1 and P2 chains within a molecule of 
hemoglobin the crosslink prevents the hemoglobin from 
dissociation into ap dimers and hence increased its 
intravascular life while it was used in transfusion in rats 
( 28) . 
The use of uncrosslinked hemoglobin as a blood 
substitute entails two limitations. First, hemoglobin 
dis soc ia te s to ap dime rs and is fi 1 te red through by the 
glomerulus of the kidneys, and secondly, hemoglobin in 
solution has inherently higher oxygen affinity due to the 
absence or very low concentration of DPG. It is reasonable 
that such limitations could be overcome by crosslinking the 
hemoglobin molecule in such a way that the hemoglobin 
molecule could be locked into the tetramer form, and the 
oxygen affinity is low, as in the a crosslinked hemoglobin 
(28). In p82XLHb A the DPG binding site is blocked and its 
conformation favors high affinity for oxygen, thus its 
difficulty in transferring oxygen may limit its use as a 
blood substitute. On the other hand, in a99XLHb A the 
oxygen affinity is similar to whole blood (28). Hence the 
transfer of oxygen would be regulated closely as that of Hb 
A in the presence of DPG. 
Snyder et al. (26) had used a99XLHb A to replace 
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15% of blood volume in rats (Sprague-Dawley rat) and 
about 
found that the intravascular retention time had increased 
by about 2 times that of the control experiments using 
uncrosslinked Hb A solution. Hemoglobin A had a half-life 
of 90 minutes compared to 3 hours that of a99XLHb A (26). 
Because of the ability of the crosslink to hold the 
hemoglobin in the tetramer form, the crosslinked hemoglobin 
was not readily eliminated by the kidneys. The increasing 
size of the a99XLHb A molecule cross linked with 
bis(sulfosuccinimidyl) suberate to trimers was shown to 
prevent renal excretion of the modified hemoglobin even 
further (26). Met a99XLHb A was transfused in rats and 
found to be reduced in the intravascular system (26). This 
suggested that either the methemoglobin reductase or 
another enzyme system in the rats was sufficient to reverse 
the oxidation of crosslinked hemoglobin. 
OTHER REAGENTS WHICH WERE DESIGNED TO REACT WITH HEMOGLOBIN 
IN THE DPG RINDING SITE 
Among other reagents which were designed to react 
with hemoglobin in the DPG binding site at the lysyl 
residues or at the amino termini, included 4,4 1 -
diisothiocyanostilbene-2,2 1 -disulfonate (DIDS) (19), hybrid 
acylaldehyde derivatives of oxalate, malonate, fumarate, 
glutarate, 5-forrnylsalicylacetate (55), and 5-(2-formyl-3-
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bydroxyphenoxy) pentanoic acid (BW12C) (56). 
Aliphatic carbonyl compounds such as, acetaldehyde, 
glycoaldehyde, glyoxalic acid, glyceraldehyde, 
dihydroxyace tone ( 5 7) , methyl ace tyl phosphate ( 5 8) , and 
glutaraldehyde (59) also could be used to react with lysine 
residues on the hemoglobin molecule. The monoaldehyde or 
bisaldehyde either modifies a lysyl group or crosslinks 
between two lysines to form a Schiff base or an amide 
linkage (55). A common properties of these reagents rest 
upon their randomness in reaction with hemoglobin. 
Therefore, it was difficult to assess the oxygen binding 
properties due to difficulty in isolation of a homogeneous 
species. Nevertheless, hemoglobin treated with dimethyl 
adipimidate without purification, a reagent which was known 
to react with hemoglobin to produce heterogeneous species, 
showed increased oxygen affinity (47). 
AUTOXIDATION OF HEMOGLOBINS 
Oxyhemoglobin in the body or in solution undergoes 
autoxidation in which the is oxidized to F 3 
resulting in methemoglobin. However, in the body the level 
of methemoglobin remains constant at 1% due to the 
reduction of methemoglobin to oxyhemoglobin by the 
methemoglobin reductase, NADH-cytochrome b5 reductase 
system (60). When oxyhemoglobin is oxidized to 
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methemoglobin it is no longer able to bind dioxygen. One 
of the requirement for the successful use of hemoglobin as 
blood substitute is the prevention of autoxidation. This 
could be achieved by the presence of enzymes or 
antioxidants in the hemoglobin solution, which act as 
superoxide and hydrogen peroxide scavengers since these 
ions are the products of autoxidation which were known to 
accelerate the autoxidation rate (61-65). 
The autoxidation of isolated a and fJ chains 
indicates that the a chain autoxidized faster than the f3 
chain, and that the rate of autoxidation was affected by 
oxygen pressure (66) and pH (67). The oxidation rate 
decreased as the pH or oxygen pressure increased (66). 
This same relationship holds true for the tetramer 
hemoglobin as well (68). However, the rate of autoxidation 
increased at either very low pH or at very high pH (67,69). 
In the presence of allosteric anions such as DPG and 
inositol hexaphosphate (IHP) the individual subunit 
autoxidized faster than in conditions in which these anions 
were absent (70). Deoxy hemoglobin A was found to be 
oxidized at a faster rate than oxy hemoglobin A and 
carbonmonoxyhemoglobin A (68,70). 
Enzymes which were often used to reduce the 
autoxidation of hemoglobin were catalase and superoxide 
dismutase (SOD) (61,62,65,71,72). A number of antioxidants 
were also found to be potent in the protection of 
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t X idation of hemoglobin (62-65,71). au o 
In aqueous solution saturated with dioxygen the 
oxidation potential for Fe+ 2 to Fe+ 3 is 0.46 V (73), 
whereas the redox potential of hemoglobin is 0.15 V (74). 
The free heme (Fe+ 2 ) in solution oxidized immediately to 
bematin (Fe+ 3 ) (75). Thus, the tendency for Fe+2 to be 
oxidized to Fe+ 3 is favored over the reverse process. The 
resistance to oxidation of heme in hemoglobin and myoglobin 
was due 1 ar ge ly to the coordination of the iron to the 
proximal histidine F8, the steric hindrance from the distal 
histidine E7 (His 63{3, His 58a:) (4) of the globin chain, 
and the hydrophobic environment encapsulating the heme, 
discriminating water molecule and other ions to react at 
the iron center (76). These properties were suggested by 
the picket fence synthetic heme models which were able to 
bind oxygen reversibly (76). 
A discussion of the autoxidation mechanism at the 
molecular level may help to bring about better 
understanding of the effect of enzyme such as catalase and 
superoxide dismutase. The autoxidation of hemoglobin 
resulted in the production of superoxide radical (02-·) and 
H202 which are believed to cause damage to cell membrane 
and tissues in the body (61,116). Misra and Fridovich (61) 
proved that 02 · · was produced during the autoxidation of 
oxyhemoglobin to methemoglobin. Several mechanisms of 
autoxidation were proposed (61,67-69, 71,77). It was 
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thought that the dioxygen was bound to the and one 
e lec tr on from the Fe+2 was transferred to the 02 in which 
the species became a superoxo-ferriheme (Fe+3~02-) complex 
( 61) . 
An investigation of the effect of anion-promoted 
autoxidation of myoglobin (Mb) suggested a 
nucleophilic attack by an anion (L-) at the iron center in 
which an intermediate complex [Mb-Fe+ 2 (02)(L-)] was formed 
( 77). In biological systems the anions accessible for such 
a reaction were and c1- (68,77-79). Kinetic 
experiments using several factors, such as pH, anions, and 
temperature, to effect the rate of oxidation of either 
myoglobin or hemoglobin were investigated by several groups 
of scientists (67-69,71,80). These investigations revealed 
that the mechanism of autoxidation of these proteins was 
much more complex than the simple models presented above by 
Satoh and Shikama (77), and Misra and Fridovich (61). 
Nonetheless, the autoxidation mechanism proposed by Wallace 
et al. (68), and Watkins et al. (71) appeared to be 
reasonable. Such a mechanism is presented below: 
Hb.Fe(II)02 ;:!: Hb.Fe(II) + 02 
Hb.Fe(II) + H+ ;:!: Hb.Fe(II)(H+) 
Hb.Fe(II)(H+) + 02 ;:!: Hb.Fe(III)H20 + (H+)o2·-
Hb.Fe(II)02 + 2H+ + 02· - + H20 -+ Hb.Fe(III)H20 + 02 + H202 
Hb.Fe(II) + H202 + H20 -+ Hb.Fe(III)H20 + OH- + HO· 
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Hb.Fe(II) + HO· + HzO Hb.Fe(III)HzO + OH-
where Hb02 and Hb represent oxy and deoxy hemoglobin 
respectively with a single heme center for simplicity. 
Based upon this autoxidation mechanism the effect of 
catalase and superoxide dismutase on the autoxidation of 
hemoglobin could reasonably be explained since they 
eliminate the peroxide and superoxide intermediates. 
HEMOGLOBIN IN LIPOSOMES 
To make a blood substitute in the form of hemoglobin 
containing liposomes (hemosomes), some investigators have 
used saturated and unsaturated phospholipids to 
encapsulated hemoglobin. The rate of oxidation of 
hemoglobin in the unsaturated liposomes was faster than the 
one in the saturated liposomes. This oxidation was caused 
by the lipid peroxidation products (65). Nonetheless, 
protective agents could be added and the rate of oxidation 
was reduced (65). 
Recently, Jopski et al. (81) had prepared hemosomes 
containing inositol hexaphosphate, in which the oxygen 
dissociation (P50, 32. 1 mmHg) was found to be nearly the 
same as that of whole blood, (P50, 27.1 mmHg) (81). The 
shelf-life of this type of encapsulated hemoglobin was 
promising. Storage of these hemosomes at 4°C for 300 days 
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resulted in only 14% methemoglobin (81). In view of these 
preliminary discoveries of hemoglobin liposomes, they 
exhibit potential use as a blood substitute. An interest 
in encapsulated crosslinked hemoglobin has yet to be 
manifested, and its properties remained to be explored as 
blood substitute in the future. 
THERMAL DENATURATION OF HEMOGLOBIN 
The assessment of thermal stability of a protein can 
be obtained as the melting temperature, the free energy, 
enthalpy, and entropy of denaturation. Thermal 
denaturation can lead to important structural information, 
such as the mechanism of denaturation and the reasons for 
the stability of the native structure. A denatured state 
is defined as a major conformational change from the native 
state of globular proteins without any alteration of the 
amino acid sequence (82). Thermal denaturation of proteins 
may be reversible or irreversible depending on the protein 
in consideration and the conditions used. A reversible 
denaturation would be one in which the native structure is 
recovered after denaturation (82). 
The thermal denaturation of hemoglobin A and 
crosslinked hemoglobin A (/382XLHb A) was investigated by 
White and 01 sen ( 8 3 ) . Subsequent investigation of the 
denaturation of carbonmonoxyhemoglobin A (CO-Hb A), 
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carbonmonoxyhemoglobin S 
(CN-Hb A), hemoglobin 
(CO - Hb S) , 
New York 
cyanomethemoglobin A 
(Hb NY), and their 
crosslinked derivatives of the ,882XLHb were examined by 
Yang and Olsen (84,85). The denaturation of hemoglobins 
under these conditions was irreversible. The denaturation 
state of these hemoglobins was thought to be a highly 
disordered state in which the heme may or may not be intact 
in the globin chain. The order of thermal stability of 
methemoglobins A, S, and A2 (86) was S <A< A2 (84,87). 
The stability of metHb A (metHb A) and its fumarate 
crosslinked derivatives as characterized by the melting 
temperature (Tm) were 41°C for metHb A, 
~82XLHb A (83-85). 
57°C for met 
The thermal transitions of imidoester crosslinked 
hemoglobins were somewhat broader due to heterogeneous 
species present during denaturation, and their stability 
was lower. 
increased 
However, 
depending 
the 
on 
stability of these 
the conditions 
hemoglobins 
during the 
cross linking reactions (i.e. at higher pH or higher 
concentration of reagent). A reaction condition in which 
the pH was 9.5 and a molar ratio of reagent to hemoglobin 
was 1000:1, produced crosslinked hemoglobins which have the 
highest Tm's for these hemoglobin derivatives and were 
comparable to those of fumarate crosslinked hemoglobins. 
The stability 
HbA-DMP 57.0°C 
of HbA-DMA was 51.5°C, HbA-DMS 55.4°C, and 
( 48) . A summary of the Tm's of crosslinked 
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hemoglobins determined previously 
sented in Table 3. pre 
The thermal denaturation of 
in this 
protein 
laboratory is 
is clearly a 
valuable 
proteins. 
method in distinguishing the stability of 
This could lead to information such as what 
crosslinking reagents could stabilize the protein structure 
the most, and at what temperature the modified protein 
could be heated without 
protein. 
causing denaturation to the 
CATALASE AND SUPEROXIDE DISMUTASE: A BRIEF OVERVIEW 
In order to understand the prevention of oxidative 
damage to hemoglobin by catalase and superoxide dismutase, 
it is necessary to present the known and proposed 
mechanisms of disproportionation of hydrogen peroxide 
(H202) and superoxide radical by these enzymes. It is of 
interest and possibly of great value to use enzymes and 
antioxidants for the protection of hemoglobin in a blood 
substitute. 
Catalase is a heme containing enzyme present in 
erythrocytes as well as in the tissues of kidney and liver 
( 8 8) . It exists in a tetrameric form, a2P2, and has a 
molecular weight of 240,000 daltons. 
catalyze the reaction (88,89): 
Catalase was known to 
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Table 3: 
The Tm values of crosslinked methemoglobins and mutant 
hemoglobins determined previously in this laboratory, from 
the soret band, 406 nm. 
met Hb I.m ( 0 c) 
Hb A2 43.5 a 
Hb A 41. 8 a 
,882XLHb A 56.6 a 
HbA-DMA 51. 5 b 
HbA-DMP 57.0 b 
HbA-DMS 55.4 b 
Hb s 39.6 a 
,882XLHb s 56.0 a 
Hb NY 40.9 a 
,882XLHb NY 55.7 a 
Hb Andrew-Minneapolis 40.9 a 
Hb 0 Indonesia 39.6 a 
a Yang, T., (86); M.S. Thesis, Loyola Univ. of Chicago, 
Chicago. 
b Corso, T. D., (48); M. S. Thesis, Loyola Univ. of 
Chicago, Chicago. 
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Superoxide dismutases (SOD) are metal containing 
enzymes distributed throughout the various tissues of 
aerobic organisms; they exist in the form of either a dimer 
or tetramer. 
and Mn. The 
The metal ions bound to SOD were Cu, Zn, Fe, 
copper (Cu+2) and zinc (zn+2) containing SOD 
is a dimer containing one of each copper and zinc per 
subunit and has a mo le cular weight approximately 3 2, 000 
daltons; those containing iron and manganese have molecular 
weight up to 97,000 daltons (90). The physiological 
function of SOD is to provide protection for an organism 
from deleterious effect of the very reactive 02·- generated 
in the biological systems (88) by catalyzing the reaction 
( 8 9) : 
The role of the zinc ion in SOD is attributed to 
mostly maintaining stability and organization of the 
protein and is not directly involved with the catalytic 
processes. The zinc and the copper centers within a 
subunit is spanned by a histidine residue (His 61) which 
separated the two by 6 A (90). The copper ion center 
served as the catalytic center for this enzyme. An overall 
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mechanism involving the copper center was thought to be as 
( 91) : 
In light of these catalytic reactions by catalase 
and SOD and the proposed autoxidation mechanisms, it may be 
possible now to explain why catalase and SOD or 
antioxidants could provide protection against oxidative 
damage to hemoglobin. Furthermore, hemoglobin in a blood 
substitute may need these enzymes to be protected against 
oxidative damage. 
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I. 
A. 
MATERIALS 
CHEMICALS 
CHAPTER II 
MATERIALS AND METHODS 
DEAE-Sephadex A-50 gel was obtained from Pharmacia 
Fine Chemicals; tris(hydroxymethyl) aminomethane 
hydrochloride (Tris), 4-morpholinepropane sulfonic acid 
(MOPS), glycine, acrylamide, N,N'-methylene-bis-acrylamide, 
bromphenol blue, ammonium persulfate, N,N,N',N'-
tetramethylethylenediamine (TEMED), Arnberlite MB-3, 
Sephadex G-25 gel, SOS protein markers (Dalton mark VII), 
catalase, and superoxide dismutase, from Sigma Chemical 
Co.; sodium cyanide, ammonium sulfate, sodium hydroxide, 
urea, and sodium phosphate, from J. T. Baker Chemical Co.; 
magnesium chloride, potassium ferricyanide and sodium 
chloride from Mallinckrodt, Inc.; dimethylpimelimidate, 
guanidine hydrochloride, trifluoroacetic acid, and sodium 
dodecylsulfate (SOS), from Pierce Chemical Co.; f3 -
mercaptoethanol, from CalBiochem.; Hydrochloric acid, and 
glacial acetic acid, from Fisher Scientific Co., N,N-
dimethylanaline, N ,N-dimethyl formamide, fumaryl chloride, 
tris(f3-chloroethyl) amine, bis(f3-chloroethyl) methyl amine, 
thionyl chloride, 3,5-dibromosalicylic acid, deuterium 
oxide from Aldrich Chemical Co. Inc.; deuterated dimethyl 
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sulfoxide from Stohler Isotope Chemicals; carboxymethyl 
c e l l u 1 0 s e ( CM 5 2 ) , from What man Ltd . ; and 3 - bro mo - 1 , 1 , 1 -
trifluoropropanone, from PCR Inc.; PHAB buffer, Amido Black 
lOB, alkaline agarose gels from Corning Medical; 0.2 M 
sodium citrate pH 2. 2, from Beckman; acetone and benzene 
were distilled from reagent grade. 
B. INSTRUMENTS 
The instruments used were: a Hewlett-Packard (HP) 
8451A UV/VIS diode array spectrophotometer, HP-7470A 
plotter, HP-9121 disc drive, NESLAB endocal refrigerated 
circulating bath RTE-9, 
3, NESLAB digital 
NESLAB temperature programmer ETP-
contro 11 er/readout DCR-4, Omega 
temperature indicator, Orion research digital pH meter, 
water bath (Blue M Electric c 0. ) ' ISCO UA-5 
absorbance/fl uore scence de tee tor, IS CO ge 1 scanner mode 1 
1312, ISCO Tris peristaltic pump, thermometer (Sargent), 
Varian VXR 300 MHz NMR spectrometer, 5 mm NMR tubes (Wilmad 
Glass Co. Inc. ) , and Sorval 1 RC- 5 B re fr igera ted super speed 
centrifuge (Dupont), small centrifuge 5414 (Eppendorf), 
Eppendorf pipettes, Sonicator 1200 (Branson), Vortex-Genie 
(Fisher Scientific), Columns (Bio-Rad Lab.), conductivity 
bridge mode 1 31, power supply mode 1 PS -4 (Heath Co.) , DC 
power supply model PS SOOXT (Hoefer Scientific 
Instruments), power supply model HV 1000, speed vacuum 
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Rota-Vapor (Savant Instruments Inc.), SDS slab gel 
electrophoresis unit SE250 (Hoefer Scientific Instruments), 
d clinical electrophoresis equipments (Corning Medical), a.n 
Beckman Microcolumn Amino Acid Analyzer Model 121M 
(Northwestern Children's Memorial Hospital). 
II. CHEMICAL SYNTHESIS 
The synthesis of bis(3,5-dibromosalicyl) fumarate 
was done according to the method of Zaugg et al. (25). In 
a three-necked 250 mL round bottom flask containing 50 mL 
of dry benzene was added 3.776 g (0.0128 mole) of 3,5-
dibromosalicylic acid, and 3.213 mL (0.0253 mole) of N,N-
dimethyl aniline (d, 0.956 g/mL). The solution was stirred 
slowly to allow homogeneity for 1 minute with a magnetic 
stirring bar. To this solution 0.675 mL (0.0062 mole) of 
fumaryl chloride (d, 1.415 g/mL) was added slowly with 
stirring. Upon completing addition of fumaryl chloride the 
solution was one phase and turned reddish brown. After 
three hours of stirring at room temperature 15 mL of water 
was added, and the solution was acidified with one or two 
drops of 12 M HCl. Upon increasing mixing speed a large 
amount of precipitate was readily observed in a two phase 
system. The stirring was continued for 20 minutes. The 
product was washed via suction-filtration three times with 
benzene and was twice recrystallized from minimum 50:50 hot 
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water-ace tone mixture. The crystalline product had a 
melting point of 226-228°C. 
Ill. PREPARATION OF HEMOGLOBIN 
Hemoglobin was prepared from outdated packed Red 
Blood Cells (RBC) obtained from Life Source according to 
the method of Dozy et al. (93). 
phosphate buffer saline (PBS). 
The RBC's were washed with 
The PBS was prepared by 
titrating 5 mM dibasic sodium phosphate (Na2HP04) to pH 8.0 
with 5 mM monobasic sodium phosphate (NaH2P04), and to this 
solution was added 8.77 g NaCl per liter (150 mM). To 20 
mL of packed cells, 80 mL of (PBS) were added. The mixture 
was stirred slowly. The blood cells in PBS were placed in 
centrifuge tubes, balanced to equal weight, and centrifuged 
at 3,000 rpm (1,075 g) for 10 minutes with a Sorvall RC5B 
refrigerated superspeed centrifuge, using an SS-34 rotor. 
The supernatant and huffy coat were removed by aspiration 
after the centrifugation. The washing of the RBC' s with 
PBS was repeated two more times to ensure that the RBC' s 
were free of the unwanted plasma materials. All these 
steps were performed at 4°C. 
The washed erythrocytes were lysed in 40 mL of ice 
cold deionized water with gentle stirring for 30 minutes in 
a cold room at 4°C. To every 80 mL of hemoglobin solution, 
20 mL of cold neutral ammonium sulfate (AS) were added. 
34 
utral AS was prepared by adding 76.7 g of AS per 100 
The ne 
deionized. water, and adjusted to pH 7. 0 with 6 M 
mL of 
sodium hydroxide. The hemoglobin solution in AS was 
stirred continuously for 30 minutes at 4°C. The mixture 
was placed in centrifuge tubes, balanced to equal weight, 
and centrifuged at 12,000 rpm (17,210 g) for 10 minutes. 
After centrifugation the hemolysate in the supernatant was 
pooled, and the residues containing the membranes and other 
precipitates at the bottom of the centrifuge tubes were 
discarded. The hemolysate was desalted by dialysis in 0.05 
M Tris, 1 mM NaCN, pH 8.5. The completion of desalting was 
checked by adding 1 M BaCl2 to the dialysis solution in a 
small beaker to test whether or not BaS04 precipitates were 
still able to form. After des al ting was complete, the 
dialysate was ready for ion-exchange chromatography. 
IV. ION-EXCHANGE CHROMATOGRAPHY 
Ion-exchange chromatography was performed according 
to the method of Huisman and Dozy (94), and Dozy et al. 
( 9 3) . DEAE Sephadex A-50 gel was swollen in 0.05 M Tris, 1 
mM NaCN, pH 8.5 in the refrigerator for two days, or boiled 
in deionized water for two hours before use. Column size 
of 30 x 1 cm or 30 x 1.5 cm was used in these experiments. 
The Sephadex gels were packed to a height of 25 cm. Prior 
to chromatography the column was equilibrated with 0.05 M 
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Tris, 1 mM NaCN, pH 8. 5 for approximately 4 hours in the 
refrigerator with a flow rate of 20 mL per hour. When the 
pH of the eluent buffer reached 8.5, the equilibration was 
stopped and the dialyzed hemolysate was applied to the top 
of the column. Separation of the different hemoglobin was 
obtained by using a decreasing linear pH gradient from 8.5 
to 7. 2 with the Tris buffer. The pH gradient system was 
set up by connecting two aspirator bottles of 250 mL at the 
base, one containing Tris buffer pH 8.5 and the other 7.2. 
The bottles were leveled and filled with equal volumes of 
250 mL of Tris buffer. During the filling of the bottles 
the tube connecting the bottles was clamped to prevent 
mixing of the solutions. The clamp was released and the 
bottle containing Tris pH 8.5 was stirred to allow 
formation of the pH gradient. The pH gradient was pumped 
from the bottle with Tris pH 8.5 to the top of the column. 
The flow rate was kept constant at 12 mL per hour with an 
ISCO peristaltic pump. The hemoglobin fractions eluted was 
monitored by an ISCO UA-5 Absorbance monitor form 280-310 
nm. The hemoglobin fractions collected were pooled 
according to each peak under the chroma to gram, CO gassed, 
and stored at 4°C, or frozen by liquid nitrogen and kept in 
the freezer (-8°C) for later use. 
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v. CONCENTRATION OF HEMOGLOBIN BY A PRO-DICON 
Concentration of hemoglobin was achieved by a Pro-
dicon, or by ammonium sulfate precipitation. The pro-dicon 
was filled with the 
fractions pooled under 
collected, dialyzed 
desired buffer. The hemoglobin 
each peak of the chromatogram were 
in the appropriate buffer, and 
transferred to the dialysis tube in the pro-dicon. The 
Micro-prodicon tubing was 
Vacuum was applied from the 
from Bio-Molecular 
water aspirator to 
Dynamics. 
the 
di con for 1 hour. The prodicon was then set in 
pro-
the 
refrigerator until the protein was concentrated to the 
minimum volume allowed in the tubing. If there were any 
precipitates present in the hemoglobin solution after 
concentration, the solution was centrifuged at 12, 000 rpm 
(17,210 g). The hemoglobin solution was collected, and the 
precipitates were discarded. 
VI. CONCENTRATION OF HEMOGLOBIN USING AMMONIUM SULFATE 
For relatively large volume of hemoglobin solution 
(100 mL or higher), the protein was concentrated by 
precipitation with ammonium sulfate (75% or 80% 
saturation). To 100 mL of hemoglobin solution 56.61 g of 
ammonium sulfate was added. The solution at ice bath 
temperature was stirred slowly with a stirring bar until 
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all the ammonium sulfate dissolved. The hemoglobin 
precipitates were then centrifuged at 12,000 rpm (17,210 
g) . The supernatant was discarded and the hemoglobin 
precipitates were mixed with minimum buffer solution to 
enable pipetting them into the dialysis tube. Since most 
of the experiments from this point on were to be carried 
out in 0.01 M MOPS, pH 7.0, the hemoglobin precipitate was 
dialyzed in this buffer. The hemoglobin precipitates were 
dialyzed against a large volume of buffer until the buffer, 
when tested with 1 M BaCl2, showed no cloudy precipitates 
of BaS04. Any precipitates due to denatured protein 
present in the solution were removed by centrifugation 
(12,000 rpm, 17,210 g). 
VII. 
A. 
CROSSLINKING REACTIONS OF HEMOGLOBIN 
REACTIONS OF HEMOGLOBIN VITH BIS(3,5-DIBROMOSALICYL) 
FUMARATE 
The cross linking reaction of hemoglobin with 
bis(3,5-dibromosalicyl) fumarate was carried out in 0.01 M 
MOPS, 1 mM NaCN, pH 7.0. Other experiments were done at pH 
7.2 of the same buffer, but the results were the same. In 
both the oxy and deoxy crosslinking reactions the molar 
ratio of hemoglobin tetramers to crosslinking reagent was 
kept at 1: 1.1 for all the experiments, regardless of the 
concentration of hemoglobin. 
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For hemoglobin crosslinking in the oxy state, the 
variation in concentration was from 6xlo-3 0.6 mM 
tetramers for different 
crosslinking in the deoxy 
experiments. For 
state, the variation 
hemoglobin 
was 2xlo-3-
0.5 mM tetramers; but most experiments were done at 0.2 mM. 
The oxy hemoglobin concentration was determined 
spectrophotometrically by using emM of 13.8 per heme at 540 
nm (114), or for higher hemoglobin concentration the emM of 
7.12 per heme at 522 nm (95) could be used. 
The crosslinking of hemoglobin in the oxy state was 
done by adding known amount of bis(3,5-dibromosalicyl) 
fumarate to oxyhemoglobin solution in a flask; the mixture 
was swirled a few times and incubated at 37°C for 2 hours. 
The mixture was swirled slowly every 30 minutes within the 
incubation period. After two hours of incubation, the 
mixture was submerged in an ice cold bath for 20 minutes to 
terminate the reaction. The hemoglobin solution was then 
dialyzed in Tris buffer pH 8.5, or in some experiments the 
solution was run through a G-25 Sephadex gel equilibrated 
with 0. 01 M MOPS, pH 7. 2 followed by dialysis with Tris 
buffer pH 8.5 before it was applied to a chromatrographic 
column. 
For deoxy crosslinking reaction, the oxyhemoglobin 
solution in a flask with multiple outlets and inlets on top 
was submerged in a 4°C ice bath and was purged with a slow 
stream of N2 gas for 1-4 hours until the solution appeared 
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purplish and the UV/VIS spectrum of deoxyhemoglobin was 
confirmed. For carbonmonoxyhemoglobin, the solution was 
exposed to light at 4°C for 1-2 hours while purging with 
Nz· After confirmation of deoxy hemoglobin 
spectrophotometrically, the solution was transferred to a 
water bath already equilibrated at 37°C. The crosslinking 
reagent was introduced while purging with N2; the solution 
was swirled a few times and incubated for 2 hours. The 
reaction was terminated in an ice bath for 20 minutes, and 
the sample was dialyzed against large volumes of 0. 05 M 
Tris, lmM NaCN, pH 8. 5 to remove any excess cross linking 
reagent present in the solution. At this point the 
solution was no longer kept deoxygenated. In some 
experiments the crosslinking mixture was passed through a 
Sephadex G-25 column (2 x 50 cm) equilibrated with 0.01 M 
M 0 PS , 1 mM Na C N , pH 7 . 2 , f o 11 owe d by di a 1 y s i s in Tr i s 
buffer pH 8.5. 
The crosslinked hemoglobin was purified by ion-
exchange chromatography by the same method above. The 
unused purified crosslinked hemoglobin was CO gassed and 
kept in the refrigerator at 4°C or was frozen and kept in 
the freezer at -80°C until the next use. 
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.6 • MODIFICATION REACTIONS OF HEMOGLOBIN WITH 
TRIS(p-CHLOROETHYL) AMINE AND BIS(p-CHLOROETHYL) 
METHYLAMINE 
The reaction of hemoglobin with tris(,8-chloroethyl) 
amine was carried out by the methods of Hiratsuka (43). 
The first reaction was carried out by mixing 9 mL of oxy Hb 
A at 0. 446 mM tetramers in 0. 01 M MOPS, 0. 05 M NaCl, pH 
7 . 8 8 direct 1 y w i th 0 . 0 11 g s o 1 id ( 5 . 0 7 mM ) o f tr i s ( fJ -
chloroethyl) amine (TCEA). The final molar ratio of TCEA 
to hemoglobin tetramers was 11:1. 
The second reaction of hemoglobin with tris(/J-
chloroethyl) amine was done by adding 5 mL of 0.0319 M 
tris(,8-chloroethyl) amine (TCEA) in 0.01 M MOPS, 0.05 M 
NaCl, pH 7.88, to 9 mL of 0.446 mM tetramers of oxy 
hemoglobin A in MOPS buffer. The final molar ratio of TCEA 
to hemoglobin tetramers was 40:1. 
The reaction of hemoglobin with bis(,8-chloroethyl) 
methylamine (BCEA) was done according to Roth et al. (42), 
and Fung et al. (44). To 4 mL of 0.627 mM tetramers of oxy 
Hb A was added 4.8xlo-3 g of BCEA (6.23 mM) The final 
molar ratio of BCEA to hemoglobin concentration tetramers 
was 10:1. 
All three reactions were carried out at room 
temperature (21°C) for one hour with slow stirring. The 
reactions were terminated by adding 2.3 mL of 1 M Glycine 
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h reaction flasks. to t e The hemoglobin solutions were 
passed through a G-25 Sephadex gel equilibrated with 0.01 M 
MOPS, pH 7.0 and dialyzed two times against 2 L of 0.01 M 
MOPS, pH 7.0 at 4°C overnight. Any precipitates formed in 
the solutions were centrifuged before storage. 
c. MODIFICATION REACTIONS OF HEMOGLOBIN WITH 
DIMETHYLPIMELIMIDATE AND DOUBLE CROSSLINKING 
The reaction of hemoglobin with dimethylpimelimidate 
(DMP) was done in 0.1 M borate, pH 9.5 at room temperature 
for one hour. The react ions of oxy Hb A, oxy ,88 2XLHb A, 
and oxy a99XLHb A were performed in the same condition and 
concentration. Two reaction conditions were used in which 
the molar ratio was 500:1 and 50:1 DMP to hemoglobin 
tetramers. For the lower molar ratio reaction the DMP was 
simply added in lesser amount. Al 1 the other conditions 
remained unchanged. 
A sample reaction of hemoglobin with DMP at 500: 1 
molar ratio was as follows: To 24.418 mL of buffer 
containing 0.051 g of DMP was added 410 µL of 1 M NaOH to 
adjust pH to 9.5, and then 172 µL of oxy Hb A (2.275 mM 
tetramers, 145.6 mg/mL) was added. The pH was periodically 
monitored. The reaction was carried out at room 
temperature (22 °C). The final concentrations of reagents 
were 7.871 mM DMP, and 0.01564 mM hemoglobin tetramers or 1 
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J11g/mL. Hence, the molar ratio of reagent to hemoglobin 
tetramers was 500:1. The pH was checked periodically 
during the reaction and maintained at 9.4-9.6. After one 
the reaction was terminated by adding 5 mL of 0.5 M hour 
glycine 
dialyzed 
in borate buffer. The reaction mixture was 
in 0. 01 M MOPS, pH 7.0 to get rid of the excess 
crosslinking reagent and glycine. 
A double crosslinking reaction was performed by 
reacting a purified a99XLHb A or ~82XLHb A with DMP. These 
reactions were performed at 500: 1 molar ratio of DMP to 
hemoglobin. All other conditions were the same as in the 
reactions of DMP with uncrosslinked Hb A. 
VIII. CROSSLINKING OF HEMOGLOBIN TO CATALASE WITH DMP 
The crosslinking of hemoglobin (Hb A) to catalase 
was performed by using DMP to bridge the two molecules. 
The reaction conditions and concentration of protein were 
the same as the DMP reaction with hemoglobins. The final 
molar ratio of DMP to hemoglobin and to catalase was 
2000:4:1. 
A sample reaction of DMP crosslinking between 
hemoglobin and catalase was as follows: A 0.051 g of DMP 
was dissolved in 24.14 mL of 0.1 M borate buffer adjusted 
to pH 9.5 with 410 µL of 1 M NaOH. To this solution was 
added 172 µL of Rb A (145.6 rng/rnL, 2.275 mM) and 278 µL of 
catalase (90 mg/mL). The final concentration of reagents 
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were 7.871 mM DMP, 0.0156 mM tetramers Hb A or 1 mg/mL, and 
o.0042 mM tetramers catalase or 1 mg/mL. The reaction was 
allowed to proceed for 1 hour at room temperature (22°C). 
The reaction was terminated by adding 5 mL of 0.5 M glycine 
in borate buffer. The reaction mixture was dialyzed in 
o.01 M MOPS, pH 7.0 to get rid of the excess crosslinking 
reagent and glycine. 
Two reaction conditions were used in which the molar 
ratio of DMP to hemoglobin and catalase were 2000:4:1 and 
1000:4:1. All other experimental conditions remained 
unchanged. 
A control experiment in which DMP was reacted with 
catalase was also performed at molar ratios of 2000:1 and 
1000:1 DMP to catalase. A protocol of this experiment at 
2000:1 molar ratio was as follows: A 0.051 g of DMP was 
added to 24.31 mL of 0.1 M borate buffer, adjusted to pH 
9.5 with 410 µL of 1 M NaOH. 
catalase (90 mg/mL) was added. 
To this solution 278 µL of 
The final concentration of 
reagents were 7.87 mM DMP and 0.0042 mM or 1 mg/mL 
catalase. The rest of the experimental conditions were the 
same as that in the DMP and hemoglobin reactions. 
IX. PREPARATION OF GLOBIN CHAINS 
AND AMINO ACID HYDROLYSIS 
The purification of globin chains was by the method 
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of Ascoli et al. (96). The hemoglobin was dialyzed in 
excess deionized water to remove all the salt present in 
the solution. The heme was removed by adding the deionized 
hemoglobin solution dropwise to rapidly stirred cold 
acetone (-20° ) containing 2% concentrated HCl. A white 
precipitate was formed, which was the globin chains, and 
the acetone solution became brownish in the presence of 
heroins. The sample was centrifuged at 5,000 rpm (2,987 g, 
4•c) to remove the precipitates. The precipitates were 
washed three times with ether followed by centrifugation to 
remove any remaining reddish particles on the precipitates 
and dried in air while the centrifuge tubes were submerged 
in ice. 
The separation of the subunits was carried out using 
CM-Cellulose (CM52), from Whatman Ltd., with a linear 
increasing ion gradient. The gradient system consisted of 
two buffer chambers, designated buffer I and buffer II (100 
mL each). Buffer I contained 0.005 M Na2HP04, 0.05 M 2-
mercaptoethanol, 8 M urea, pH 6. 7. Buffer II contained 
0.05 M Na2HP04, 0.05 M 2-mercaptoethanol, 8 M urea, pH 6. 7. 
The conductivity of the buffers I and II, by a Conductivity 
Bridge Model 31, were 1,020 and 6,800 o-1 µ ' 
respectively. The column packed with CM-52 gel (25cm x 1 
cm) was equilibrated with buffer I for at least 2 hours or 
until the conductivity of the eluent matched that of the 
buffer I. When the conductivity of the equilibrated eluent 
and that of the buffer I matched within 1-2%, then the 
globin chains sample was loaded on to the top of the column 
d was washed with buffer I for 15 minutes, and then the an 
gradient was started. 
The globin chains obtained through the ion exchange 
chromatography were freed from urea, salt, and (3-
mercaptoethanol by dialysis against a large volume of 
deionized water. The globin solution was placed in acid 
cleaned test tubes and the water was evacuated by using a 
Speed Vacuum Rota-Vapor. After the water was completely 
evacuated the required amount of solid globin chains were 
mixed with 1 mL of 6 M predistilled HCl. The middle of 
the test tube above the solution was made smaller by 
heating and pulling the test tube while it was melting. 
The test tube was allowed to cool down. The bottom of the 
test tube was immersed in dry ice cold acetone solution, 
and air was evacuated from the test tube. After it was 
evacuated the small middle portion of the test tube was 
sealed by flame, and the test tube was placed in ll0°C oil 
bath to allow hydrolysis of the polypeptide chains. The 
hydrolyzate was filtered, mixed with 0.2 M sodium citrate, 
pH 2.2 buffer (from Beckman), and analyzed by a microcolumn 
amino acid analyzer (model 121M, Beckman) at Northwestern 
University of Chicago Children's Hospital in Dr. Mir 
Shamsuddin's laboratory. The number of amino acids was 
estimated by multiplying the average residues (142) to the 
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area ratio of individual amino acid to the total area of 
all residues from the a and p chains. The a-chain has 141 
residues and the p-chain has 146 residues. The average 
residue is calculated as shown below: 
Average Residue = (141 + 146 - 3)/2 142 
Thus, the average residue is 142. The subtraction of 3 was 
due to the three tryptophan residues per ap dimer. 
X. NMR SAMPLES PREPARATIONS AND EXPERIMENTS 
The lH and 1 3c spectra were taken in deuterated DMSO 
in 5 mm tubes. For the proton spectrum the nucleus was set 
at 
was 
1.250 with a spectral width of 4000 Hz. 
300 MHz. The acquisition time was 
The frequency 
3. 7 5 2 sec. ; the 
pulse width was 20 µsec. and no delay time was used. The 
number of scans collected was 4-16. 
The 13c spectrum was run at 75 MHz with the nucleus 
set at 13. 250 and no delay time was used. The spectra 1 
width was 16501.7 Hz. The acquisition time and pulse width 
were set at 1.639 sec. and 8.7 µsec., respectively. The 
total number of transients was 7,248. 
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XI. CLINICAL ALKALINE AGAROSE GEL ELECTROPHORESIS 
The alkaline agarose gel electrophoresis was 
performed, using commercially available Corning Medical 
films. The agarose film consists of 1% (w/v) agarose, 5% 
(w/v) sucrose, 0.002 M Na2EDTA, 0.0059 M boric acid, and 
0.053 M Tris buffer, pH 8.8. 
The electrode buffer, also commercially prepared by 
corning Medical, contained 17.7 g sodium barbital, 2.6 g 
barbital, 1.0 g sodium chloride, 0.7 g disodium EDTA, 
sucrose octaacetate. This buffer was dissolved in 2 L of 
deionized water to produce 0.05 M buffer with 0.035% EDTA, 
pH 8.6. The buffer was stored at 4°C in the refrigerator 
for later use. 
Prior to electrophoresis the power supply was warmed 
up for about 10 minutes. The alkaline agarose film was 
peeled off from the protective plastic, and the wells were 
each filled with 1 µL of the sample. The two chambers in 
the electrophoresis cell were each filled with 75 mL of the 
electrode buffer. The loaded agarose film was inserted 
face down in the electrophoresis cell cover with the 
matching of the electrode marks (anode to anode and cathode 
to cathode), and was fitted on to it. The electrophoresis 
was carried out for 20 minutes at 240 volts. The film was 
removed and stained in Ami do Black lOB for 10 minutes. 
Then it was transferred to a 5% acetic acid solution for 30 
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seconds with slow stirring to wash off the excess stain. 
The film was washed with deionized water and dried in an 
oven at 55-65°C for 1 hour. After the film was dried, it 
was taken out from the oven and cooled to room temperature 
for 10 minutes. Then it was destained in a 5% acetic acid 
with agitation for 1 minute. This process was repeated in 
a new acetic acid solution one more time, and the film was 
immersed in water to remove the excess acid and dried at 
55-65°C. After drying at this step the film was ready for 
visual inspection and gel scanning. 
XII. SDS GEL ELECTROPHORESIS 
The sodium dodecylsulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) was carried out in slab gel 
according to Laemmli (97), with minor modifications. Two 
set of gels were used; one (Savant) with dimension of 22 x 
16 x 0.15 cm, and the other (Hoefer mighty small) with 7.5 
x 8.0 x 0.05 cm. 
For the larger gel after the glass plates system was 
set up, the gel plug was polymerized by using a fourth of 
the volumes of the solutions of the separating gel at the 
bottom of the glass plates. The 11% acrylamide separating 
gel was polymerized by mixing the following reagents: 12 
mL of 1.875 M TRIS, pH 8.8; 22 mL of 30% acrylamide (15 g 
acrylamide, 0.41 g N,N'-methylene-bis-acrylamide in 50 mL 
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of deionized water); 0.6 mL of 10% SDS in deionized water; 
and 26.96 mL of deionized water. The mixture was degassed 
for 15 minutes before adding 400 µL of 10% freshly made 
ammonium persulfate, and 80 µL of N,N,N'N'-tetramethyl-
ethylenediamine (TEMED). The final concentration of the 
separating gel was: 0.375 M TRIS, 0.1% SDS, 11% 
acrylamide, pH 8. 8. 
The stacking gel was polymerized by mixing the 
following reagents: 7.52 mL of 1. 0 M TRIS, pH 6 . 8 ; 3.0 mL 
of 30% acrylamide; 300 µL of 10% SDS; and 18.96 mL of 
deionized water. The mixture was again degassed to prevent 
air bubbles before adding 100 µL of 10% ammonium 
persulfate, and 20 µL of TEMED. The final concentration of 
the stacking gel was: 
acrylamide, pH 6.8. 
0.273 M TRIS, 0.1% SDS, 3.2% 
The electrode buffer contained 0.025 M TRIS, 0.192 M 
glycine, 0.1% SDS, pH 8.8. The digestion mixture solution 
contained 0.229 M TRIS, pH 6.8, 3.7% SDS, 18.3% glycerol 
(v/v), 8. 3% .B-mercaptoethanol (v/v), and 0. 02% bromphenyl 
blue. 
The protein markers used were bovine serum albumin 
(Mr 66,000), egg albumin (Mr 45,000), glyceraldehyde-3-
phosphate dehydrogenase (Mr 36,000), carbonic anhydrase (Mr 
29,000), trypsinogen (Mr 24,000), trypsin inhibitor (Mr 
20,100), and o:-lactalbumin (Mr 14,200). 
The electrophoresis was carried out by a power 
so 
supply model PS-4 (Heath Co.) at constant current at 35 mA 
il the dye reached the bottom of the gel. This process unt 
took approximately 8 hours. After the electrophoresis, the 
· s were fixed in the gel with 40% methanol and 7% protein 
acetic acid solution for 4 hours and stained with coomassie 
brilliant blue for 4 hours. The fixing step was not 
necessary. The gel was destained by repeated washing with 
a solution of 40% methanol and 7% acetic acid. After 
destaining, they were stored in 5% acetic acid. The 
molecular weights of the unknown proteins were estimated 
from the graph of the log of molecular weight versus 
relative mobility of the marker proteins, and the 
percentage of crosslinking can be estimated by gel 
scanning. 
XIII. DENATURATION EXPERIMENTS 
The thermal denaturation of uncrosslinked and 
crosslinked hemoglobins were carried out according to White 
and Olsen (83), and Yang and Olsen (84). Thermal 
denaturation was done in 0.01 M MOPS, pH 7.0, in the 
presence of 0.9 M guanidine. The guanidine solution was 
prepared fresh prior to the experiments. The optical 
density of the Soret band of each experiment was kept at 
1. 0; this corresponded to a hemoglobin concentration of 
approximately 7 µM per heme. The hemoglobins were 
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thermally denatured as 
denaturation 
aethemoglobin 
minutes. 
the oxy 
by 9.7 µM 
methemoglobins. Prior to 
hemoglobin was oxidized to 
potassium ferricyanide for 15 
A movable seven cuvettes holder in the 
spectrophotometer was used. Seven cuvettes were used in 
each experiment; six were hemoglobin samples and one was 
the reference. The program for this denaturation 
experiment was written to take a measurement of each sample 
in 15 second intervals. The time interval between the same 
sample was 1.75 minutes. For each round of measurement the 
reference which contained 9.7 µM potassium ferricyanide was 
taken prior to measurement of the samples. The wavelengths 
used to monitor the denaturation were 280 nm, 406 nm, 418 
nm, 522 nm, 540 nm, 576 nm, and 630 nm. Seven entire 
spectra were taken from 200-650 nm in every 7°C interval 
for observation of base line shift. The method of analysis 
was based on a two-state model, in which the protein was 
thought to be in equilibrium between either the native or 
the denatured state (82,89). The fraction denatured was 
calculated from the following equation: 
where A was the absorbance at a specified temperature. AN 
and Ao were the absorbance effect of the native state and 
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denatured state due to temperature, respectively. From the 
value of the Fo the apparent thermodynamic parameters of 
Ko, ~Go, ~Ho, and ~So could be estimated. 
From the plot of Fo versus temperature for each 
sample, the Tm was the temperature at which the Fo equaled 
0.5. A second method to obtain the Tm was to calculate the 
first derivative of the absorbance with respect to 
temperature. The temperature corresponding to the minimum 
or maximum was the Tm. 
XIV. AUTOXIDATION EXPERIMENTS 
The autoxidation of hemoglobins was monitored by the 
formation of methemoglobin according to the method of 
Tomita et al. (99). In a sample mixture of oxy and met 
hemoglobins all the methemoglobin could be converted to 
cyanomethemoglobin. The percent methemoglobin could be 
determined indirectly from oxy and cyanomet hemoglobins by 
using the ratio of extinction coefficient of oxyhemoglobin 
to cyanomethemoglobin, the resulting absorbance of oxy and 
cyanomethemoglobin 
hemoglobin. Figure 
mixture 
1 shows 
and 
the 
that of pure cyanomet 
theoretical derivation of 
this method. At 100% oxyhemoglobin and cyanomethemoglobin 
the absorbancy at 576 nm are indicated by A3 and A2, 
respectively. In a sample mixture of oxy and met 
hemoglobins after converting all the methemoglobin to 
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.fj.gure 1: 
The visible spectra of hemoglobin used for the 
calculation of percent met hemoglobin in autoxidation. The 
absorbance o'f 576 nm at AJ is 100% oxyhemoglobin at zero 
time, at At after the hemoglobin is partially autoxidized, 
and at A2 after conversion to 100% cyanomet hemoglobin. 
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cyanomethemoglobin with cyanide, the resulting absorbancy 
The value of k, the ratio of molar extinction 
coefficient of oxy to cyanomet form, could be determined 
experimentally by dividing the absorbance of 100% 
oxyhemoglobin to the absorbance of cyanomethemoglobin of 
the same sample after conversion to 100% cyanomet 
hemoglobin at 576 nm. Multiplying k by the absorbancy A2 
is equal to A3, corresponding to the absorbancy of 100% 
oxyhemoglobin. 
(at 100% oxy or cyanomet (1) 
hemoglobin) 
k.A2 = A3 (2) 
The percent of methemoglobin is calculated by: 
% methemoglobin (3) 
[(kA2 - A1)/(kA2 -A2)] x 100% (4) 
[ (k/k-1) - (l/k-1) x (A1/A2)] x 100% (5) 
The experimental value of k determined by Tomita et al. 
(68) was 2. 285, and the percent of methemoglobin is then 
calculated by the following equation or by substituting the 
experimental k value for equation 5 above: 
% methemoglobin = [1.778 - 0.778 x (A1/A2)] x 100% (6) 
Ai is the absorbance at 576 nm of oxy and cyanomet 
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hemoglobin mixture at the first measurement, and A2 is the 
absorbance at 576 nm after conversion of any oxy to all 
cyanomet form at the second measurement. 
For the determination of k value the spectra of 
oxyhemoglobin at 2 mM heme, which 
density (O.D.) equaled to 1.4 at 540 
crystal of potassium ferricyanide 
produced an optical 
nm, were recorded. A 
was added to the 
oxyhemoglobin solution in the cuvette; the cuvette was 
capped and tilted upside down three to four times, then the 
solution in the cuvette was allowed to equilibrate for 5 
minutes at room temperature. The oxyhemoglobin was all 
converted to methemoglobin at this point. Then a crystal 
of sodium cyanide was added to the methemoglobin solution 
to convert all of it to the cyanomet form. The spectrum of 
the cyanomethemoglobin was recorded. The value of k is 
then calculated experimentally by dividing the absorbance 
of 100% oxyhemoglobin (A3) to that of 100% cyanomet 
hemoglobin The k values determined in this 
laboratory for oxy Hb A, oxy a99XLHb A, and oxy ~82XLHb A 
were 2.163 ± 0.009, 1.953 ± 0.048 and 2.047 ± 0.008, 
respectively. The percent methemoglobin in this research 
was calculated based on these k values. 
The experiments were done at 37°C at room 
temperature (22°C). Fresh hemoglobin was used for these 
experiments. The hemoglobin samples were incubated in 
sterilized test tubes from Nutrex. The variation in 
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hemoglobin concentration in the test tubes between 
experiments was 1. 9 mM, 2. 2 mM, and 3. 2 mM per heme. The 
incubation of hemoglobins was carried out in 0.01 M MOPS, 
pH 7. 0. Prior to this incubation the hemoglobin samples 
were dialyzed and concentrated by a pro-dicon in 0.01 M 
MOPS, pH 7.0 to get rid of any free cyanide from previous 
preparation 
containing 
steps. During 
the hemoglobin 
the incubation 
samples were 
the test 
covered 
tubes 
with 
polystyrene test tube caps and sealed with parafilm to 
prevent evaporation of water. At the specified times, an 
aliquot of hemoglobin solution predetermined to yield an 
absorbance of 1.4 at 540 nm was pipetted and mixed with 
appropriate amount of the reference buffer. The sample 
cuvette was capped and tilted up side down several times to 
obtain a homogeneous mixture prior to measurement of the 
absorbance. For the first measurement, the hemoglobin 
solution was mixed with 1 µL of 0.1 M NaCN solution 
buffered at pH 7. 0 or in some experiments, a crystal of 
sodium cyanide was added directly in the cuvette. The 
hemoglobin solution was allowed to equilibrate at room 
temperature for 5 minutes before measurement. After 5 
minutes any met hemoglobin present in the solution would 
have been converted to cyanomethemoglobin, and the 
remaining was oxy hemoglobin. The spectrum from 500-700 nm 
of the hemoglobin sample was then recorded. 
For the second measurement, the hemoglobin solution 
58 
from the first measurement was mixed with 1 µL of 0.1 M 
potassium ferricyanide buffered at pH 7.0 or a crystal of 
potassium ferricyanide, and the solution was allowed to 
equilibrate at 37°C for 20 minutes before measurement. 
After this incubation period the hemoglobin sample were all 
converted to cyanomet hemoglobin. The spectra were 
recorded from 500-700 nm simultaneously by the Hewlett-
Packard diode array spectrophotometer 8451A. 
XV. AUTOXIDATION OF HEMOGLOBIN IN THE PRESENCE 
OF CATALASE AND SUPEROXIDE DISMUTASE 
The experiments on the autoxidation of hemoglobin in 
the presence of catalase and superoxide dismutase were 
carried out as described above for the autoxidation of 
hemoglobin (99), except catalase and superoxide dismutase 
or both were added to the hemoglobin solution under 
investigation. For catalase, a 9.1 µL solution of catalase 
(90 mg protein/mL, 44,000 U/mg protein) was added to 500 µL 
of ox y hem o g 1 ob in ( 2 . 2 2 mM heme ) pr i or to the start of 
incubation. The total enzyme uni ts added were 36, 036 U, 
corresponding to 70,784 U/mL, or 16,530 U/mM heme. A unit 
of activity of catalase is defined by the supplier (Sigma) 
as the amount of enzyme which will decompose 1 µmole of 
per minute at pH 7.0 at 25°C while 
concentration falls from 10.3 to 9.2 µmoles per mL of 
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reaction mixture. 
For superoxide dismutase, a 2 mg solid sample of SOD 
(Cu/Zn SOD, 4, 300 U/mg solid) was dissolved in 200 µL of 
buffer, and 40 µL of this solution was added to 500 µL of 
oxyhemoglobin (2.22 mM heme) prior to incubation. The 
total enzyme units added were 16,000 U, 3,185 U/mL or 835 
U/mM heme. In one experiment, the SOD ( 2, 990 U/mg solid) 
was added directly at 8. 8 mg to 500 µL of oxyhemoglobin 
(2.20 mM heme). The total units were 26,400 U, 52,600 U/mL 
or 12,000 U/mM heme. 
In the experiments in which both catalase and SOD 
were present the above described conditions and amount of 
enzymes were added to 500 µL of oxyhemoglobin (2.22 mM 
heme). The autoxidation was followed by the 576 nm 
wavelength as described above. The SOD and catalase were 
used without further purification and the enzymes activity 
was assumed to be as stated by the supplier. 
The first order rate constant was obtained by 
plotting the -log[Ao A]/[Ao - A~J versus time, where Ao 
and A~ represented the absorbance at 576 nm of 100% 
oxyhemoglobin and 100% cyanomethemoglobin, respectively, 
and A was the absorbance of oxyhemoglobin at 576 nm at the 
end of each time interval. The apparent rate constant kapp 
(hr-1) was obtained by the slope of this plot. The percent 
inhibition of autoxidation by the enzymes was estimated by 
the percent difference of the slopes. 
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J. 
CHAPTER III 
RESULTS 
SYNTHESIS OF BIS(3,5-DIBROMOSALICYL) FUMARATE 
The bis(3,5-dibromosalicyl) fumarate was a white 
crystalline powder with a melting point of 226-228°C. A 
small amount of the crystal was dissolved in a 1 M ferric 
chloride solution and the color remained yellowish, 
indicating the absence of a phenolic proton. Figures 2(A) 
and (B) show the 1H NMR spectra of bis(3,5-dibromosalicyl) 
fumarate and its presumed structure. There were four 
resonances, matching the four H's on half of the molecule. 
The singlet resonance at 7.34 ppm was from the fumarate 
H's. The doublet resonance at 8.33 ppm and 8.34 ppm arose 
from the benzyl proton of position 4, and the one at 8.08 
ppm and 8.09 ppm was due to the benzyl proton at position 
6. The broad resonance at 3. 35 ppm was from the acidic 
proton of the carboxylic acid group. The multiplets 
(pentets) centered at 2. 49 ppm was due to the H from the 
dimethyl sulfoxide (DMSO). The integration of the 
resonance at 7.34 ppm, 8.08 ppm, and 8.33 ppm indicated a 
ratio of 2:1:1, respectively. 
Chemical shifts of substituted benzene and 
substituted ethylene from the literature were used to 
predict the NMR spectra. The observed chemical shifts and 
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2: figure 
1£U_: The lH NMR spectrum of bis(3,S-dibromosalicyl) 
fumarate (BBSF) ran at 300 MHz in deuterated DMSO and its 
presumed structure. 
proton of DMSO . 
.LJU_: 
The resonance at 2.49 ppm is from the 
The expanded lH NMR spectrum of BBSF. The 
resonances are: fumarate lH, 7.34 ppm; H(4), 8.33 and 8.34 
ppm; and H(6), 8.08 and 8.09 ppm. 
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ones matched within 0.2 ppm for the predicted 
resonances. The following equations were used to calculate 
the predicted chemical shifts (100,101). 
For lH in substituted benzene: 
o(ppm) 7.27 + :l-:: S(o) 
For lH in substituted ethylene: 
o(ppm) - 5.28 + :l-:: S(o) 
For 13c in substituted benzene: 
o(ppm) 128.5 + :l-:: S(o) 
The S(o) is the incremental shift of each individual 
or in relation to either the or of 
nonsubs ti tu ted ethylene or benzene. The lH incremental 
shifts for substituted benzene and ethylene were taken from 
Gunther (Table 4.6 and 4.7, p. 98-99) (100). The predicted 
and observed chemical shifts for lH were tabulated in Table 
4, and those of 13c, in Tables 5 and 6. Figures 3(A) and 
(B), the 13c spectra show 9 resonances which agree with the 
nine identical carbons of bis(3,5-dibromosalicyl) fumarate. 
The chemical shift of each carbon on the benzene due to the 
substituted groups were calculated by using the 
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Table 4: 
The predicted and observed 1H chemical shifts of bis(3,5-
dibromosalicyl) fumarate from TMS. 
Substituents !!.Lil H..l§.l H(fumarate) 
(ppm) (ppm) (ppm) 
C02H o.2oa 0.80 
OCOR -0.02 -0.02 
Br(3) 0.22 -0.03 
Br(5) 0.22 0.22 
cis, OCOR 1. 15 
gem, OCOR 0.84 
Predicted 7.89 8.24 7.27 
Observed 8.08 8.33 7.34 
8.09 8.34 
* H(4) and H(6) are protons on the benzene ring at 
positions 4 and 6 respectively. 
a Values for the incremental shift were taken from Gunther 
(100) Tables 4.6 and 4.7, p. 98-99. 
Solvent for the observed values was deuterated DMSO. 
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Table 5: 
The predicted 1 3 c chemical shifts using the incremental 
13c shiftsa in ppm of the aromatic carbon atoms of 
roonosubstituted benzene from 128.5 ppm of benzene carbons 
referencing from TMS. 
~ COOR OCOCH3 Br(3}c Br{S}c I3g_o 
Cl 2.1* -6.4 1.7 1. 7 127.6 
C2 1.5 23.0* 3.4 -1.6 151.8 
C3 0.0 -6.4 s.s* 1. 7 118.3 
C4 5.1 1. 3 3.4 3.4 141.7 
cs 0.0 -2.3 1. 7 -s.s* 122.4 
C6 1.5 1. 3 -1. 6 3.4 133.l 
a Values were taken from Silverstein (101), Table VII, p. 
265. 
b The carbon positions on the benzene ring. 
c Br(3) and Br(S) are the bromine from position 3 and 5 
on the benzene ring. 
d 13c chemical shifts were calculated by adding the sum of 
the incremental 13c chemical shifts due to each 
substituted group to 128.5 ppm. 
* The substituent group is attached to the carbon 
corresponding to this row number. 
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Table 6: 
The predicted and observed 13 c chemical shifts of 
bis(3,5-dibromosalicyl) fumarate from TMS. 
g_a Predicted (ppm) Observed (ppm) 
Cl 127.6 127.39 
C2 151.8 146.07 
C3 118.3 119.53 
C4 141.7 133.87 
cs 122.4 118.97 
C6 133.1 133.37 
C7 165-185b 163.32 
cs 140-190c 161.39 
C9 l36.3d 138.94 
a This column represents the carbon position in the 
benzene ring. 
b Value for the carboxylate carbon of carboxylic acid from 
Silverstein et al. (101), Appendix C, p. 289. 
c Value for the ester carbon with two R groups, one 
attached to the carbon and the other to the oxygen, from 
Gunther (1973), p. 364. 
d Value from Wehrli and Wirthlin (115), Table 2.10, p. 
41-42. 
Solvent for the observed values was deuterated DMSO. 
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EJ_gure 3: 
ill_: The decoupled 13c NMR spectrum of BBSF ran at 
5 4 MHz in deuterated DMSO. 7 . 
The expanded 13 c 
resonance peaks. 
Inset is the DMSO peak. 
spectrum of BBSF, showing 9 
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values in Table 5 (p. 265) from Silverstein et al. (101). 
The ester group was assumed to be an acetate group. The 
13c chemical shifts were assigned in accordance with the 
agreement between the predicted values and observed values 
as shown in table 6. The septet centered at 39.50 ppm was 
from the carbon of DMSO. These data were consistent with 
the presumed structure of bis(3,5-dibromosalicyl) fumarate. 
II. PURIFICATION AND CROSSLINKING OF HEMOGLOBINS 
A. PURIFICATION OF NORMAL AND CROSSLINKED HEMOGLOBINS 
Hemoglobin A was isolated from the minor hemoglobins 
and other red cell components by ion exchange 
chromatography, using Sephadex A-50 gel. The resolution of 
each component was achieved by a linear gradient from pH 
8.5 to 7.2. Figure 4 shows the chromatogram for the 
purification of Hb A from a hemolysate obtained from packed 
red blood cells. The resultant chromatogram shows four 
peaks. After purification the protein fractions under each 
peak were pooled and clinical gel electrophoresis was 
performed to identify the proteins and check for 
contaminants. The protein under peak II was analyzed to 
contain Hb peak III, Hb A· 
' 
and peak IV, Hb or 
glycosylated Hb A. Si nee the net charge on the Hb A2 
molecule is more positive (+4) than that on the Hb A 
molecule, it is expected to elute before Hb A. In Hb Arc 
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f.J- gure 4: 
The chromatogram showing the elution of Hb A from 
sephadex A-50 gel. Peak II is Hb A2; peak Ill, Hb A; and 
peak IV, Hb Arc· The pH gradient profile is plotted on top 
of the chromatogram. 
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the amino termini of the f3 chains reacted with glucose in 
the red cell, and as a consequent two positive charges at 
the amino termini were deleted from the hemoglobin 
molecule. Therefore, the Hb Arc would be more negatively 
charged and retained on the A- 50 gel longer and eluted 
later than Hb A. The break on peak IV was due to upsetting 
the pH gradient upon addition of buffer after the original 
gradient buffer ran out. A small peak (peak I) prior to 
the e 1 u t ion of Hb A2 was probably due to other red ce 11 
proteins, most likely glyceraldehyde-3-phosphate 
dehydrogenase. 
The purified Hb A represented in peak III of Figure 
4 was used to crosslink with bis(3,5-dibromosalicyl) 
fumarate in either the oxy or deoxy state and was resolved 
on Sephadex A- 50 gel. The purification of crosslinked 
hemoglobins was carried out by the same chromatographic 
method described above. Figure 5 shows a chromatogram for 
the elution of the f382XLHb A sample. The crosslinking was 
not quantitative and a small percentage of Hb A remained 
uncross linked. 
have occurred. 
Also, a small percent of side reactions may 
The resultant elution shows two major 
peaks. After crosslinking between two lysines the positive 
charge on the hemoglobin molecule would have been lowered 
by two, and hence, it was expected to elute after 
uncrosslinked Hb A. The protein under peak I was analyzed 
by clinical gel electrophoresis to be Hb A and peak II, 
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~: 
The chromatogram for the elution of ,B82XLHb A from 
sephadex A-50 gel. 
II, ,B82XLHb A. 
Peak I is uncrosslinked Hb A and peak 
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p82XLHb A. The smal 1 amount of the unknown cross 1 inked 
product obtained was apparent on the shoulder of peak II. 
No further characterization of this modified protein was 
carried out. 
Figure 6 shows the chromatogram for the elution 
profile of an a99XLHb A sample. This chromatogram shows 
three clear peaks. Again, the crosslinking between two 
lysyl residues would have deleted two positive charges, and 
thus, the a99XLHb A was expected to elute after Hb A under 
these conditions. The protein in peak I was Hb A; peak II, 
a99XLHb A; and peak III, an unknown crosslinked hemoglobin, 
denoted XLHb A. The yield of this second crosslinked 
product was higher than in the p crosslinking reaction, and 
it may contain a mixture of the p or a crosslinked 
hemoglobin with additional reacted sites. Amino acid 
analysis of the globin chains of this second unknown 
product (Fig. 6, peak III) suggested that at least one 
product was a P-P crosslinked hemoglobin. 
Tables 7 and 8 show the percent of crosslinking of 
hemoglobin with bis(3,5-dibromosalicyl) fumarate in the oxy 
and deoxy conditions respectively. The percent of p 
cross linked hemoglobin obtained at 1.1: 1 molar ratio of 
reagent to hemoglobin was higher than the a crosslinked 
hemoglobin. In the oxy state the crosslinking ranged from 
70-90%; in the deoxy state it was also in this range, but 
the yield of a99XLHb A was lower due to the formation of 
78 
.f._:it?;ure 6: 
The chromatogram for the elution of a:99XLHb A from 
sephadex A-50 gel. Peak I is uncrosslinked Hb A; peak II, 
a99XLHb A; and peak III, an unknown crosslinked hemoglobin, 
denoted XLHb A. 
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Table 7: 
percent yield of ,882XLHb A and other products in the 
crosslinking reaction of oxy hemoglobin with bis(3,5-
dibromosalicyl) fumarate. 
N.Q...._ ll!.tla [BBSF]a % tJ82XLHb A % Hb A 
1. 0.1319 0.1568 71. 0 20.8 
2. 0.2775 0.3097 87.5 12.5 
3. 0.5778 0.6356 67.0 29.0 
a [Hb] and [BBSF] are in mM. 
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Table 8: 
Percent yield of a99XLHb A and other products in the 
crosslinking reaction of deoxy hemoglobin with bis(3,5-
dibromosalicyl) fumarate. 
No. l!:Utla [BBSF]a % a99XLHb % XLHb % Hb A 
1. 2.36x10- 3 0.0002507 (no significant XL was 
produced) 
2. 0.2747 0.3350 44.06 21.83 31.60 
3. 0.0549 0.06913 50.26 - - - - - 24.00 
4. 0.4490 0.5459 27.00 44.80 28.2 
5. 0.0785 0.08635 43.90 52.70 3.30 
6. 0.1319 0.1508 10.90 17.80 61.00 
a [Hb] and [BBSF] are in mM. 
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the unknown crosslinked species in this 
a99XLHb A obtained ranged from 30-50% plus 
reaction. The 
the additional 
unknown crosslinked protein which ranged from 20-50%. 
B. PURIFICATION OF a AND p GLOBIN CHAINS AND AMINO ACID 
ANALYSIS 
The glob in chains of the second cross linked 
hemoglobin from the a crosslinking reaction shown in Figure 
6, peak III, were abstracted free of hemes, purified by 
carboxymethyl 
hydrolyzed to 
cellulose (CM52) chromatography in urea and 
amino acids. The number of amino acids were 
compared to those known ones in the a and f3 chains to 
identify whether the crosslink span was between the a or f3 
chains. Figure 7 shows the elution profile for the non-
crosslinked a and f3 globins by CM52 gel. The elution 
resulted in two peaks of relatively equal amount (peak A 
56%, peak B 44%) as expected for the a and f3 chains. Under 
these chromatographic conditions, the more negatively 
charged protein would be eluted first, and thus, peak A 
would be the f3 chain (Fig. 2 3, lane 3), and peak B the a 
chain (Fig. 23, lane 8). 
Figure 8 (A), (B) and (C) show the CM52 chromatograms 
for the elution of globin chains from a99XLHb A, {382XLHb A 
and XLHb A, respectively. In Figure 8(A), the protein 
under peak C and D were analyzed by SDS (Fig. 22, lanes 1, 
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7: wure 
The chromatogram for the elution of a and ~ globins 
from CM52 gel. 
glob in. 
Peak A is the ~ glob in and peak B, a 
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The chromatograms for the purification of 
globin chains from o:99XLHb A. 
globins and peak D, p globin. 
Peak C is o:-o: crosslinked 
.L!U.: The chromatogram for the purification of 
globin chains from p82XLHb A. Peak E is P-P crosslinked 
globins and peak F, o: globin. 
The chromatogram for the purification of 
glob in chains from the second unknown crosslinked 
hemoglobin from peak III of figure 6. Peak G represents 
crosslinked globins and peak H, uncrosslinked one. 
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2 and 3,) and shown to contain dimers and monomers 
respectively. Hence, the globin chains in peak C would be 
the o:-o: crosslinked globins, and those under peak D, {J's. 
In Figure 8 (B), the glob in in peak E was analyzed to be 
dimers which would be the crosslinked {3-{3 chains (Fig. 22, 
lane 4) and thus, peak F, the o: chains (Fig. 22, lane 6). 
In Figure 8(C), the protein under peak G contained dimers 
(Fig. 23, lanes 4 and 5) and peak H, monomers (Fig. 23, 
lanes 6 and 7). These conclusions were based on the SDS 
gel electrophoresis results of the globin chains eluted 
under each peak of the chromatogram. The elution time of 
the different globins in these chromatograms could not be 
compared since the columns were repacked and buffers were 
remade. These changes may cause differences in the column 
bed volume and slight deviation in the salt gradient. 
After the glob in chains were hydrolyzed to amino acids, 
their amount were quantitated. Figures 9(A), (B), and (C) 
show the chromatograms for the elution of the individual 
amino acids. Figure 9(A) was a standard run containing 17 
amino acids, excluding tryptophan, asparagine, and 
glutamine. Figures 9(B) and (C) show the elution profile 
for the amino acids obtained from the purified o: and f3 
chains, respectively 
chromatograms show the 
(Fig. 7, 
presence 
peak 
of 15 
B and 
amino 
A). 
acids 
These 
in the 
hydrolysate. 
Gln, and Asn. 
The four amino acids missing were Ile., Trp, 
Neither of the a nor f3 globin contains Ile. 
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.[igure 9: 
.!A.l.: The chromatogran showing 
standard amino acids at 0.25 µM each. 
the elution of 
.LJil.: The chromatogram showing the elution of amino 
acids from the a globin . 
.Lill.: The chromatogram showing the elution of amino 
acids from the ~ globin. 
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The Trp was destroyed in the acid hydrolysis and would not 
be present in the hydrolysate. The Gln and Asn residues 
were oxidized to glutamate and aspartate, respectively and 
would be eluted under the known glutamate and aspartate 
peaks. Figures lO(A) and (B) show the chromatograms for 
the elution of the amino acid hydrolysate obtained from 
peaks G and H, respectively. The number of amino acids 
were consistent with those in Figure 9. Table 9 shows the 
printout results of the retention time, the relative area 
and the total amount of the amino acids corresponding to 
the chromatograms on Figures 9 and 10. The number of amino 
acid residues found experimentally were compared to the 
theoretical number. Table 10 shows the data obtained for 
the amino acid residues from the a and p chains compared to 
the amino acid residues obtained from the globins of the 
unknown crosslinked Hb A. The columns for peaks H and G 
correspond to the number of amino acid residues found from 
the globin chains eluted in the chromatogram of figure 
8(C), peaks H and G. The number of amino acid residues 
obtained under peak G (Fig. 8(C) and Fig. lO(A)) matched 
closely with the experimental and theoretical residues of 
the f3 chain, and those obtained under peak H (Fig. 8(C) and 
Fig. lO(B)) matched with the number of residues from the 
experimental and theoretical values of the a chain. Based 
on these findings the globins under peak G must be P-/3 
crosslinked. 
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£_igure 10: 
J.JLl_: The chromatogram showing the elution of amino 
acids from the globins under peak G of figure 8(C). 
The chromatogram showing the elution of amino 
acids from the globins under peak Hof figure 8(C). 
~O(A) !:: ::: 
lO(B) 
Table 9: 
Amino acid composition as determined by the Beckman 
Microcolumn Amino Acid Analyzer Model 121M. The amount is 
in µM. Runs 35 and 36 correspond to a and f3 chains 
respectively; runs 73 and 74 correspond to peak G and H of 
figure 8(C) 
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Table 10: 
comparison of the number of amino acid residues found 
from peaks G and H of figure 8 (C) to the theoretical and 
experimental residues of the a and p chains. Large 
differences in the number of amino acids between the a and 
p chains are underlined. 
Amino 
acids 
Asp 
Thr 
Ser 
Glu 
Pro 
Gly 
Ala 
Val 
Met 
Leu 
Tyr 
Phe 
His 
Lys 
Arg 
12 
9 
11 
5 
7 
7 
21 
13 
2 
18 
3 
7 
10 
11 
3 
13 12.5 
7 8.0 
5 8.0 
11 8.0 
7 7.0 
13 10.0 
15 18.0 
18 15.5 
1 1. 5 
18 18.0 
3 3.0 
8 7.5 
9 9.5 
11 11. 0 
3 3.0 
@ From theoretical values. 
* From experimental values. 
12.3 13.4 12.0 12.5 
9.3 6.5 8.3 6.5 
10.5 4.5 10.8 5.2 a 
5.4 10.7 =6~·=1~-=1=1~·~4 
2.4 3.2 4.7 4.5 
6.8 11.7 =8~·=2~-=1=3~·~8 
20.6 15.3 ~1_9~·-9~-=1~4~·~9 
12.6 14.6 =1=2~·=2~-=1~4~·~8 
2.4 2.5 2.3 1.2 
18.2 17.4 18.1 17.4 
4.4 7.7 3.4 3.2 
8.0 8.9 7.5 8.4 
10.4 9.8 12.7 11. 2 
11. 1 10.8 14.7 14.4 
3.1 3.0 2.9 3.1 
a Underline indicates large differences in amino acid 
between a and p chains. 
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c. CROSSLINKING OF HEMOGLOBIN A WITH 
DIMETHYLPIMELIMIDATE, TRIS(p-CHLOROETHYL) 
AMINE AND BIS(p-CHLOROETHYL) METHYLAMINE 
The hemoglobins crosslinked with dimethyl-
pimelimidate, tris(~-chloroethyl) amine, and bis(~­
chloroethyl) methylamine were not isolated by ion exchange 
chromatography due to the heterogeneous nature of the 
products as indicated by the alkaline clinical gel 
electrophoresis. Such a separation would not have yielded 
a single cross linked species. Nevertheless, the SDS gel 
electrophoresis indicated several species of molecular 
weight ranging from monomers to polymers. 
D. CLINICAL ALKALINE AGAROSE GEL 
ELECTROPHORESIS RESULTS 
The clinical alkaline agarose gel electrophoresis 
was used to identify the different proteins and check for 
homogeneity of the proteins. In this gel system the 
proteins were native, and those proteins which possessed 
higher negative charge would be moving faster toward the 
anode. Since the net surface charge on the Hb A molecule 
is more negative than that of Hb A2, Hb A would be expected 
to move faster anodically. Figure 11 shows the clinical 
gel of Hb A and Hb A2. The pools of hemoglobin samples 
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11: f.i.gure 
The clinical alkaline agarose gel electrophoresis of 
Hb A and Hb Az. Lane 1 is Hb A and lane 2, Hb Az from 
previous preparation. Lanes 3 is Hb A (Fig. 4, peak III), 
and lane 4, Hb Az (Fig. 4, peak II). 
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under each peak (Fig. 4, peaks II and III) corresponding to 
Hb A2 and Hb A were shown to be homogeneous based on this 
condition. 
Figure 12(A) shows the clinical gel of uncrosslinked 
and crosslinked Hb A prior to purification. Figure 12(B) 
shows the clinical gel electrophoresis scans for the a 
crosslinked hemoglobin sample. 
hemoglobin samples on the clinical 
The 
gel 
a crosslinked 
showed at least 
three major bands which were well separated from each 
other; one corresponded to the uncrosslinked hemoglobin, 
and the other two were modified proteins which had higher 
electrophoretic mobility than uncrosslinked Hb A. This 
property demonstrates that the crosslinked proteins could 
be purified free of contamination from each other. Of the 
two modified hemoglobins, one had slightly higher 
electrophoretic mobility than the other, and were less 
intense as judged by this gel. The gel scans (Fig. 12(B), 
scans 1 and 2) show a broad shoulder indicating the 
presence of this second modified protein. 
Figure 13 shows the clinical gel for the purified 
a99XLHb A sample from Figure 6. After purification by ion 
exchange chromatography the crosslinked hemoglobin could be 
resolved to a single band. Both the a99XLHb A and ~82XLHb 
A have the same electrophoretic mobility (Fig. 13, lanes 2, 
3 and 5). Figures 14(A) and (B) show the clinical gel for 
the ~82XLHb A sample and its gel scans, respectively. The 
99 
Clinical gel electrophoresis of fumarate 
crosslinked hemoglobins prior to purification. Lane 1 is 
a99XLHb A sample at higher hemoglobin concentration and at 
pH 7.0 during reaction (Fig. 6); lane 2, a99XLHb A sample 
at lower concentration and at pH 8.4 during reaction; lane 
3, control Hb A; lanes 4 and 5 are repeats of lanes 1 and 
2; lane 6, purified P82XLHb A; lane 7, control Hb A2. 
Gel scans of the clinical gel of fumarate 
crosslinked hemoglobins in figure 12(A). The scan numbers 
correspond to the lane numbers in figure 12(A). The 
crosslinked hemoglobins have higher electrophoretic 
mobility toward the cathode since two positive charges from 
two lysines were deleted due to covalent crosslinking to 
the fumarate group. 
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I..igure 13: 
Clinical gel electrophoresis of purified fumarate 
crosslinked hemoglobins. Lane 1 is Hb A (Fig. 6, peak I); 
lane 2, purified a:99XLHb A (Fig. 6, peak II); lane 3, 
purified ~82XLHb A; lane 4, the unknown crosslinked 
hemoglobin (XLHb A) (Fig. 6, peak III); lane 5, purified 
a99XLHb A; lane 6, Hb A; lane 7, control Hb A; and lane 8, 
control Hb A2· 
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ill.: Clinical gel electrophoresis of ,882XLHb A 
sample. Lanes 1 and 2 are unpurified ,882XLHb A; lane 3, 
purified ,882XLHb A; lane 4 and 5, control Hb A and Hb A2, 
respectively; lane 6, co-mixture of Hb A and unpurified 
,B82XLHb A; and lane 7, co-mixture of Hb A and purified 
,B82XLHb A . 
..UU..: Gel scans of the clinical gel of figure 14(A) 
showing the relative position of the ,882XLHb A to Hb A. 
The scan numbers correspond to the lane numbers in figure 
14(A). 
Hb A. 
The ,882XLHb A moves faster toward the cathode than 
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p crosslinked hemoglobin samples shows two major bands 
which corresponded to the uncrosslinked Hb A and the 
pB2XLHb A as shown on the clinical gel of Figure 14(A) 
lanes 1, 2, 6 and 7, and scans 1 and 2 of Figure 14(B). 
The p82XLHb A could be purified from contamination of Hb A 
to homogeneity by ion exchange chromatography as shown in 
figure 5 (peak II) and lane 3 of figure 14(A). 
Figures 15(A) and (B) show the clinical gel for 
hemoglobin treated with dimethylpimelimidate 
gel scans, respectively. Figures 16 (A) and 
(DMP) and its 
(B) show the 
clinical gel and its scans, respectively, for a99XLHb A 
treated with DMP. Figures 17(A) and (B) show the clinical 
gel and its scans for the nitrogen mustards treated 
hemoglobins. 
The crosslinking of hemoglobins using the imidoester 
and the nitrogen mustards caused diffused bands for the 
crosslinked hemoglobin on the clinical gel. The amount of 
modification is dependent on the crosslink concentration. 
When the same imidoester crosslink between two lysines the 
net charge remains the same, but if one end is hydrolyzed 
then a positive charge would have been added since the 
imidate nitrogen is positively charged under these 
conditions. Thus, the microheterogeneity was caused by the 
reaction being nonselective 
functional end of the reagent. 
extent of modification on the 
and reacted at only one 
Hence, depending upon the 
hemoglobin molecule, those 
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Clinical gel electrophoresis of Hb A-DMP. 
Lane l, control Hb A; lane 2, control P82XLHb A; lane 3, Hb 
A-DMP; and lane 4, p82XLHb A-DMP. 
Gel scans of the clinical gel in figure 15(A). 
The scan numbers correspond to the lane numbers of figure 
15 (A). The DMP treated hemoglobins indicate heterogeneous 
modified species in both Hb A-DMP and P82XLHb A-DMP. In 
the p82XLHb A-DMP more negatively charged species were 
obtained. The broaden shoulders on both sides of scans 3 
and 4 indicate both negatively and positively charged 
species were formed. 
move cathodically. 
A small amount of modified species 
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iAl_: Clinical gel electrophoresis of DMP treated 
a99XLHb A sample. Lane 1 is control Hb A; lane 2 and 4, 
a99XLHb A-DMP; and lane 3, control P82XLHb A. 
Gel scans of the clinical gel in figure 16(A). 
The scan numbers correspond to the lane numbers of figure 
16(A). The DMP treated a99XLHb A indicates heterogeneous 
modified species 
were formed. The 
with different electrophoretic mobility 
broaden shoulder on both sides of the 
peak (scans 2 and 4) indicates that both negatively and 
positively charged species were obtained. 
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start 
17: wure 
.!..Al_: Clinical gel electrophoresis of TCEA and BCEA 
treated hemoglobins. Lanes 1 and 2 are Hb A-TCEA; lane 3, 
Hb A-BCEA; lane 4, control Hb A; lane 5, control P82XLHb A; 
and lane 6, control a99XLHb A. The Hb A-TCEA and Hb A-
BCEA appear as diffused bands on the gel due to 
heterogeneous modified species. 
less diffused. 
However, the Hb A-BCEA is 
Gel scans of the nitrogen mustards treated 
hemoglobins from figure 17(A). The scan numbers correspond 
to the lane numbers of figure 17(A). The amount of 
positively charged species obtained is predominated in Hb 
A-TC EA. 
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derivatives that are highly modified due to higher reagent 
concentration will have lower electrophoretic mobility and 
move slower than others which have fewer modifications. 
This agrees with the results from side reaction of the 
imidoester with ammonia, glycine and trizma buffer (48). 
In some reactions, a small amount of the highly DMP 
modified species moved cathodically instead. Based on the 
net charge of the modified protein DMP reacted with Hb A, 
a99XLHb A 
(Fig. 15 
and ~82XLHb A, to give heterogeneous species 
and 16). In the a99XLHb A-DMP and ~82XLHb A-DMP 
at least one modified protein which had the same net charge 
as Hb A was predominant (Fig. 15(B), scan 4; Fig. 16(B), 
scans 2 and 4). 
The nitrogen mustard derivatives also caused diffuse 
bands for the crosslinked hemoglobins on the clinical gel. 
This was due to the same reasons as for the imidoester 
crosslinked hemoglobins. The nitrogen mustards reacted 
with hemoglobin randomly to yield heterogeneous species. 
Some of these modified species having large number of 
positively charge groups on them due to the positive charge 
of the nitrogen, moved cathodically. The hemoglobin 
crosslinked with BCEA diffused less than the hemoglobin 
crosslinked with TCEA (Fig. 17(A) lanes 1, 2, and 3). The 
PKa's of diethylamine and triethylamine are 10.99 and 
10.76, respectively (117). Under the conditions of the 
clinical gel used (pH 8.6) both of these reagents would 
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bear positive charges at the nitrogen. By analogy to the 
derivatives of these compounds, BCEA and TCEA which are 
tertiary amine, would argue strongly in favor of a positive 
charge at the nitrogen of these reagents. The TCEA appears 
to be more reactive than BCEA, and hence the BCEA reaction 
yielded less crosslinked species. 
In the Hb A-TCEA reaction at least three predominant 
modified hemoglobin species were obtained based on the net 
charge of the proteins. Some crosslinked species yielded 
in this reaction were more positively charged than Hb A, 
and a small fraction was more negatively charged (Fig. 
17(B), scans 1 and 2). The SDS results indicated clearly 
two cross linked species having molecular weight 
corresponding to a dimer (Mr 32,000) and a trimer (Mr 
48,000) species in addition to some tetrameric and 
polymeric species (Fig. 19(A) and (B), lanes or scans 2, 3, 
and 4) . 
In the Hb A- BCEA react ion only dimer i c cross 1 inked 
species were obtained as judged by SDS results (Fig. 19(A), 
lane 2) . The gel scan shows one predominant peak 
corresponding to that of Hb A, and a broaden shoulder at 
the base of the peak indicating the diffused species shown 
on the clinical gel (Fig. 17 (A) , lane 3 ) . This 
demonstrated that the crosslinked species were present in 
less amount compared to uncrosslinked species. 
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s. SDS GEL ELECTROPHORESIS RESULTS 
Figure 18 shows the SDS gel results of purified 
crosslinked hemoglobins. From these results all the 
crosslinked proteins show two bands of equal intensity 
corresponding to molecular weight of a monomer (Mr 16,000) 
an a a dimer (Mr 3 2 , 0 0 0 ) . This demonstrated that the 
cross linking span was between two subunits, and that the 
crosslinking was selective at specific sites. 
shows only one band corresponding to a monomer. 
The Hb A 
Figures 19(A), (B), (C) and (D) show the SDS results 
for the hemoglobin crosslinked with DMP and nitrogen 
mustard derivatives. The DMP reactions with both 
uncrosslinked and crosslinked hemoglobins at 500:1 molar 
ratio of reagent to hemoglobin yielded crosslinked species 
which have molecular weight corresponding to dimers (Mr 
32,000), trimers (Mr 48,000), tetramers 
polymers (Mr > 64, 000) as shown on lane 8 
scan 8 (Fig. 19(B)) and lanes 1 and 7 
(Mr 64, 000) 
(Fig. 19(A)) 
(Fig. 21). 
and 
or 
The 
reaction of DMP with hemoglobin resulted in crosslinked 
species which did not concentrate as sharp bands on the SDS 
gel but were diffused compared to other known crosslinked 
species ran on the same gel. The crosslinked species were 
predominant compared to the monomers present. The low 
amount of monomers, as shown by the SDS gels, would be in 
agreement with the large percent of crosslinked species 
120 
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SDS gel electrophoresis of fumarate crosslinked 
hemoglobins. Lanes 1, 2, 9 and 10 are repeats of a99XLHb 
A; lane 3, unknown crosslinked hemoglobin (XLHb A) (Fig. 6, 
lanes 4 and 8, control Hb A· 
' 
lanes 5 and 6, peak III); 
,882XLHb A; and lane 7, marker proteins. The marker 
proteins used are: bovine serum albumin (Mr 66K), egg 
albumin (Mr 45K), glyceraldehyde-3-phosphate dehydrogenase 
(Mr 36K), carbonic anhydrase (Mr 29K), trypsinogen (Mr 
24K), trypsin inhibitor (Mr 20. lK) and a- lactalbumin (Mr 
14.2K). The direction of movement is from top to bottom. 
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SDS gel electrophoresis of DMP and nitrogen 
mustards treated hemoglobins. Lane 1 is Hb A; lane 2, Hb 
A-BC EA; lane 3, Hb A-TCEA from reaction I; lane 4, Hb A-
TCEA from reaction II; lanes 5 and 10, marker proteins; 
lane 6, catalase; lane 7, mixture of CAT-DMP and Hb A-DMP 
(200:4:1); lane 8, a99XLHb A-DMP (500:1); and lane 9, Hb A-
DMP (50: 1). The direction of movement is from top to 
bottom. 
ill.: Gel scans of the SDS gel in figure 19(A). The 
scan numbers correspond to the lane numbers in figure 
19(A). The dimer, trimer and tetramer are apparent in 
scans 3 and 4 (Hb A-TC EA), and scans 8 (a99XLHb A-DMP, 
500:1) and 9 (Hb A-DMP, 50:1). 
Estimation of the molecular weight of 
crosslinked species in Hb A-TCEA by the plot of Log(MW) 
versus relative mobility. This estimation was from the 
large SDS gel. T represents trimer; D, dimer; and M, 
monomer. 
Estimation of the crosslinked species in DMP 
and nitrogen mustards treated hemoglobins. The majority of 
crosslinked species are dimeric, trimeric and tetrameric as 
indicated by X's. 
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obtained. The gel scan resolution showed that the 
crosslinked species in relative percent were 4.3% monomers, 
19.7% dimers, 30.3%, trimers, and 45.7% both tetramers and 
polymers 
obtained 
for a99XLHb A-DMP. 
in fi82XLHb A-DMP 
The 
are 
percent of each species 
5.2%, monomers; 14.7%, 
dimers; 27.2%, trimers; and 52.9%, tetramers. 
The percent of trimeric and tetrameric species 
obtained in the Hb A-DMP (500:1) compared to those of 
a99XLHb A or fi82XLHb A (500:1) were lower, but the dimer 
was higher. The crosslinked species in the Hb A-DMP 
(500:1) had the same molecular weights as those in the 
a99XLHb A-DMP and fi82XLHb A-DMP (500:1). The percent of 
species in Hb A-DMP obtained from SDS gels were 6.7% 
monomers, 40.9% dimers, 27.0% trimers and 25.4% tetramers. 
The DMP reaction with Hb A at 50:1 yielded 
predominantly dimers, some trimers, and a small fraction of 
tetramers. The corresponding percent of each species as 
judged by SDS results were 22.4% monomers, 55.1% dimers, 
18.4% trimers and 4.1% tetramers. 
In Figure 19(C), the estimation of the molecular 
weight of the Hb A-TCEA crosslinked species was done on a 
larger SOS slab gel. The plot of log(MW) versus relative 
mobility showed that the crosslinked species obtained in 
this crosslinking reaction were largely dimers and trimers; 
a small percent of polymers were obtained as well.. The 
corresponding percentage of these species as determined by 
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the SDS gel scan were 25.6% monomers, 46.5% dimers, 18.5% 
trimers and 9.3% tetramers (Fig. 19(A) lanes 3 and 4; Fig. 
19(B) scans 3 and 4). For the Hb A treated with BCEA the 
sDS gel scan showed 43.9% dimers and 54.8% monomers (Fig. 
19(A) lane 2; Fig. 19(B) scan 2). 
In Figure 19(D), the estimation of the molecular 
weight of species crosslinked by DMP, TCEA and BCEA show 
that the crosslinked species fall in three regions: dimer, 
trimer and tetramer. But there are more scattering points 
around the region of tetramer due to polymeric species. 
Table 11 shows the percent of uncrosslinked and crosslinked 
hemoglobins treated with DMP, TCEA, and BCEA as obtained 
from the SDS gel scan results. Table 12 shows the 
difference in Tm's with respect to the number of crosslinks 
per tetramer or species. Figure 20 shows the average 
minimum number of crosslinks per tetramer or species with 
respect to .6Tm. The number of crosslinks per species is 
reflected in the increase in .6Tm· 
Figure 21 shows the SDS results for the reaction of 
DMP with Hb A and CAT. This was an attempt to try to 
crosslink the Hb 
catalase complex 
A to CAT with DMP, to 
(CAT-Hb A-DMP). The 
form hemoglobin-
DMP was able to 
crosslink both the CAT and Hb A separately, but did not 
bridge the hemoglobin molecule to the catalase molecule. 
The reaction with a molar ratio of 2000:4:1 of reagent to 
Hb A to CAT yielded species with molecular weight similar 
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Table 11: 
percent of uncroslinked and crosslinked hemoglobins 
reacted with DMP, TCEA, and BCEA as determined by SDS gel 
scans. 
@.. Monomer Dimer Trimer Tetramer 
Hb A-BCEA 54.8 45.2 
Hb A-TCEA I 25.6 46.5 18.5 9.3 
Hb A-TCEA II 31. 0 48.3 17.2 3.4 
Hb A-DMP (50:1) 22.4 55.l 18.4 4.1 
Hb A-DMP (500:1) 6. 7 40.9 27.0 25.4 
a99XLHb A 45.5 54.5 
,882XLHb A 35.4 64.5 
XLHb A 49.1 50.9 
a99XLHb A-DMP 
(500:1) 8.3 18.8 29.2 43.7 
,882XLHb A-DMP 
(500:1) 5.2 14. 7 27.2 52.9 
Minimum Number 
of Crosslinks 
per Species 0 1 2 3 
Minimum Number 
of Crosslinks 
per Tetramer 0 2 2 3 
Table 12: 
The minimum average number of crosslinks per species or 
tetramer for crosslinked hemoglobins. 
~mo glob ins 
Hb A-BCEA 
Hb A-TC EA 
Hb A-DMP (500:1) 
a99XLHb A-DMP 
(500:1) 
,882XLHb A-DMP 
(500:1) 
-0.1 
8.2 
15.1 
17.0 
19.4 
Cross links 
per Species 
0.45 
0.93 
1. 71 
2.08 
2.28 
Crosslinks 
per Tetramer 
0.90 
1. 41 
2.12 
2.27 
2.42 
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~: 
The average number of crosslinks per species (0) and 
per tetramer (x) with respect to ~Tm. From lower to higher 
ll.Tm the points represent consecutively Hb A-BCEA, Hb A-
TCEA, Hb A-DMP (500:1), a99XLHb A-DMP (500:1) and ,882XLHb 
A-DMP (500: 1). 
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SDS gel electrophoresis of DMP treated hemoglobin 
d CAT-Hb A-DMP complex. Lane 1 is Hb A-DMP (500:1); lane an 
2' 
CAT-Hb A-DMP complex (2000:4:1); lane 3, CAT-DMP 
(2000:1); lane 4, Hb A-DMP (50:1); lane 5, CAT-Hb A-DMP 
(200:4:1); lane 6, CAT-DMP (200:1); lane 7, a:99XLHb A-DMP 
(500:1); lane 8 and 10, marker proteins; and lane 9, Hb A. 
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- 45K 
1 2 3 8 9 10 
tO that in 
the Hb 500:1, except there was one 
additional band at high molecular weight 116,000). 
ThiS high molecular weight species was due to the 
crosslinked dimer of CAT, and the catalase monomer band was 
buried with the tetramer band of the Hb A-DMP (Fig. 21, 
lanes 1 and 2) . The reaction with the molar ratio of 
200:4:1 yielded four bands (lane 5 ) , but two of the bands 
with molecular weight of 58,000 daltons and 116,000 daltons 
corresponded to the monomer and dimer of CAT (Fig. 21, 
lanes 3 and 6); and the other two bands at molecular weight 
of 3 2, 000 dal tons and 48, 000 da 1 tons co rre s p on de d to the 
dimer and trimer of Hb A (Fig. 21, lane 4). If Hb A had 
been crosslinked to CAT at least a species of molecular 
weight 74,000 daltons would have been observed. Thus, the 
DMP was unable to bridge the Hb A and the CAT to form a 
hemoglobin-catalase complex at both of these conditions. 
Figures 22 shows the SDS results of globin chains 
obtained by cation exchange chromatography from Figures 
8(A) and (B). The globin chains in lanes 1, and 2 
indicated that only dimer species were present under peak C 
(Fig. 8(A)). Since these globins were from a99XLHb A, the 
globin chains under peak C were the a-a crosslinked 
globins, and those under peak D (Fig. 8(A)) were the 
uncrosslinked ~ chains as indicated by the monomer species. 
The globin chains on lanes 4 and 6 were from the P82XLHb A. 
On lane 4 the globins present were dimers, and lane 6 were 
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SDS gel electrophoresis of globin chains purified 
from CM52 gel. Lane 1 and 2 are repeat of glob in chains 
under peak C of figure 8(A) (a-a crosslinked globins); lane 
3, globin chains under peak D of figure 8 (A) ({:J globin); 
lane 4, globin chains from peak E of figure 8(B) ({:J-{:J 
crosslinked globins); lane 5, marker proteins; and lane 6, 
globin chains from peak F of figure 8(B) (a globin). 
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111onomers. This demonstrated that the globins in peak E 
(Fig. 8(B)) were the fJ-{:J crosslinked globins, and lane 6 
(Fig. 8(B), peak F) contained the uncrosslinked a globins. 
Figures 23 shows the SDS results of globin chains 
from Hb A (Fig. 7) and the unknown crosslinked hemoglobin 
(Fig. 6, peak III). Lanes 1, 3, and 8 all indicated that 
monomers were present, which should be the case since these 
lanes contained uncrosslinked globin chains. Lanes 4 and 5 
contained only dimers (Fig. 8(C), peak G) and lanes 6 and 7 
contained only monomers (Fig. 8(C), peak H). The globins 
in peak G were identified to be fJ-fJ's and peak H, a's. 
III. 
A. 
THERMAL STABILITY OF HEMOGLOBINS 
THERMAL STABILITY OF a99XLHb A VERSUS 
p82XLHb A AND NORMAL Hb A 
The thermal stability of hemoglobins crosslinked 
between the a chains was determined and compared with that 
of the fJ crosslinked and uncrosslinked hemoglobins. Figure 
24 shows the plot of absorbance versus wavelength as 
temperature was raised for a sample of Hb A. The 
temperature effects a decrease on the Soret absorbance of 
the hemoglobin as the temperature was raised. However, the 
chromophore at the near ultraviolet region was increased as 
the temperature was raised. The denaturation of hemoglobin 
is not reversible. After the denaturation experiment the 
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wure 23: 
SDS gel electrophoresis of globin chains from Hb A 
and the unknown crosslinked hemoglobin (Fig. 6, peak III). 
Lane 1 is Hb A (a and~ chains); lane 2, marker proteins; 
lane 3, globin chains under peak A (~ globin) (Fig. 7); 
lanes 4 and 5, repeat of glob in chains under peak G of 
figure B(C) (cross linked globins); lanes 6 and 7, repeat of 
globins under peak H of figure B(C) (uncrosslinked 
globins); and lane 8, globin chain under peak B (a globin) 
(Fig. 7). 
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EJ_.gure 24: 
The effect of temperature on the absorbance of 
plotted as absorbance with respect to hemoglobin 
wavelength. From top to bottom at 410 nm, the solid line 
( _____ ) represents the absorbance at 25°C, 31°C, 39°C, 
48°C, 56°C, 65°C and 74°C. The (- • --) is the return 
spectrum after cooling to room temperature (22°C). 
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Ple was cooled back to room temperature and the original salll 
Um was not recovered fully, however, the return spec tr 
spectrum was recovered nearly 50% as shown by the dash-dot 
line. Figure 25 shows the denaturation transition 
monitored by using the absorbance at 406 nm with respect to 
temperature. The temperature transition on the Soret band 
is broad and begins at approximately 30-50°C until it 
reaches a plateau. 
Figure 26 shows the first derivative spectra of the 
absorbance at 406 nm with respect to temperature for Hb A, 
a99XLHb A, p82XLHb A, and the unknown XLHb A. The single 
crosslink on the hemoglobin molecule either between the Lys 
82P1 and Lys 82P2 or Lys 99a1 and Lys 99a2 causes a higher 
denatured transition in the diaspirin cross linked 
hemoglobins than in the uncrosslinked Hb A. The 
temperature transition spans from 46-66°C. The minimum of 
the a99XLHb A is at 56.7°C, those of the p82XLHb A and XLHb 
A are 56.6°C and 57.6°C respectively, compared to 41°C of 
Hb A; within the limit of error all of these crosslinked 
proteins have the same thermal stability. 
B. THERMAL STABILITY OF SINGLE CROSSLINKED HEMOGLOBINS 
WITH DIMETHYLPIMELIMIDATE, TRIS(p-CHLOROETHYL) AMINE 
AND BIS(p-CHLOROETHYL) METHYLAMINE. 
The imidoester and nitrogen mustard derivatives 
144 
Figure 25: 
The plot of absorbance versus temperature showing 
the denaturation transition at 406 nm of hemoglobin. 
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2 6 ·. fj_gure 
The first derivative of absorbance with respect to 
temperature at 406 nm for Hb A <~~-), a99XLHb A ( .... ), 
i982XLHb A (- . -- • - ) , and XLHb A ( ____ ) . The 
Tm is the temperature at the minimum. The a99XLHb A, 
i982XLHb A and XLHb A have the same stability. 
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reacted with hemoglobins randomly and did not produce a 
single crosslinked protein as judged by clinical and SDS 
gels. The thermal stability of these modified proteins 
thus represents an average value of the crosslinked species 
in the mixture. At the high end temperature the hemoglobin 
treated with DMP formed turbidity in the so 1 u t ion during 
thermal denaturation and thus caused light scattering. 
This problem was corrected by subtracting the absorbance of 
a wavelength which did not change over the entire 
denaturation time span of a sample in which turbidity was 
not observed. During the denaturation span turbidity was 
not observed in the Hb A sample, and the optical density at 
522 nm did not change. Thus, the absorbance of 522 nm was 
subtracted from the absorbance of a wavelength under 
examination at each temperature of the same sample. Figure 
27 shows the effect of temperature on the absorbance at 406 
nm, 522 nm and the application of the subtraction method. 
There was very little or essentially no effect on the 
absorbance at 522 nm as the temperature was raised (Fig. 
27, dotted line). The solid line is the non-subtractive 
plot; the dash-dot-dash line, closely tracing the non-
subtractive curve, is a demonstration of the subtraction 
from the absorbance at 522 nm, and the dotted line is the 
absorbance tracing at 522 nm without any subtraction. In 
this case there was not any precipitation in the sample, so 
using the subtractive and non-subtractive method yielded 
149 
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The effect of subtraction in a non-precipitated 
sample at 406 nm ( ___ ) and 522 nm ( .... ) of Hb A. The 
subtracted absorbance of a non-precipitated Hb A sample at 
4 O 6 nm ( - • - • -) · For a non-precipitated sample the 
non-subtracted or subtracted curve has the same transition. 
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-·- SUBTRACTIVE PLOT AT 401 ,. 
••••••• NDN-SUBTRACTJVE PLOT AT S22,. 
I· 
....................................................... ·-............................................. . 
24 28 39 40 -44 48 52 se eo 14 •• 72 
TEMPERATURE <C> 
the same temperature transition. 
Figure 28 shows the application of the subtraction 
method for an a99XLHb A-DMP sample at 406 nm and 522 nm. 
The solid line is the non-subtractive plot; the dash-dot-
dash line is the subtractive plot, and the dotted line is 
the absorbance tracing at 522 nm. It was assumed that the 
temperature effect on the optical density at 522 nm of a 
crosslinked sample did not change as in the case of Hb A, 
and that the changes observed in the absorbance at 522 nm 
of the DMP treated samples were caused by light scattering 
due to precipitation of the samples. This assumption means 
that the absorbance at 522 nm with respect to temperature 
must be a straight line; and it is so if any changes in 
absorbance are subtracted from themselves. The effect of 
light scattering on the absorbance at 522 nm and the 
absorbance of a wavelength under examination is assumed to 
be the same. Since the temperature at the initial increase 
in absorbance at 522 nm corresponds to the same temperature 
as the break due to precipitation of the non-subtractive 
plot, any increase in absorbance beyond this point was due 
to precipitation. All the non-precipitating samples did 
not show any increase in absorbance at 522 nm. This 
subtraction corrects the base line of all spectra to be the 
same. The extrapolation to correct the base line by 
plotting absorbance versus A4 and the subtraction using 630 
nm yielded the same Tm's. Therefore, this assumption 
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~: 
Comparison of the subtracted and non-subtracted 
transition curve at 406 nm for a99XLHb A-DMP sample. The 
absorbance at 522 nm ( ... ) is subtracted from that at 406 
nm ( ___ ) · The ( __ 
subtracted curve at 406 nm. 
__ ) is the result of the 
All the DMP treated hemoglobin 
samples are analyzed by this method. 
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should be correct. All the hemoglobins modified with DMP 
were analyzed by the subtractive method. 
Figure 29 shows the effect of stabilization by 
single crosslinking on Hb A plotted as the 
denatured (fo) with respect to temperature at 406 
fraction 
nm. The 
transition for hemoglobin treated with BCEA, TCEA and DMP 
is much broader than the ones observed for Hb A and the 
diaspirin crosslinked Hb A. The transition of Hb A-BCEA 
covered from 32-56°C, that of Hb A-TCEA, 32-60°C, and 38-
660C for Hb A-DMP. All the modified hemoglobins have a 
temperature transition higher than that of Hb A, except for 
the hemoglobin crosslinked with BCEA. The Hb A-BCEA (10:1) 
has a transition equal to that of Hb A. The hemoglobin 
crosslinked with diaspirin produced the most stable single 
crosslink proteins. These are the a99XLHb A and ~82XLHb A; 
their Tm's are 57°C. The next most stable hemoglobin 
derivative is Hb A-DMP at 500:1 molar ratio of reagent to 
hemoglobin; its Tm is 56.l°C. The Hb A-DMP at 1000:1 molar 
ratio has comparable Tm (57°C) to those of the diaspirin 
crosslinked hemoglobins (48). The Hb A-TCEA at 10:1 molar 
ratio yielded an intermediate temperature transition; its 
Tm is 49.3°C (48). 
C. THERMAL STABILITY OF DOUBLE CROSSLINKED HEMOGLOBINS. 
The a99XLHb A and ~82XLHb A were double crosslinked 
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~: 
The effect of stabilization on the singly 
crosslinked hemoglobins plotted as fn with respect to 
temperature for Hb A <~~-), Hb A-BCEA ( .... ) , Hb A-TCEA 
( __ ~ ~), Hb A-DMP (500:1) <~. ~. ~), a99XLHb A 
<~ __ ~- __ ~-), and ~82XLHb A<~-_~-_~-). 
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with DMP at a molar ratio of 500: 1 pH 9. 5 in order to 
produce crosslinked proteins with higher molecular weight. 
Figure 30 shows the effect of double crosslinking on the 
thermal stability of the a and f3 crosslinked hemoglobins 
analyzed by the first derivative of the absorbance with 
respect to temperature. The diaspirin double crosslinked 
hemoglobins have slightly higher Tm's than the singly 
crosslinked proteins. The increase in Tm of the double 
crosslinked hemoglobins is approximately 3°C compared to 
that of the singly crosslinked hemoglobins. The {382XLHb A-
DMP has slightly higher stability than the a99XLHb A-DMP, 
but within the limit of error they both have the same 
stability. In comparison to Hb A the Tm of the double 
crosslinked proteins has increased by l8°C. 
Table 13 shows the values of Tm's for all the 
crosslinked hemoglobins determined from the Soret band at 
406 nm, and 418 nm; and the aromatic chromophore at 280 nm. 
Table 14 shows the change in Tm's of 
hemoglobins relative to uncrosslinked Hb A. 
cross linked 
The average 
Tm's of Hb A was taken to be 43°C for the data determined 
at 280 nm, and 41°C for those determined from 406 nm and 
418 nm. 
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The effect of stabilization on the double 
crosslinked hemoglobins plotted as the first derivative 
with respect to temperature for Hb A (~~-), a99XLHb A 
(___ _ ~- ____ ), a99XLHb A-DMP (_ _ _), p82XLHb A 
( ______ ), ,882XLHb A-DMP (_. _. _). 
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Table 13: 
The Tm values of modified hemoglobins at 280 nm, 406 nm, 
and 418 nm as de te rmi ned by the fraction denatured with 
respect to temperature. 
280 nm 
Hb A 42.5 ± 1.9 
Hb A-BCEAa 41.7 ± 2.0 
Hb A-TCEA Ia 50.5 ± 0.82 
Hb A-TCEA Ila 49.1 ± 1.3 
Hb A-DMPb 58.5 ± 0.71 
a:99XLHb A 57.9 ± 1.1 
,882XLHb A 57.9 ± 1.8 
XLHb A 59.0 ± 0.21 
a:99XLHb A-DMPb 54.5 ± 1.4 
,882XLHb A-DMPb 61.1 ± 3.9 
406 nm 418 nm 
40.9 ± 0.75 40.8 ± 1.5 
41.3 ± 1.1 40. 8 ± 1. 8 
49.3 ± 1.2 50.8 ± 0.96 
45.2 ± 1.6 46.5 ± 1.3 
56.1 ± 1.5 56.2 ± 1.9 
56.7 ± 1.1 56.5 ± 1.2 
56.6 ± 0.37 56.2 ± 0.24 
57.6 ± 0.32 57.3 ± 0.33 
58. 7 ± 0.36 59.4 ± 0.57 
60.4±1.7 61.4 ± 1.5 
a The molar ratio of reagent to hemoglobin used in the 
reactions were 10:1 for BCEA, 11:1 for TCEA I, and 40:1 
for TCEA II. For the TCEA II the reagent was dissolved 
in the buffer before mixing with hemoglobin. 
b The DMP molar ratio to hemoglobin was 500:1. 
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Table 14: 
The t.Tm values showing the effect of stabilization due to 
single and double cross linking relative to the Tm of Hb A. 
for Hb A, at 280 nm the average Tm is 43°C and at 406 nm, 
41•c. 
ilt 280 nm 406 nm 418 nm 
Hb A-BCEA -2.0 ± 1. 5 -0.l ± 1. 6 0.3 ± 0.88 
Hb A-TCEA I 7.5 ± 0.82 8.2 ± 1. 2 11.0 ± 1. 4 
Hb A-TCEA II 5.8 ± 1. 5 4.2 ± 1. 6 6.4 ± 1. 4 
Hb A-DMP 15.5 ± 0.71 15.1 ± 1. 5 15.2 ± 1. 9 
a99XLHb A 14.9 ± 1. 2 15.4 ± 0.78 15.5 ± 1. 3 
,882XLHb A 14.9 ± 1. 8 15.6 ± 0.37 14.8 ± 0.21 
XLHb A 16.0 ± 0.25 16.6 ± 0.37 16.3 ± 0.40 
a99XLHb A-DMP 11.5 ± 1. 4 17.0 ± 1. 7 17.9 ± 1.3 
,882XLHb A-DMP 18.1 ± 3.9 19.4 ± 1. 7 20.4 ± 1. 5 
AUTOXIDATION OF HEMOGLOBINS IV. 
A. THE AUTOXIDATION OF Hb A, a99XLHb A AND p82XLHb A 
The hemoglobin used in the autoxidation experiments 
was freshly 
purification 
purified and used 
of hemoglobins 
within 
by the 
four days. The 
method described 
elsewhere in this dissertation should have removed all the 
DPG and other red cell proteins. Figure 31 shows the 
change of the Hb A spectra between 500-700 nm as a result 
of autoxidation at 37°C between zero and 107 hours. At 107 
hours the absorbance at 540 nm and 576 nm decreased, and 
that at 630 nm increased (dash-dot-dash curve); this 
the demonstrated that met hemoglobin was formed in 
hemoglobin solution, and the oxy hemoglobin concentration 
was diminished. After addition of sodium cyanide to the 
solution the result due to oxy and cyanomet hemoglobins 
present in the mixture is shown by the dash double - dash 
curve. The decrease in absorbance at 576 nm compared to 
the original spectrum at zero hour (solid curve) indicated 
that little oxy hemoglobin was present and a large amount 
of it was converted to cyanomethemoglobin. After complete 
conversion to 100% cyanomet hemoglobin the spectrum was 
shown by the dash curve. 
Figure 32 shows the linearity of the absorbance 
versus oxy hemoglobin concentration with an optical density 
below 2.0 for the wavelengths at 540 nm (solid line), 576 
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The visible spectral change of hemoglobin during 
autoxidation between zero and 107 h at 37°C; at zero hour, 
l00% oxy hemoglobin <~~~->; at 107 h, mixture of met and 
oXY hemoglobin <~- . ~~>; after addition of NaCN 
<- - - -- and after complete conversion to 
100% cyanomet hemoglobin <~ ~ ~ 
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Linearity of absorbance versus hemoglobin 
concentration at 540 nm <~~- 576 nm ( .... ), and 630 nm 
<-
relationship 
absorbance. 
with 
___ ). The absorbance has a linear 
concentration up to 2.0 unit of 
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nm (dotted line), and 630 nm (dash-dot-dash line). All 
three wavelengths still have linear relationship with 
respect to hemoglobin concentration at an optical density 
below 2.0. The deviation of absorbance from linearity with 
concentration begins at 2.6 for this spectrophotometer. 
This result agrees with that obtained by Corso (48), and by 
using a sample of ferricyanide as well (data not shown). 
Figure 33(A) shows the development of met hemoglobin 
with respect to time for Hb A and diaspirin crosslinked 
hemoglobins. At 37°C the percent of met hemoglobin in 
a99XLHb A (open circle curve) at any given time is higher 
than what was in the ~82XLHb A (open triangle curve), or Hb 
A (solid circle curve). The met hemoglobin developed in 
~82XLHb A was slightly higher than what was in Hb A. The 
autoxidation of Hb A at room temperature (22°C, solid 
triangle curve) is slower than at 37°C (solid circle curve) 
and at 4°C, in the refrigerator, Hb A essentially had not 
autoxidized during the period of autoxidation experiment 
(open square curve). After 130 h the met hemoglobin 
remains at 5%. Figure 33(B) shows the formation of met 
hemoglobin during the first 20 hours of autoxidation. The 
percent of met hemoglobin developed under these conditions 
is directly proportional to time. Tab le 15 shows the 
percent of met hemoglobin with respect to time for Hb A, 
Q99XLHb A and ~82XLHb A. 
Figure 34(A) and (B) show the rate of autoxidation 
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_El...gure 33: 
fAl.: The development of met hemoglobin as a 
function of time for Hb A at 4°C (-0-0-), Hb A at 22°C 
( • '* ) , Hb A at 3 7 ° C ( e e ) , fJ 8 2XLHb A at 
3 7 ° C ( ----6.----/}--) , and a9 9XLHb A at 3 7 ° C ( --0--0--). 
_(fil: The autoxidation of hemoglobin within 20 h at 
37°c for Hb A (--e • ), fJ82XLHb A ( -t::.-b.--), and 
a99XLHb A (---0---0---), showing the linear relationship of 
met hemoglobin with respect to time. 
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Table 15: 
Autoxidation of oxy Hb A and a99XLHb A in 0.01 M MOPS, pH 
7 .o at 37°C. The concentration of hemoglobins were 1.95 mM 
Hb A, 1.90 mM a99XLHb A, and 1.90 mM ~82XLHb A per heme. 
J:_ime (h) % met Hb A % met a99XLHb % met 882XLHb 
0.0 1. 52 ± 0.63 4.50 ± 0.13 1.8 ± 1. 05 
1. 0 1. 56 ± 0.00 
------------ ------------
2.5 4.11 ± 3.55 13.55 ± 2.44 4.63 ± 1. 20 
5.0 8.68 ± 3.92 21.27 ± 0.88 10.76 ± 1.69 
7.5 12.00 ± 7.23 32.95 ± 2.63 17.78 ± 2.55 
10.0 19.35 ± 5.95 39.07 ± 2.09 24.51 ± 3.03 
15.0 28.73 ± 5.04 47.31 ± 0.06 35.39 ± 2.03 
20.0 37.53 ± 5.23 58.38 ± 2.45 43.37 ± 1. 95 
30.0 56.62 ± 2.25 
------------ ------------
54.0 71.39 ± 1. 7 7 
------------ ------------
59.0 66.47 ± 2.16 86.30 ± 3.01 
------------
63.0 78.20 ± 1.58 
------------ ------------
67.5 71. 4 7 ± 2.11 87.81 ± 0.71 
------------
83.0 75.47 ± 3.05 90.96 ± 0.23 
------------
91. 5 77.81 ± 1.04 90.38 ± 0.88 
------------
93.5 85.01 ± 1.44 
------------ ------------
116.5 85.98 ± 1. 39 
------------ ------------
127.0 80.28 ± 3.23 92.98 ± 0.01 
------------
132.0 83.44 ± 1. 32 94.12 ± 0.12 
------------
141.5 85.98 ± 1. 39 
------------ ------------
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~: 
i.fl)_: The rate of autoxidation of hemoglobin plotted 
a.s -Log[ (Ao-A)/(Ao-Aco)] with respect to 130 h at 37°C for 
Hb A ( --1e.--ee--), j382XLHb A (-t:r----t:r--), and o:99XLHb A 
(--<Y----0--) . 
..uu_: The autoxidation of hemoglobin in the first 
phase (20 h) at 37°C for Hb A --·----·~-), j382XLHb A 
( -t:r---l::r-) , and a 9 9 XLH b A (-0--0--) . 
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within 130 and 20 hours respectively for Hb A and diaspirin 
crosslinked hemoglobins plotted as the -log[(Ao-A)/(Ao-Aoo)] 
with respect to time. The autoxidation of hemoglobin is 
complex and does not have a simple linear relationship with 
respect to time; it appears to be bi-phasic, indicating a 
multistep autoxidation mechanism. Nevertheless, the first 
phase below 20 hours appeared to have a linear relationship 
with respect to time. Thus, an apparent rate constant 
could be estimated for the autoxidation of 
hemoglobin within this period. Since the autoxidation of 
hemoglobin is slow, the apparent rate constant based on a 
linear relationship within 20 hours would be reasonable 
despite the multiple mechanistic steps. As expected from 
the measurement of the percent of met hemoglobin with 
respect to time, the rate of autoxidation of a:99XLHb A 
(open circle curve) is faster than either one of the 
,882XLHb A (open triangle curve) or Hb A (solid circle 
curve). Table 16 shows the kapp values and the percent 
inhibition due to the addition of SOD and catalase. The 
kapp of Hb A is 2.20xlo- 2 hr-1; and those of a:99XLHb A and 
,882XLHb A are 3.93xlo- 2 and 2.69xlo- 2 h -1 r ' 
respectively (Table 16). The a:99XLHb A autoxidizes faster 
than Hb A by a factor of 1.8. The ,882XLHb A has an 
intermediate rate between Hb A and a:99XLHb A. Of the two 
crosslinked hemoglobins, the a:99XLHb A autoxidizes 1.5 fold 
faster than ,882XLHb A. 
Table 16: 
Autoxidation of hemoglobins in the presence or absence of 
CAT and SOD. The concentrations of CAT and SOD were 5.77 
µM tetramers and 23.l µM dimers, respectively. 
Hemoglobins kap"PxlOO 
:B.lus enz:![mes (hr ~ 
Hb A 2.20±0.300 
Hb A+CAT 0.785±0.500 
Hb A+SOD 1.16±0.400 
Hb A+CAT+SOD 0.399±0.160 
,882XLHb A 2.69±0.150 
,882XLHb A+CAT 1.38±0.240 
,882XLHb A+SOD 1.52±0.140 
,882XLHb A 
+CAT+ SOD 0.670±0.040 
o:99XLHB A 3.93±0.680 
o:99XLHb A+CAT 1.72±1.44 
o:99XLHb A+SOD 2.44±0.266 
o:99XLHb A 
+CAT+SOD 1.29±0.799 
koxlOO 
(h;:-r) 
-1.55±2.75 
-2.60±3.33 
0.122±0.257 
0.924±1.70 
-2.92±2.48 
0.498±3.57 
0.420±2.08 
-3.20±1.43 
11.35±21.47 
18.57±13.82 
11.10±15.06 
6.68±11.45 
% In -total percent of enzyme inhibition. 
% In % In 
I!er ~M 
enz:![me 
64 11. 1 
47 2.0 
82 
49 8.5 
43 1. 9 
75 
56 9.7 
38 1.6 
67 
% In per µM enzyme -total percent of enzyme inhibition per 
µM of each enzyme. 
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B. THE EFFECT OF CATALASE AND SUPEROXIDE DISKUTASE 
ON THE RATE OF AUTOXIDATION OF Hb A, 
a99XLHb A AND p82XLHb A 
The autoxidation of hemoglobin was known to generate 
superoxide radical and subsequently reducing it to hydrogen 
peroxide (29). The 02 · - and 02- 2 are reactive and can 
cause severe damage to tissues by oxidizing the lipids on 
the membrane (116). The presence of 02·- and 02-2 would 
accelerate the rate of autoxidation of hemoglobin by 
oxidizing the Fe(II). Two of the enzymes which are able to 
catalyze the redox reactions of are 
superoxide dismutase and catalase, respectively; thus, 
reducing the damage caused by these species. These enzymes 
were used to reduce the autoxidation of hemoglobin. Figure 
35 shows the effect of catalase, superoxide dismutase and 
both on the autoxidation rate of Hb A. Bo th enzymes are 
able to reduce the rate of autoxidation by 11.1%/µM of 
enzyme by CAT and 2.0%/µM by SOD (Table 16). 
The effect of inhibition on autoxidation by both 
enzymes together is stronger than just one acting 
independently. The two enzymes together are capable of 
inhibiting the autoxidation of Hb A up to 82% (Table 16). 
Tables 17, 18 and 19 show the autoxidation of Hb A in the 
presence of SOD, CAT and both. The results of these 
experiments were normalized to 2% met hemoglobin initially. 
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.EJ_.gure 35: 
The effect of CAT and SOD or both on the 
autoxidation of Hb A at 37°C; control Hb A ( • • ), Hb A 
plus SOD ( 6 6 ), Hb A plus CAT ( o 0 ), and Hb A plus SOD 
and CAT ( • • ) . The concentrations are: Hemoglobin, 0.48 
mM tetramers; CAT, 5.77 µM tetramers; and SOD, 23.1 µM 
dimers. 
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Table 17: 
The autoxidation of Hb A in the presence of CAT, SOD and 
both, measured as percent of methemoglobin. The 
concentration of Hb A was 2.22 mM heme, of CAT, 5.77 µM 
tetramers, and of SOD, 23.1 µM dimers. Experiment was done 
on 3-14-89. 
Time None CAT SOD SOD+CAT 
o.o 2.00 2.00 2.00 2.00 
1. 0 5.92 0.00 3.55 3.33 
2.5 8.47 7.18 5.62 7.19 
5.0 16.09 15.30 9.91 8.39 
15.0 38.77 26.19 23.70 11.40 
25.0 48.65 34.36 36.91 21.49 
38.5 61.90 32.65 48.90 33.45 
48.5 70.17 46.13 68. 77 39.25 
62.0 77.60 54.35 80.44 49.43 
Table 18: 
The autoxidation of Hb A in the presence of CAT, SOD and 
both, measured as percent methemoglobin. The concentration 
of Hb A was 2.22 mM heme, of CAT, 5.77 µM tetramers, and of 
SOD, 23.1 µM dimers. Experiment was done on 3-23-89. 
SOD+CAT 
0.0 2.00 2.00 2.00 2.00 
1. 0 1.56 10.10 3.88 2.87 
2.5 2.73 11.03 4.59 2.08 
5.0 10.93 9.39 7. 73 4.49 
7.5 20.32 14.48 9.56 5.97 
10.0 19.14 11.67 11.88 5.46 
25.0 38.52 25.84 25.16 10.88 
31. 0 51.72 35.74 34.71 20.49 
50.5 63.72 42.59 46.08 26.36 
73.0 76.16 54.88 63.26 54.31 
97.0 71.26 68.29 72.77 
118.0 80.43 71.10 78.74 
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Table 19: 
The autoxidation of Hb A in the presence of SOD, CAT and 
both, measured as percent methemoglobin. The concentration 
of Hb A was 2.20 mM heme, of CAT, 5.77 µM tetramers, and of 
soD, 23.l µM dimers. Experiment was carried out on 5-19-
89. 
J:_ime None CAT SOD SOD+CAT 
0.0 2.00 2.00 * * 
1. 0 6.95 0.40 
2.5 7.07 3.94 
5.0 13.72 7.93 
7.5 14.93 6.05 
10.0 24.77 7.76 
20.0 39.78 24.29 
25.0 51.52 29.22 
54.0 75.67 57.10 
70.0 78.44 69.30 
* 
The experiment with SOD or both with SOD and CAT were 
not carried out. 
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Under the conditions used, SOD and CAT were also 
a.b le to slow the rate of autoxidation for the crosslinked 
hemoglobins as well. The reduction in the rate of 
a.utoxidation by SOD, CAT and both appear to be lower than 
that for uncrosslinked Hb A. However, the pattern of 
inhibition by SOD, CAT and both on the crosslinked 
to be the same as that in the 
Figure 36 shows the inhibition of SOD, 
hemoglobins appear 
uncrosslinked Hb A. 
CAT and both on the autoxidation of ~82XLHb A. The 
inhibition are 1. 9%/µM by SOD, and 8. 5%/µM by CAT; both 
enzymes together inhibited the autoxidation up to 75% 
(Table 16). Tables 20 and 21 show the autoxidation of 
~82XLHb A in the presence of SOD, CAT and both, measured as 
percent met hemoglobin. Figure 37 shows the inhibition of 
SOD, CAT and both on the autoxidation of a99XLHb A. The 
inhibition on the autoxidation of a99XLHb A by SOD and CAT 
are 1.6%/µM, and 9. 7%/µM, respectively (Table 
in hi b i ti on by both enzymes is 6 7 % ( Tab 1 e 16 ) . 
16). The 
Tables 22, 
23 and 24 show the percent of met hemoglobin developed 
during the autoxidation of a99XLHb A in the presence of 
SOD, CAT and both. Table 25 shows the relative rate 
constants of autoxidation of Hb A either in the absence or 
presence of SOD and CAT or both to the corresponding 
crosslinked hemoglobin samples in the absence or presence 
of the enzymes. 
By assuming a first order rate for autoxidation, a 
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~: 
The effect of CAT and SOD or both on the autoxidation of 
pB 2XLHb A at 37°C; control ,882XLHb A ( • • ) ' ,882XLHb A 
plus SOD ( ~ ~ ), ,882XLHb A plus CAT ( O O ), and ,882XLHb A 
plus SOD and CAT ) . The concentration are: 
Hemoglobin, 0. 48 rnM tetrarners; CAT, 5. 77 µM tetrarners; and 
SOD, 23.l µM dimers. 
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Table 20: 
The autoxidation of ~82XLHb A in the presence of SOD, CAT 
and both, measured as percent methemoglobin. The 
concentration of ~82XLHb A was 2.22 mM heme, of CAT, 5.77 
µM tetramers, and of SOD, 23 .1 µM dimers. Experiment was 
carried out on 3-14-89. 
Time None CAT SOD SOD+CAT 
0.0 2.00 2.00 2.00 2.00 
1. 0 1.17 3.03 1.15 2.88 
2.5 5.71 7.12 3.42 6.51 
5.0 11.62 7.27 7.11 8.54 
15.0 30.83 22.19 18.98 14.75 
25.0 48.81 34.13 31. 42 26.21 
38.5 60.19 50.13 46. 54 42.61 
48.5 65.92 48.65 53.87 44.08 
62.0 72.46 65.53 61.19 58.45 
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Table 21: 
The autoxidation of p82XLHb A in the presence of SOD, CAT 
and both, measured as percent methemoglobin. The 
concentration of P82XLHb A was 2.20 mM heme, of CAT, 5.77 
M tetramers, and of SOD, 23 .1 µM dimers. Experiment was 
~arried out on 6-3-89. 
SOD+CAT 
o.o 2.00 2.00 2.00 2.00 
1. 0 1. 60 2.42 2.93 0.35 
2.5 5.27 3.89 5.32 0.69 
5.0 10.74 8.32 9.93 2.65 
7.5 20.29 8.39 14.18 4.54 
10.0 31.65 17.97 16.36 5.57 
15.0 38.20 20.56 27.61 11.58 
25.0 54.34 32.13 39.77 20.23 
30.0 59.25 36.30 48.21 22.87 
51.0 74.26 54.82 66.69 43.45 
60.0 78.41 56.97 72.75 51.81 
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figure 37: 
The effect of CAT and SOD or both on the autoxidation of 
a99XLHb A at 37°C; control a99XLHb A ( e e ), a99XLHb A 
plus SOD ( ~ ~ ) , a99XLHb A plus CAT o o ) , and a99XLHb A 
plus SOD and CAT ( • • ) . The concentration are: 
Hemoglobin, 0.48 mM tetramers; CAT, 5.77 µM tetramers; and 
SOD, 23.l µM dimers. 
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Table 22: 
The autoxidation of a99XLHb A in the presence of SOD, CAT 
and both, measured as percent methemoglobin. The 
concentration of a99XLHb A was 2.22 mM heme, of CAT, 5.77 
µM tetramers, and of SOD, 23. 1 µM dimers. Experiment was 
carried out on 3-23-89. 
Time None CAT SOD SOD+CAT 
0.0 2.00 2.00 
* * 
1. 0 16.41 14.50 
2.5 34.95 23.77 
5.0 53.82 38.45 
7.5 62.20 46.19 
10.0 69.54 51.2 
25.0 81.53 72.94 
31. 0 86.77 78.66 
50.5 91.17 89.25 
73.0 94.92 81.00 
97.0 92.09 80.25 
118.0 89.69 81. 48 
* The experiment with SOD and both SOD and CAT were not 
carried out. 
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Table 23: 
The autoxidation of a99XLHb A in the presence of SOD, CAT 
and both, measured as percent methemoglobin. The 
concentration of a99XLHb A was 2. 20 mM heme, of CAT, 5. 77 
mM tetramers, and of SOD, 23 .1 µM dimers. Experiment was 
carried out on 5-19-89. 
Time None CAT SOD SOD+CAT 
0.0 2.00 2.00 * * 
1. 0 2.26 3.24 
2.5 2.98 8.89 
5.0 15.84 5.03 
7.5 18.71 3.66 
10.0 27.55 17.06 
20.0 45.95 11.16 
25.0 54.47 32.76 
54.0 74.20 84.17 
70.0 84.12 84.06 
* The experiment with SOD or both SOD and CAT were not 
carried out. 
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Table 24: 
The autoxidation of a99XLHb A in the presence of SOD, CAT 
and both, measured as percent of methemoglobin. The 
concentration of a99XLHb A was 2.20 mM heme, of CAT, 5.77 
µM tetramers, and of SOD, 23.1 µM dimers. Experiment was 
done on 6-3-89. 
Time None CAT SOD SOD+CAT 
0.0 2.00 2.00 2.00 2.00 
1.0 4.01 7.92 0.61 3.26 
2.5 13.36 7.55 5.65 10.09 
5.0 17.33 15.09 12.25 7.77 
7.5 33. 70 15.04 18.63 12.40 
10.0 37.12 16.63 24.10 13.66 
15.0 50.17 35.84 38.59 20.66 
25.0 67.50 38.32 51.27 29.50 
30.0 78.26 46.76 58.14 38.25 
51.0 87.69 52.62 78.56 60.57 
60.0 80.43 77.22 84.14 67.16 
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Table 25: 
comparison of relative ratea in the presence or absence 
of SOD, CAT or both of Hb A to o99XLHb A and ,882XLHb A 
assuming first order rate of autoxidation. 
Hl2. None CAT SOD CAT+SOD 
Hb A 1. 0 1. 0 1. 0 1. 0 
,B82XLHb A 1.2±0.1 1.8±0.3 1.3±0.1 1.7±0.1 
a99XLHb A 1.8±0.3 2.2±2.1 2.1±0.2 3.2±2.0 
a The relative rate is calculated by taking the ratio of 
kapp of crosslinked hemoglobins to kapp of Hb A. 
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reasonable estimate of the half-life (t1;2) of oxy 
hemoglobin could be determined. Table 26 shows the t1;2 of 
oxyhemoglobins based on the assumption that autoxidation 
follows first order kinetics. The tl/2 of a99XLHb A (17.6 
h) was shorter than either one of Hb A (31.5 h) or ~82XLHb 
A (25. 8 h). The effects on the tl/2 of Hb A by CAT, SOD 
and both are 2.2, 2.0 and 6.0 (Table 27) fold increases, 
respectively. The increase in t1;2 of ~82XLHb A in the 
presence of SOD and CAT or both are 2.0, 1.8 and 4.0 fold, 
respectively (Table 27). For a99XLHb A the t1;2 increase 
by 1.9, 1.6 and 4.5 (Table 27) fold due to the presence of 
SOD, CAT, and both enzymes, respectively. Table 27 shows 
the fold increase due to the presence of enzymes relative 
hemoglobin samples without any enzymes. This indicated 
that CAT is slightly more effective in inhibiting the 
autoxidation of hemoglobin than SOD. Both enzymes, CAT and 
SOD, can inhibit the autoxidation by approximately 4 fold. 
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Table 26: 
comparison of average t1;2 (h) values for autoxidation of 
hemoglobins in the presence of CAT and SOD, assuming first 
order rate of autoxidation. 
CAT+SOD 
Hb A 31. 5 88.3 59.7 173.7 
,882XLHb A 25.8 50.2 45.5 103.4 
a99XLHb A 17.6 40.3 28.4 53.7 
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Table 27: 
Comparison of the average fold changes due to the 
presence of SOD, CAT and both to those samples without any 
enzymes. 
Hb None CAT SOD CAT+SOD 
Hb A 1.0 -2.2±1.1 -2.0±0.6 -6.0±2.4 * 
,882XLHb A 1. 0 -2.0±0.3 -1.8±0.2 -4.0±0.2 
a99XLHb A 1.0 -1.9±1.1 -1. 6±0. 2 -4.5±3.8 
* 
The negative sign indicates the rate is decreasing. 
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The following 
CHAPTER IV 
DISCUSSION 
discussion will explain the 
significance of this research and provide an explanation as 
to what these discoveries mean. The goal is to present an 
interp re tat ion which wi 11 exp lain the data. The results 
from crosslinking and thermal stability of hemoglobins 
using four reagents will be discussed. The effect of 
single and double crosslinking on the thermal stability of 
hemoglobin will be addressed. 
The findings on the autoxidation of uncrosslinked 
and cross linked hemoglobins will be examined with 
mechanisms and their relationship to the three-dimensional 
structure. The effect of slowing down the autoxidation 
rate of hemoglobin by superoxide dismutase and catalase 
will be examined based on the proposed autoxidation 
mechanisms. Any implications or problems relevant to the 
making of blood substitute will be suggested. Finally, 
conclusions will be drawn from these findings and a summary 
of the discoveries will be attached to emphasize the 
importance of these findings. 
I. SYNTHESIS OF BIS(3,5-DIBROMOSALICYL) FUMARATE 
The bis(3,5-dibromosalicyl) 
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fumarate (BBSF) was 
synthesized from 3,5-dibromosalicylic acid and fumaryl 
chloride by a base catalyzed reaction using N ,N-dimethyl 
aniline. 
reaction. 
Figure 38 shows the reaction mechanism for this 
The bis(3,5-dibromosalicyl) fumarate has a m.p. of 
226-228°C which agrees well with what was reported by 
Walder et al. ( 30). When the compound was tested with 
ferric chloride for the presence of phenolic proton the 
result was negative (yellowish color), indicating that the 
ester linkage between the fumaryl and the phenol groups has 
occurred. A color for a positive test of the phenolic 
proton of 3,5-dibromosalicylic acid is purplish. The 
singlet resonance at 7. 34 ppm is due to the two fumaryl 
protons. 
chemically 
Hence, the 
These two protons are trans to each other and are 
equivalent, and there are no adjacent protons. 
signal 
ppm and 8.09 ppm, 
is a singlet. The two doublets at 8. 08 
and 8.33 ppm and 8.34 ppm are the benzyl 
protons at position 4 and 6, respectively. These benzyl 
protons are different in their chemical environment and are 
not equivalent. Al though there are no adjacent protons 
next to H4 and H6, in high magnetic field the proton on the 
benzene ring can couple with each other through four bonds. 
Therefore, a doublet resonance arises for each of these 
protons. The integration ratio of the resonance at 7. 34 
ppm to the ones at 8.08 ppm and 8.33 ppm was 2:1:1. This 
agrees with the ratio of the fumaryl protons to the two 
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[igure 38: 
The reaction mechanism for the synthesis of bis(3,5-
dibromosalicyl) fumarate. 
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benzyl protons of the presumed structure of BBSF. The 
assignment of the resonance position to each proton was by 
prediction using the incremental shifts from the literature 
(100) and the reasoning from the inductive effect of the 
substituent groups on the benzene ring. 
In the presumed structure of bis(3,5-dibromosalicyl) 
fumarate there are nine carbons. The 13 c NMR spectrum 
demonstrates that indeed the compound synthesized contained 
nine 13 c signals. The calculated and observed 13c chemical 
shifts of the benzene ring agreed within 3% of error, 
except for the carbon at position 4 which had an error of 
5. 8%. These errors may have been arisen from the fact that 
a different solvent was used in measuring the l3c spectrum. 
The 1 3 c chemical shifts used for the prediction were taken 
in CDCl3, and the solvent used in this research was 
deuterated DMSO. At the C2 position on the benzene ring 
the OCOR group was assumed to be OCOCH3. This assumption 
may contribute to the difference in the predicted 13c 
chemical shift for the C2 and the rest as well. The 1 3c of 
the ester carbon (CB), carboxylate carbon (C7) and fumaryl 
carbon (C9) are sensitive to change depending on the exact 
substituent group attached to these carbons and their 
chemical environment, thus, a prediction of an exact value 
is not possible. Nevertheless, the 13c shift of these 
carbons fell within the normal range observed. With the 
structural information from the NMR data coupled with the 
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physical data, it is without doubt that bis(3,5-
dibromosalicyl) fumarate has the presumed structure. 
II. PURIFICATION AND CROSSLINKING OF HEMOGLOBINS 
A. PURIFICATION OF UNCROSSLINKED HEMOGLOBINS 
The hemoglobin used for crosslinking reactions and 
subsequent experiments was purified to homogeneity as 
judged by the clinical and SDS gel electrophoresis results. 
All the hemoglobins eluted with the Sephadex 
diethylaminoethyl (DEAE) A-50 gel were consistent with 
their known properties, such as the net surface charge on 
the protein. In the anion exchange chromatographic system 
used, the A-50 gel surface is permeated with positive 
charges, and the proteins were separated as a function of 
net surface charge. A protein with higher negative charge 
would be retained on the column longer than one which is 
less negatively charged. All three hemoglobins, Hb A, Hb 
Arc, and Hb A2 have different net charge from each other; 
consequently, they can be separated by the A-50 gel. The 
Hb Arc is a derivative of Hb A in which the amino termini 
of the fJ subunits had reacted with glucose forming a Schiff 
base. When the glucose attached to the fJ subunits are 
oxidized to fructose, the hemoglobin derivative becomes 
stable (52). This reaction would have deleted two positive 
charges on the Hb A molecule. As a consequence, the Hb 
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has different electrophoretic mobility from Hb A. 
Since two positive charges were deleted, the Hb Aic would 
have higher net negative charge and be retained on the A-50 
gel longer, thus it would be eluted later than Hb A (Fig. 
4). Of the three hemoglobins, Hb A has an intermediate 
charge between Hb A2 and Hb Aic; therefore, it eluted in 
the middle (Fig. 4). In Hb A2 the 6 chain has 10 amino 
acids different from the fJ chain of Hb A. As a result of 
these differences, the net charge on the Hb A2 molecule is 
more positive than Hb A by +4 ( 4 ) . Hence Hb A2 would elute 
from the column before Hb A and Hb Ale· 
B. PURIFICATION OF a AND p CROSSLINKED HEMOGLOBINS 
The bis(3,5-dibromosalicyl) fumarate was used to 
crosslink Hb A in the oxy state between Lys 82,81 and Lys 
82fJ2 (29,30) and between Lys 99a1 and Lys 99a2 in the deoxy 
state (28). The crosslinking reaction could occur in three 
ways: 
CE~ 1 fJ1(82)-Lys-NH-~CH=HCg-HN-Lys-(82)fJ2 
Br :-1: Lys-NH2 -+ + 2 
a1(99)-Lys-NH-gCH=HCg-NH-Lys-(99)a2 Lys-NH2 -+ ce-g 
' 
3 -Lys-NH-~CH=HCg-0_ Br -+ 
The reaction pathways 1 and 2 were well established 
t>Y Walder et al. (29,30). If one end of the reagent 
,:eacted with an amino group and the other was hydrolyzed 
pefore it had a chance to react, then reaction 3 would have 
occurred. If only this reaction occurred the hemoglobin 
~olecule when analyzed by the SDS gel would have resulted 
only in monomer species and with different electrophoretic 
~obility from Hb A on the clinical electrophoresis gel. 
'.fhis sort of modified species was not observed to occur 
8 1one but as extra modification on the already crosslinked 
11emoglobin. 
The crosslinking is highly selective and specific at 
these lysine residues mentioned; theoretically it should be 
quantitative. However, in practice a small amount of 
11emoglobin did not get crosslinked due to hydrolysis of the 
reagent before it had a chance to react with it. The molar 
ratio in the crosslinking reaction was 1:1.l hemoglobin to 
reagent, regardless of what the concentration of hemoglobin 
way be (Tables 7 and 8). The efficiency of the ~ 
crosslinking was near 90%, but the a crosslinking yielded 
wuch lower crosslinked species, 50% (Table 8). 
The ~ crosslinking reaction yielded predominantly 
one crosslinked species (Fig. 5, peak II). A small percent 
of side reactions may have occurred as shown by the 
shoulder on the right side of the chromatogram in Figure 5 
peak I I. The clinical gel electrophoresis results of the ~ 
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crosslinked sample showed that there were three bands; one 
corresponding 
cross linked 
to uncrosslinked Hb A, and the other 
Of the 
two, 
hemoglobins (Fig. 14(A)). two 
crosslinked hemoglobins, one band corresponded to the 
p82XLHb A, 
hemoglobin. 
and the other, to an unknown crosslinked 
This second crosslinked product may have 
arisen from extra modification on the ~82XLHb A, since its 
electrophoretic mobility was slightly higher than that of 
the ~82XLHb A. The second crosslinked protein was very 
small compared to what was obtained in the a crosslinking 
reaction, and could not be resolved well by ion exchange 
chromatography. 
investigated. 
Therefore, this product was not further 
In the a crosslinking reaction, besides the a99XLHb 
A product, the second unknown crosslinked hemoglobin was 
much higher than in the ~ crosslinking reaction. The yield 
of this product was up to 50% (Table 8). The unknown 
crosslinked hemoglobin either in the ~ or a crosslinking 
reaction always eluted after the ~82XLHb A or a99XLHb A. 
Since it eluted from the column after the a99XLHb A or 
~82XLHb A, its net charge must be more negative than that 
of the known cross linked protein indicating extra 
modification on the lysine residues. The extra 
modification would have deleted the positive charge and 
made the protein more negatively charged. Hence it would 
have had a stronger interaction with the positively charged 
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A-50 gel and eluted after the f382XLHb A or the a99XLHb A. 
Both {382XLHb A and a99XLHb A eluted from the A-50 gel after 
Hb A. Thus, it was possible to purify the crosslinked 
hemoglobins from contamination. 
The clinical gel electrophoresis showed that both 
the a99XLHb A and {382XLHb A have the same electrophoretic 
mobility, but the unknown crosslinked hemoglobin moved 
slightly faster than either the f3 or a cross linked 
hemoglobins (Fig. 13, lane 4). This agrees with the fact 
that in either the a or p crosslinking reaction two 
positive charges were deleted by the crosslink, and in the 
unknown crosslinked hemoglobin at least one more positive 
charge is deleted by the extra modification. The SDS gel 
electrophoresis demonstrated that f382XLHb A, a99XLHb A and 
the unknown crosslinked protein consist of dimers and 
monomers only in relative amount of 50% each (Fig. 18 and 
Table 11). If an extra lysine was modified in the unknown 
crosslinked hemoglobin, the charge on the protein would 
have decreased by -2 due to the hydrolysis at the ester 
linkage of the reagent. Based on these results, it is most 
likely that only one extra modification occurred in the 
unknown crosslinked hemoglobin, as depicted in the fumarate 
crosslinking reaction pathway 3 above or a crosslink within 
a subunit had occurred. 
or f3 subunits. 
The modification could be on the a 
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c. CROSSLINKING OF HEMOGLOBIN WITH DIMETHYLPIMELIMIDATE 
The hemoglobin crosslinked with DMP by the condition 
described elsewhere in this dissertation demonstrates that 
hemoglobin crosslinked with these reagents resulted in 
heterogeneous crosslinked species (Fig. lS(A), lanes 3 and 
4). The condition used to analyze the proteins on the 
clinical gel was non-denaturing, and the proteins were in 
their native state. They did not move on the gel in 
discrete bands but were smeared on it. The cause of 
diffusion of the derivative proteins on the clinical gel 
may have arisen from two possibilities. Firstly, the DMP 
may have caused a conformational change in the hemoglobin, 
thus exposing negatively charged residues. Secondly, the 
hemoglobin may have been highly and randomly modified, 
producing derivative 
surface charges from 
would not validate 
hemoglobins 
that on Hb A. 
the fact that 
which bear different 
The first possibility 
the visible spectral 
characteristics of the oxy Hb A-DMP was still the same as 
the unmodified oxy Hb A. Therefore, if any conformational 
changes occur at all it is at minimum level. The 
hemoglobin is not expected to be denatured, since the 
thermal denaturation still displays a temperature 
transition which indicates the unfolding of the modified 
protein. Furthermore, several samples of already denatured 
protein after re-equilibration and one already denatured in 
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1 mM SDS were subjected to denaturation again and found to 
display no temperature transition, except for a slight 
decrease in absorbance of the denatured protein due to the 
effect of temperature. Figure 39 demonstrates this 
observation. The second possibility agrees with the usual 
observation of the electrophoretic results based on the 
charge property of the protein. 
The imidoester compounds exhibit high specificity 
for reacting with the t-amino group of lysine. The 
reaction between an imidate and an amine results in an 
amidine, which has a pKa value of approximately 11. Thus, 
in a protein solution of pH less than 9 the amidine 
maintains the charge characteristic of a lysine, and hence 
a charge-induced conformational change of the protein is 
not expected (45). An analysis to determine the number of 
reacted lysines per mole of hemoglobin at 1000:1 molar 
ratio was found to be 11 lysines per one mole of hemoglobin 
(48). 
It is conceivable that at high pH the nitrogen on 
the DMP could act as a nucleophile, and making the two DMP 
centers available for reaction with electrophilic carbons. 
However, the condition used in this research has a pH of 
9. 5, and therefore, the DMP should exist in the protonated 
form. Since other nucleophiles besides lysine could have 
conceivably reacted with the electrophilic carbon of DMP, 
the reaction is complex and could result in crosslinking 
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39: wure 
Demonstration for the absence of denaturation 
transition in an already denatured Hb A; transition from an 
undenatured Hb A (~~-' from a denatured Hb A ( ..... ). 
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the protein at other amino acid residues in addition to the 
lysyl residues. Figure 40 shows the general reaction in 
w-hich any nuc leophi 1 ic amino acid residues may react with 
DMP. Therefore, this mechanism does not preclude the 
reaction of sulfhydryl of cysteine or the carboxyl groups 
of aspartic and glutamic acid with the DMP. In reaction 
pathway 1 both ends of the DMP reacted to crosslink the 
protein, whereas in pathway 2 one end is hydrolyzed before 
reacting with the nucleophile. 
Ferris and Smith (45) had used DMA, a similar 
imidoester with four carbons and a crosslink span of 8.6 A, 
to crosslink hemoglobin and found two crosslinks between 
Lys 70:1 and Lys lla2 (9 A), and Lys 82,81 and Lys 82,82 (6 
A). Also their SDS results showed that there were four 
species, monomers, dimers, trimers and tetramers, which 
agree with the present DMP-treated hemoglobin result. 
Obviously the DMA was able to crosslink the hemoglobin 
between several subunits to form the above described 
species. The DMP span is 9.2 A, and it should have similar 
ability to crosslink protein the same way as DMA, except 
for steric reasons due to the length of DMP being longer. 
Examination of the crystal structure of hemoglobin reveals 
six possible a-,8 crosslink candidates with interresidue 
distance of 11, 15, 18, 20, 21 and 21 A· 
' 
seven ,8-,8 
crosslink candidates with interresidue distance of 6, 9, 
12, 15, 18, 18, and 19 A, and ten a-a possibilities with 
.f.1.Zure 40: 
A general reaction for a nucleophile to react with 
oMP. Pathway 1 demonstrates a crosslinking reaction; 
pathway 2, a modification reaction in which one ends of the 
oMP is hydrolyzed. AH2 represents a nucleophile. 
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interresidue distance of 5,10, 11, 12, 13, 15, 16, 17, 17, 
a.nd 19 A (45). Although the interresidue distances of 
these €-amino groups are much wider than the DMP span of 
9.2 A, in solution the mobility of the lysines may come 
close enough for the crosslink to occur. 
The SDS gel electrophoresis of the Hb A-DMP 
indicates that the derivative hemoglobin was crosslinked 
between subunits to form four bands at the positions 
expected for monomer, dimer, trimer and tetramer (Fig. 20, 
lane 1). In addition a small percent of polymeric species 
were formed as well. Under this condition the hemoglobin 
concentration was 1 mg/ml (62 µM heme), and intermolecular 
cross linking may be minimized. Nevertheless, the 
observation of polymeric species is a proof that some of 
the cross links are 
Lockhart and Smith 
on the surface of the 
(46) had used DMA to 
suggested 
subunits. 
cross link 
that hemoglobin to hap to glob in and 
hemoglobin-haptoglobin-DMA complex was formed by 
the 
the 
crosslink being on the surface of the hemoglobin molecule. 
The tetramer on the SDS gel was visibly composed of 
two bands. The dimer and trimer regions were diffused, 
perhaps indicating a variety of crosslinks randomly on the 
hemoglobin molecule causing a slight difference in 
molecular weight of the derivative hemoglobins. Thus, a 
variety of crosslinks could be introduced into the subunits 
in addition to the intersubunit crosslinks, preventing 
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complete unfolding of the protein into individual a- and p-
subunits by SDS. The cross 1 inking between subunits is 
observable on the SDS gel, however it does not disprove 
intrasubunit crosslinking. Based on the molecular weight 
of the marker proteins used the crosslinked species have 
the following molecular weight: dimer, 27,200 daltons; 
trimer, 4S,400 daltons and tetramers, 62,400 daltons (Fig. 
19(D)). The species with molecular weight higher than 
64,000 daltons did not form well defined bands on the SDS 
gel (Fig. 19(A), lane 9; Fig. 21, lane 1) due to the fact 
that these species are highly crosslinked and have 
different molecular weights. 
In this reaction the amount of crosslinked species 
is dependent upon the concentration of DMP. In comparison 
between the crosslinking condition at SO:l and SOO:l molar 
ratio, the amount of trimers and tetramers in the SO: 1 
molar ratio are less than those in the SOO:l (Fig. 19(A), 
lane 9. 
' 
Fig. 21, lane 1). The second additional band in 
the tetramers is not apparent in the SO: 1 molar ratio 
reaction. 
Looking at the pairs of lysines suggested by Ferris 
and Smith (4S) as potential candidates for intersubunit 
crosslinking, it is certainly possible to yield dimeric, 
trimeric and tetrameric species. Besides, if other 
nucleophilic residues reacted with the DMP as suggested, 
then the possibilities of intersubunit cross linking 
increases even higher. At least one can conclude that the 
reaction of hemoglobin with DMP is random, and 
heterogeneous crosslinked species could be obtained in the 
form of dimer, trimer and tetramer. 
D. CROSSLINKING REACTION OF HEMOGLOBIN 
WITH NITROGEN MUSTARDS 
The nitrogen 
chloroethyl) 
methylamine 
amine 
(BCEA) 
mustard derivatives, tris(~­
(TCEA) and bis(~-chloroethyl) 
were compared in cross linking 
hemoglobin. Nitrogen mustard is a good alkylating agent. 
It was known to react with Hb S, producing modified Hb S 
with increased solubility (42). Its derivatives, TCEA and 
BCEA, have been used to crosslink ATPase (43) and 
hemoglobin (44). The TCEA is a potential tri-functional 
alkylating agent and the BCEA, bi-functional. The 
crosslink span of these agents is 5 A. It is hypothesized 
that the TCEA can crosslink between three subunits and the 
BCEA, two subunits. Nitrogen mustard was known to react 
with anionic sites on proteins (42,75). The typical 
reactions of nitrogen mustards with nucleophilic residues 
are shown in Figure 41. 
On the clinical electrophoresis gel the nitrogen 
mustard hemoglobin derivatives, Hb A-TCEA and Hb A-BCEA, 
appear diffused (Fig. 17(A), lanes 1, 2 and 3). These 
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41: wure 
The TCEA and BCEA reactions with nucleophiles. The 
AH 2 represents a nucleophile from the amino acid side 
chain. 
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~CEA reaction with nucleophiles: 
Cl... yH3 __ • ..Cl 
·;cH2CH2 -N-CH2CH2· 
H~H 
' 
' 
+ •• 
"b" 
.i~ 2 HCl 
Cl 
--
·,vil; 
C~' 1H2 /,Pl 
'~H2CH2-N-CH2CH2 
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H~H 
.i ~ 3 HCl 
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results show that the TCEA reaction produced mostly slower 
moving species than those obtained in the BCEA reaction. 
In the TCEA reaction the hemoglobin appeared to be highly 
modified compared to the BCEA reaction (Fig. 17(A), lanes 1 
and 2; Fig. 17(B), scans 1 and 2). It was believed that 
the nitrogen mustards alkylated the negatively charged 
carboxyl group 
acid and the 
of the C-terminal, aspartic acid, glutamic 
ring nitrogens of histidines (102) and 
produced electrophoretic species which would migrate slower 
toward the anode. Roth et al. (42) had suggested that 
conformational changes due to alkylation may expose new 
negative charges at the protein surface and accelerate 
migration of protein toward the anode. The results with 
TCEA and BCEA appear to diffuse in both directions. Thus, 
this if conformational changes were responsible for 
behavior, 
species. 
then the changes resulted in heterogeneous 
However, the modified hemoglobins still retain 
the same spectral characteristics. Moreover, and the 
thermal denaturation of these nitrogen mustard hemoglobin 
derivatives still exhibits temperature transition; 
therefore, the proteins were not denatured by these agents 
(Fig. 39). If the protein had already been unfolded by the 
presence of the nitrogen mustards, then such a transition 
would not have been present in the course of denaturation 
of the proteins. 
with TCEA and 
The clinical gel of hemoglobin modified 
BCEA in this research confirms the 
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heterogeneous nature of the modified hemoglobins as 
reported by Roth et al. (42). Nitrogen mustard is also 
known to undergo strong electrophilic chemical reactions 
with lysine (42) and cysteine residues ( 43) . It is 
conceivable that various nucleophilic substances could 
react with these agents. If the TCEA and BCEA reacted at 
only one functional group at a lysyl residue, then the 
crosslinked species would be unaffected by the charge at 
neutral pH. However, if it is modified at a carboxyl 
group, then the net positive charge on the cross linked 
species would be +l relative to the unmodified hemoglobin 
at physiological pH. On the other hand, if the BCEA and 
TCEA reacted with all their functional groups at the lysyl 
residues, then the net charge on the protein would be 
decreased by -1 for BCEA and -2 for TCEA. 
The hemoglobin modified with TCEA is more diffused 
on the clinical gel than the product obtained in the 
reaction with BCEA at the same molar ratio. Roth et al. 
(42) observed that at increasing molar ratio both fast and 
slow moving species were observed and at low molar ratio 
only the fast moving species predominated. 
The clinical gel results demonstrate that the TCEA 
and BCEA reacted with hemoglobin in a random manner. This 
created some modified species which are more positively 
charged than Hb A, as seen by the diffusion of the 
derivative proteins on the clinical gels toward the cathode 
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(Fig. 17(A) lane 1, 2 and 3; Fig. 17(B) scans 1, 2 and 3). 
It is difficult to pinpoint and relate the charge property 
to that of Hb A because the species are highly 
heterogeneous and discrete bands were not obtained. 
Therefore, the charge could not be related in magnitude to 
that of Hb A. This remains to be determined. 
The BCEA was used to modify Hb S in order to test 
for its antisickling effect. It was discovered that at 
20:1 molar ratio of BCEA to hemoglobin the resonance at 
-3.68 ppm vanished completely. The resonance at -3.68 ppm 
arises from the proton of C2 of {J2 histidine. This was 
interpreted that the BCEA reacted with {J2 histidines (44). 
The {J97, {Jl43 and {Jl46 histidine residues between -3.2 and 
-3.6 ppm were broaden. These residues are located near the 
a1/J2 subunit contact. The NMR spectrum in this region is 
used to probe conformational changes of the hemoglobin 
molecule. Therefore, the NMR results suggested that BCEA 
either reacted with one of these histidines or all of them, 
or the changes may come from the induction of 
conformational changes due to the binding at {J2 histidine. 
From this investigation the BCEA treatment of Hb S does not 
alter the heme environment or the subunit interfaces (44), 
and the oxygen affinity remains the same (42). 
conclusion most likely is also true in Hb A. 
cross linked species obtained from 
This 
reacting The 
hemoglobin with BCEA were predominately dimers as 
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determined by SDS gel electrophoresis (Fig. 19(A), lane 2), 
whereas the TCEA reaction produced some trimers, tetramers 
and polymers in addition to the dimers (Fig. 19(A), lanes 3 
and 4) . This can only mean that the protein is crosslinked 
between two subunits. Therefore, the BCEA must have 
reacted with other nucleophilic amino acid residues to 
crosslink the protein besides the histidines. With the SDS 
results, the modification loci could not be determined, but 
at least the inference of intersubunit crosslinking could 
be concluded. The dimeric, trimeric, tetrameric and 
polymeric species indicated that intersubunit crosslink had 
occurred. Intermolecular crosslinking is not likely, since 
the hemoglobin concentration is dilute (0.45 mM tetramer). 
The crosslinked species observed on the SDS gel were 
slightly diffused. This diffusion would indicate that 
within a crosslinked species, either a dimer, trimer or 
tetramer, several modifications also occurred thereby 
creating a slight difference in the apparent molecular 
weight of the crosslinked species (Fig. 19(A) lanes 2, 3 
and 4) . Based on the molecular weight of the marker 
proteins used, the dimer has a molecular weight of 30, 162 
daltons and trimer, 46,847 daltons (Fig. 
species with molecular weight matching 
19(C)). 
that of 
The 
the 
tetramers and polymers are weak and could not be estimated, 
but such species in the TCEA reactions are present (Fig. 
19(A), lanes 3 and 4; Fig. 19(B), scans 3 and 4). These 
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higher molecular weight species did not form well defined 
bands on the SDS gel due to the fact that they are highly 
crosslinked and have different molecular weights. 
In general, the possibilities of crosslinked species 
formed by reacting hemoglobin with BCEA would yield the 
same results as the DMP reactions since it is a bi-
functional reagent. Since the TCEA is a tri-functional 
reagent and the BCEA, bi-functional, the TCEA would be more 
reactive than the BCEA and thus more crosslinked species 
would be generated with this reagent. 
E. DOUBLE CROSSLINKING OF a99XLHb A AND p82XLHb A WITH 
DIMETHYLPIMELIMIDATE 
The fumarate crosslinked hemoglobins, a99XLHb A and 
~82XLHb A, were further reacted with DMP to produce what is 
called "double crosslinked hemoglobin". In the first 
reaction of hemoglobin with bis(3,5-dibromosalicyl) 
fumarate, either in the deoxy or oxy state, resulted in 
crosslinking between the a or ~ subunits. The reaction of 
DMP with a99XLHb A and ~82XLHb A produced additional 
cross linked species, trimers, tetramers, and polymers, 
which are also observed in the DMP reaction with 
uncrosslinked hemoglobin (Fig. 19(A) lane 8· 
' 
Fig. 19(B) 
scan 8· 
' 
Fig. 21 lane 7). At the same molar ratio of 
reagent to hemoglobin ( 500: 1) the amount of dimer in the 
double crosslinked hemoglobin, a99XLHb A-DMP or ,882XLHb A-
DMP, is depleted and the amount of trimer and tetramer are 
increased compared to those in Hb A-DMP (Table 11). This 
suggested that when a crosslinked hemoglobin was double 
cross linked the dimers already present 
crosslinked within a molecule by the second 
were easily 
cross linking 
reagent (DMP) to form the higher crosslinked species. 
The chance for the intersubunit crosslinking between 
two molecules is feasible also, but the probability is low 
since the hemoglobin concentration in the reaction mixture 
is low (0.015 mM tetramer). The loci of modification have 
not been <let-ermined, and one can only make qualitative 
assessment whether or not the crosslink is bridged between 
the subunits. Obviously in both the a9 9XLHb A- DMP and 
p82XLHb A-DMP, a small amount of monomer (8%) is still 
present as judged by the SDS gels. Therefore, a small 
amount of the uncrosslinked subunits, either the .8 in 
a99XLHb A-DMP or in ,882XLHb 
uncross linked. 
F. PURIFICATION OF a AND p GLOBINS 
AND AMINO ACID ANALYSIS 
A DMP, remained 
The purification of a and .8 globins was carried out 
with the cation exchange chromatography using the 
carboxymethyl cellulose (CM52) gel in the presence of urea 
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(Fig. 7). In the a chain the number of positively charged 
amino acids are higher than in the fJ' s by +4, so in this 
chromatographic system the fJ chain would elute from the 
column first. 
In the fJ82XLHb A the {J-{J crosslinked globins were 
expected to elute from the column before the uncrosslinked 
a globin. The purified globin under each peak (Fig. 8(B)) 
was analyzed by the SDS to determine which was the 
crosslinked globin and which one was uncrosslinked (Fig. 
22, lanes 4 and 6). As expected the first peak (peak F) 
was the crosslinked {J-{J globins. The globin in the second 
peak (peak F) contained only monomers, the a globin. 
the content of the amino acids in the fJ globin 
resulted in more negative charge than those in 
Since 
already 
the a 
globin, the two crosslinked fJ globins together would be 
even more negative than the native fJ globin by -2 and would 
move even faster than the native fJ globin through the CM52 
gel. 
In the a-a crosslinked hemoglobin (Fig. 8(A)), the 
globin under peak C was determined by SDS to be dimer (Fig. 
22, lanes 1 and 2), and the one under peak D, monomer (Fig. 
22, lane 3). The a-a crosslinked globins move faster 
through the CM52 gel than the uncrosslinked fJ globin. This 
elution is not consistent with the net charge property of 
the a-a globins and the uncrosslinked fJ globin. The native 
fJ globin has a net charge of -4 compared to the native a 
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glob in. When the a: g 1 ob ins are c r o s s 1 inked , a - 2 ch a r g e 
was added. The overall net charge of the crosslinked a:-a: 
globins together is -2 compared to -4 of the native f3 
glob in. A difference of -2 charge still remains for the 
native f3 globin over the crosslinked a:-a: globins. Due to 
other properties not yet understood, the a:-a: crosslinked 
globins elute from the column before the uncrosslinked 
native f3 globin. 
In the unknown crosslinked hemoglobin (Fig. 8(C)), 
the globins under peak G were of dimers (Fig. 23, lanes 4 
and 5), and those under peak H, monomers as determined by 
SDS (Fig. 23, lanes 6 and 7). At this point it was not 
clear whether the crosslinked globins were the a:'s or {J's. 
The globins under both peaks were hydrolyzed to amino 
acids, and their amino acids were compared to those of the 
a: and f3 globins (Table 10). The amino acid residues were 
corrected for errors by using the average area from the 
concentration. 
The results of amino acid from the globin under peak 
H matches those of the a: chain, and those from peak G 
matches those of the f3 chain. Therefore, the globins under 
peak G must be {3-{3 crosslinked ones. Chatterjee et al. 
(28) had suggested that the unknown crosslinked protein 
under the third peak of the a: crosslinking reaction 
contained a mixture of cross linked proteins, and that at 
least one product was the {3-{3 crosslinked hemoglobin. 
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Based on the electrophoretic mobility of this crosslinked 
hemoglobin compared to the o: or /3 crosslinked one, it must 
have an additional modification site on the hemoglobin 
molecule since it moves faster than both the o: and /3 
crosslinked hemoglobins. The locus of modification on the 
subunit has not been determined. The modification could be 
crosslinked or o: uncrosslinked subunit. It is on the /3·/3 
most likely that only one additional modification had 
occurred. 
III. 
A. 
THERMAL STABILITY OF CROSSLINKED HEMOGLOBINS 
THE EFFECT OF a CROSSLINKING ON 
THE THERMAL STABILITY OF Hb A 
The thermal stability of met f382XLHb A was 
investigated by White and Olsen (83). Its was 
determined to be 57°C. Subsequent denaturation met 
f382XLHb S (84) and f382XLHb New York (85) showed that their 
Tm's are 55°C and 54°C, respectively. The crosslinked 
hemoglobin, o:99XLHb A, has the same thermal stability as 
the f382XLHb A. Its Tm is 56. 7°C (Fig. 26). Crosslinking 
between two subunits of the same type resulted in the same 
thermal stability. 
The hemoglobin in solution, particularly in dilute 
solutions, exists in equilibrium between the tetramer and 
dimer, such as 0:2/32 -" 2o:f3. The equilibrium constant for 
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deoxyhemoglobin is 2.4xlo-ll M-1 (74). The crosslinking of 
hemoglobin between the f3 subunits was believed to stabilize 
the hemoglobin in the tetramer form according to 
LeChatelier' s principle (83, 84). The crosslink prevents 
the hemoglobin from dissociating to o:/J dimers. The same 
principle should apply to crosslinking between the two o: 
subunits. Therefore, crosslinking between either the two 
{J's or o:'s prevent dissociation of the hemoglobin to o:/J 
dimers. This shift in equilibrium favoring the tetramer is 
very important in thermal stability as well as in clinical 
aspects. 
It was believed that before thermal unfolding of the 
subunits, they must be dissociated from the tetramer to 
dimer (84). During the denaturation processes, in the 
f382XLHb A, when the subunits dissociate to o:f3 dimer it is 
believed that the f3 chains are still hook up together by 
the cross link (84). Such a rationale would still be true 
in the o:99XLHb A. Thus, when the o:99XLHb A dissociates to 
o:/J dimer, the o: chains are intact by the crosslink. The 
resistance to dissociation provides an additional stability 
barrier in the denaturation besides what comes from the 
crosslink on the globin chains. The most important factor 
in resisting denaturation, however, is from the crosslink 
itself holding the subunits together, thus preventing them 
from unfolding. 
The thermal stability of the second crosslinked 
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hemoglobin (XLHb A) from the a crosslinking reaction, which 
was determined to be {3-{3 crosslinked with an additional 
modification site also has the same thermal stability as 
the a99XLHb A and {J82XLHb A. Its Tm is 57. 6°C (Fig. 26). 
Within the limit of errors, the three cross linked 
hemoglobins {J82XLHb A, a99XLHb A and XLHb A have the same 
stabilities. The additional modification on the XLHb A did 
not significantly stabilize or destabilize the crosslinked 
protein. Since the crosslink is between the f3 chains, the 
effect on the equilibrium and thermal denaturation would be 
practically the same as the {J82XLHb A. 
In view of the clinical aspect of a blood 
substitute, the ability of a crosslink to stabilize the 
hemoglobin in the tetrameric form would eliminate the 
problems of kidney filtration in which the a{J dimer could 
easily pass through the glomeruli. When the hemoglobin is 
in the tetrameric form, its size is large and cannot pass 
through the glomeruli of the kidneys. Therefore, 
stability of the tetramer form would enhance 
intravascular life time of the hemoglobin in vivo. 
the 
the 
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B. THE EFFECT OF SINGLE CROSSLINKING BY 
DIMETHYLPIMELIMIDATE, TRIS(fi-CHLOROETHYL) AMINE 
AND BIS(fi-CHLOROETHYL) METHYLAMINE ON THE THERMAL 
STABILITY OF Hb A 
The thermal denaturations of hemoglobins crosslinked 
with DMP, TCEA and BCEA were done according to the same 
method described elsewhere in this dissertation. In these 
reactions the cross linking and modification are non-
specific and dependent on the concentration of the reagent 
and pH. Thus, heterogenous species were produced as judged 
by the clinical and SDS gels electrophoresis. From these 
results at least the heterogenous species are dimers, 
trimers, tetramers, and some polymers (Fig. 19(A), lanes 2, 
3, 4, 8 and 9; Fig. 21, lanes 1, 4, and 7). 
Since these cross linked species are heterogeneous, 
it is difficult to separate them into unique species. So, 
the thermal transition of these samples represents an 
average transition of all the modified species present in a 
sample. In this interpretation the less modified protein 
would have a low temperature transition similar to that of 
unmodified Hb A, and the highly modified protein would have 
an increased transition temperature. The .6.Tm increases 
linearly with respect to the number of crosslinks per 
species (Table 12, Fig. 20). A transition temperature 
representing an overall average value would appear to be 
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broad, and this was observed to be so. The hemoglobin 
sample crosslinked with DMP at 500:1 molar ratio has a Tm 
of 56.l°C (Fig. 29). The broadness of the transition 
indicates that some modified species, which are less 
modified have lower temperature transitions, and some which 
are highly crosslinked have high temperature transitions. 
This result indicates that in the Hb A-DMP at least one 
crosslinked species has nearly the same stability as the 
fumarate crosslinked hemoglobins. 
The hemoglobin crosslinked with TCEA and BCEA at 
10:1 molar ratio exhibit lower temperature transitions than 
the Hb A-DMP. The Tm of Hb A-TCEA and Hb A-BCEA are 49.3°C 
and 4l.3°C, respectively (Fig. 29). The transition 
temperature of the Hb A-TCEA shifts higher by 8°C than that 
of Hb A, but the stability of the Hb A-BCEA remains the 
same as that of Hb A. The nitrogen mustards crosslinked 
hemoglobins analyzed by SDS showed that there are dimeric, 
trimeric, tetrameric and polymeric species in Hb A-TCEA, 
but only the dimeric species predominate in the Hb A-BCEA 
sample (Fig. 19(A), lanes 2, 3 and 4; Fig. 19(B), scans 2, 
3 and 4). The higher Tm in Hb A-TCEA is also reflected in 
the higher numbers of crosslinks per species compared to Hb 
A-BCEA (Fig. 20, Table 12). 
All the single crosslinked hemoglobins, Hb A-DMP, Hb 
A-TCEA, a99XLHb A and p82XLHb A are more stable than Hb A, 
except for Hb A-BCEA which has the same stability as Hb A. 
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Even though, there are dimeric, trimeric, tetrameric and 
polymeric crosslinked species present in Hb A-DMP, Hb A-
TCEA and Hb A-BCEA, the thermal transition of these 
crosslinked hemoglobins are not higher than the single 
fumarate crosslink hemoglobins, a:99XLHb A and {382XLHb A. 
One would expect that the presence of trimers and tetramers 
due to multiple crosslinks would stabilize the protein 
more, but such an expectation was not observed. The 
explanation for this incongruity would mean that not all 
crosslinks stabilize proteins. Putting several crosslinks 
on the protein may destabilize its secondary and tertiary 
structure, leading to a less stable protein even though 
three or four subunits are linked together. In the 
hemoglobins crosslinked with DMP, TCEA and BCEA such an 
interpretation would be reasonable since the temperature 
transition did not effect a higher Tm for the dimers, 
trimers and tetramers present compared to the fumarate 
crosslinked hemoglobins. 
The specific single crosslink either between the two 
a: - or {3-subunits produced the most stable single 
crosslinked hemoglobin derivatives. The hemoglobin treated 
with DMP has a transition temperature comparable to the 
diaspirin crosslinked hemoglobins depending on the degree 
of modification. In the reaction at 1000:1 molar ratio pH 
9.5 the sample has a Tm (57°C) equal to that of the 
fumarate crosslinked hemoglobins (48). The BCEA hemoglobin 
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derivative is less stable than all the crosslinked 
hemoglobins investigated. 
C. THE EFFECT OF DOUBLE GROSSLINKING ON THE THERMAL 
STABILITY OF HEMOGLOBIN 
The thermal denaturations of double crosslinked 
hemoglobins, a:99XLHb A-DMP and ,882XLHb A-DMP, were done 
according to the same method described above. As mentioned 
before the second DMP reaction generated heterogeneous 
species which are difficult to purify, thus, the thermal 
transition of these double cross linked hemoglobins 
represent an overall average value for the a:99XLHb A-DMP 
and ,882XLHb A-DMP. The Tm of a:99XLHb A-DMP and ,882XLHb A-
DMP at 500:1 molar ratio are 58.7°C and 60.4°C 
respectively, compared to 56.1°C of Hb A-DMP (Table 13; 
Fig. 30). The ,882XLHb A-DMP has slightly higher stability 
than a:99XLHb A-DMP. This may be due to the R state being 
more favorable for DMP crosslinking than the T state. The 
number of crosslinks per species (Table 12) is higher in 
,B82XLHb A-DMP, hence, its t.Tm is higher. When Hb A is 
crosslinked with DMP the first time, the stability is 
increased by 15°C, but in the a:99XLHb A-DMP and ,B82XLHb A-
DMP it increases by only 3-4°C. Therefore, the effect due 
to DMP crosslinking (t.Tm) is not additive. 
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IV. AUTOXIDATION OF HEMOGLOBINS 
A. THE AUTOXIDATION OF Hb A 
The autoxidation of Hb A was monitored 
spectrophotometrically in 0. 01 M MOPS, pH 7, according to 
the method of Tomita et al. (99). 
hemoglobin appears to be bi-phasic. 
The autoxidation of 
In the first phase the 
methemoglobin rises linearly with respect to time until it 
reaches 20 h (Fig. 33(B)). Beyond 20 h the autoxidation 
reaches a plateau (Fig. 33(A)). This curve shape indicates 
that the autoxidation involves multisteps in the 
autoxidation mechanism. The autoxidation of Hb A at room 
temperature (22°C) and at 4°C was compared to that at 37°C 
and found to be much slower. At 4°C the autoxidation 
within 130 h essentially has not changed; the percent met 
hemoglobin remains at 5%. At room temperature the 
autoxidation is slightly faster than at 4°C but still is 
much slower than at 37°C. The autoxidation still maintains 
a linear curve within 160 h for the experiments done at 
room temperature and 4°C (Fig. 33(A)). 
The plot of the rate of disappearance of oxy 
hemoglobin with respect to the whole time (130 h) indicates 
that the rate of autoxidation is non-linear (Fig. 34(A)). 
Since the first phase of autoxidation is linear, it can be 
interpreted as pseudo-first order rate of autoxidation 
dependent upon the concentration of hemoglobin. For this 
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reaction the rate is given by: 
-df Hb02l 
dt 
kapp x [Hb02) 
From this assumption the apparent pseudo-first order rate 
constant could be determined by plotting -log(Ao-A)/(Ao-
with respect to time, where the numerator term 
indicates the concentration of oxyhemoglobin at time t and 
the denominator represents the total oxyhemoglobin 
concentration at the beginning. The kapp determined for Hb 
A based on the above equation is 0. 022 h -1. This value 
agrees well with 0.032 h- 1 determined by Mansouri and 
Winterhalter (66) and 0.042 h- 1 by Watkins et al. (71). 
When adding a crystal of sodium cyanide to the 
hemoglobin solution the pH may rise a little, but the 
cyanomethemoglobin spectrum is independent of pH, and such 
a change in pH was not observed when 1 µl of 0.1 M buffered 
sodium cyanide was added to the solution. The buffer was 
not expected to cause the autoxidation of hemoglobin. 
The temperature effects an increase in the rate of 
autoxidation due to the shift in equilibrium toward the 
release of 02. Therefore, at 37°C the autoxidation would 
be faster than at lower temperature. The use of 
temperature at 37°C is only to facilitate the monitoring of 
the autoxidation of hemoglobin and to match that of the 
body temperature (37°C). 
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The autoxidation of Hb A was investigated by Misra 
and Fridovich (61) and found to be caused by the self 
The autoxidation transition 
in which 02 is ligated to the iron atom was believed to be 
caused by the migration of one electron toward the 02, and 
such species has the superoxo-ferriheme structure, [Fe+3 __ 
Misra and Fridovich (61) used epinephrine to prove 
that 02 · - and H202 are generated in the autoxidation of 
hemoglobin. The H202 causes peroxidation of epinephrine, 
and oxidizes epinephrine to adrenochrome. The 
oxidation of epinephrine 
either SOD or catalase, 
to adrenochrome was inhibited by 
proved that the or both. This 
autoxidation of hemoglobin generates superoxide anion and 
hydrogen peroxide (61). Catalase and SOD do not inhibit 
epinephrine oxidation completely. The inhibition by 
ca ta lase is about 70%, and that by SOD is 60%. This 
further proves the multistep mechanism in which catalase 
only inhibits the oxidation caused by H202, and SOD 
inhibits the oxidation caused by 02 · - . The oxidation of 
epinephrine is almost completely inhibited by both enzymes 
( 61) . 
Satoh and Shikama ( 7 7) concluded that the 
autoxidation of oxy myoglobin was induced by anion, and the 
mechanism is by a nucleophilic displacement. Such a 
mechanism is a SN2 mechanism, and may be written as: 
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,L -
MbFe(II) .02 + L- ~ [Mb Fe (I I I )c.-:' ] ~ Mb Fe (I I I) . L - + 0 2 · -
"·o 2 -
where L- represents an anion. The H20 and OH- can act as 
anions and react with the iron as described in vivo (77). 
Sugawara and Shikama (67) proposed a similar mechanism in 
which H20 reacts directly at the iron, and the distal 
histidine is involved in hydrogen bonding to the ligated 
di oxygen. 
The effect of pH on the autoxidation of myoglobin 
and hemoglobin was investigated by a number of 
investigators (66-70). These investigators found that 
autoxidation is dependent upon pH, at higher pH the rate of 
autoxidation decreases and at lower pH it increases. The 
allosteric anions, 2,3-diphosphoglycerate (DPG) and 
inositol hexaphosphate (IHP), cause the autoxidation rate 
to increase (66,70). The increase in oxygen pressure 
causes a decrease in the autoxidation rate (66,70). Deoxy 
hemoglobin was found to autoxidize two order of magnitude 
faster than oxy hemoglobin (68,70). 
The mechanisms proposed so far do not explain 
satisfactorily the fact that SOD and catalase have partial 
inhibition on the autoxidation despite its simplicity and 
attractiveness. Obviously, the presence of 02 · - and H202 
accelerate the autoxidation rate, and the catalytic break 
down of these species slows down the autoxidation rate. 
So, the autoxidation is caused in part by 02 · - and H202. 
Site-directed mutagenesis to replace the highly 
conserved distal histidine (His E7) in sperm whale 
myoglobin demonstrates that the autoxidation rate increases 
by 40-350 fold (80). Springer et al. (80) suggested that 
the increase in autoxidation rate appears to be due to a 
decrease in oxygen affinity and an increase in solvent 
anion accessibility to the distal pocket (80). The idea 
that iron autoxidation is at least regulated by the distal 
His is supported by three evidences. First, X-ray 
crystallographic analysis of model heme-CO complexes (103) 
have shown that the distal histidine sterically prevents 
the formation of linear Fe=C=O bonding. Second, neutron 
diffraction studies of sperm whale myoglobin have revealed 
that the distal histidine is hydrogen bonded to the bound 
02 at the iron atom (104,105). Third, Traylor et al. (106) 
had suggested that local polarity of the ligand also 
contribute to the iron autoxidation. 
According to the theories above, the distal 
histidine would certainly play a role in regulation of the 
channel for the ligand to come in and react with the iron. 
Other residues in the ligand binding vicinity may also have 
a role in steric regulation of ligand binding as well. It 
was well known that the quaternary and tertiary structures 
of the oxy and deoxy hemoglobins are different (11). 
During the transition from R to T state, at the heme 
environment, the F helix moves clockwise with respect to 
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the heme axis; the CD corner moves away from the heme, but 
the E helix moves closer to it. These displacements cause 
the Phe CDl, Leu F7 and His F8 to move away from the heme, 
but His E7, Val Ell and Leu FG3 move closer to it (17). In 
the T state it would seem that His E7 and Val Ell would 
block the ligand pathway to the iron, but despite this 
seemingly paradox about the heme environment being more 
closed, it is possible that the ligand could enter easily 
from the Phe CDl channel since it moves away from the heme. 
Ligands such as, H20, HO·, 02·- and H202, are small enough 
that this slight closing at the iron center may not matter, 
and the pathway is still large enough for these ligands to 
diffuse in and react with the iron. This argument is not 
in contrary to the fact that deoxy hemoglobin autoxidizes 
faster than oxy hemoglobin. Another contributing factor to 
the slower autoxidation rate of oxy hemoglobin compared to 
deoxy hemoglobin is that in oxy hemoglobin 02 is bound to 
the Fe(II), so any ligands which will cause the oxidation 
of the Fe(II) must interact with this complex. Hence, the 
02 may simply act in protecting the Fe(II) from oxidation, 
whereas in deoxy hemoglobin the Fe(II) is free to react 
with any ligands which come in contact with it. These 
arguments suggest the reasons that deoxyhemoglobin would 
autoxidize faster than oxy hemoglobin. 
For these many reasons the multistep mechanism in 
the autoxidation of hemoglobin which appears to 
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satisfactorily explain the bi-phasic nature of the 
autoxidation curve was proposed by Wallace et al. (68) and 
modified by Watkins et al. (71). In addition to the 
proposed reactions a number of reactions could s ti 11 be 
postulated where the superoxide radical, hydrogen peroxide 
and hydroxyl radical are thought to react with Fe(II) in 
hemoglobin: 
(1) Hb.Fe(II)02 
(2) Hb.Fe(II) + H+ 
(3) Hb.Fe(II)(H+) + 02 + H20 
Hb.Fe(II) + 02 
Hb.Fe(II)(H+) 
Hb.Fe(III)H20 + H+o2·-
In these reactions the initial required step is the 
dissociation of 02 from the Fe(II), and the formation of 
Once 02 · - is formed it can spontaneously dismutate 
to hydrogen peroxide ( 1 0 7 ) 
deoxyhemoglobin at the iron. 
(4) 
or 
-+ 
react directly with 
H202 + 02 
Hb.Fe(III)H20 + H202 
The H202 formed from the dismutation reaction and from 02·-
reacting with Fe(II) can react with deoxyhemoglobin to 
produce OH- and the very reactive hydroxyl radical, HO·. 
This is the well known Fenton reaction (91). 
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( 6) ~ Hb.Fe(III) + OH-
~ Hb.Fe(III)H20 + OH- + HO· 
When HO· is formed it can react with H202 producing H02 · 
and water. It can further react with itself to give H202 
and dioxygen (91). 
( 8) 
The H02· can reduce the Fe(III) in met hemoglobin to the 
Fe(II) (91). 
(9) Hb.Fe(III)H20 + H02· 
The HO· can oxidize the iron in oxy and deoxy hemoglobin to 
methemoglobin and OH-. 
Weiss reaction (91). 
This reaction is part of the Haber-
(10) Hb.Fe(II) + HO· + H20 
Since there are many possible reactions at the iron 
center, these reactions are different in reactivity and 
perhaps mechanism as well. Thus, their rates of reaction 
are different, and the superimposed rates of all these 
reactions happening at the same time would appear to be a 
higher order rate of reaction. 
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The autoxidation of the isolated a and f3 chains 
appear to be linear for 100 hours (66, 70). The a chain 
autoxidizes faster than the f3 chain. The first order rate 
constant for the a chain is 0.025 h- 1 and 0.009 h-1 for the 
f3 chain at pH 7.2. The two phases of autoxidation may be 
contributed from the fast and slow components of the a and 
f3 chains respectively. 
B. THE EFFECT OF CROSSLINKING ON THE AUTOXIDATION OF 
HEMOGLOBIN 
The cross linking of hemoglobin by bis(3,5-
dibromosalicyl) fumarate in the oxy state puts the 
cross link between Lys 82/31 and Lys 82/32 (30), and in the 
deoxy state, Lys 99a1 and Lys 99a2 (28). This is due to 
the fact that in the oxy state the two Lys 82{3's are closer 
to each other ( 6 A) than the two Lys 99a's (9 A), whereas 
in the deoxy state the Lys 82{3's are 8.1 A apart and the 
Lys 99a's, 5 A apart. Also in the oxy state the Lys 82{3's 
are stereochemically favorable for the crosslink to occur 
and not the Lys 99a's, whereas the reverse is true in the 
deoxy state. This is the reason why all four lysines are 
not crosslinked in attempting to double crosslink the 
hemoglobin with BBSF. 
The hemoglobins crosslinked between either the a- or 
{)-subunits display markedly different autoxidation rates. 
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The autoxidation of a99XLHb A is faster than that of 
,B82XLHb A or Hb A (Fig. 33(A)). The ,882XLHb A autoxidizes 
slightly faster than Hb A, but the limit of error is close. 
The rate of autoxidation of a99XLHb A is 0.0393 h-1 
compared to 0.0269 h-1 and 0.022 h-1 of ,882XLHb A and Hb A, 
respectively (Table 16). Since the autoxidation of a99XLHb 
A is faster than Hb A or ,882XLHb A, its half-life in the 
oxy state is also shorter. The half-life is 17.6 h for 
a99XLHb A, compared to 25.8 h for ,882XLHb A and 31.5 h for 
Hb A, as determined by the first-order rate approximation. 
The faster rate of autoxidation of a99XLHb A than 
that of ,882XLHb A results from the different quaternary 
structures due to crosslinking in the two proteins. The 
crosslinking in the a99XLHb A took place in the deoxy state 
and in ,882XLHb A, in the oxy state. The crosslink in the 
a99XLHb A holds it in the T state and in ,882XLHb A, in the 
R state. After reoxygenation of the deoxy a99XLHb A, a 
conformation closely related to the T state (a pseudo T 
state) is still retained. The facts that a99XLHb A binds 
oxygen less tightly than the ,882XLHb A (28,29) and that 
deoxyhemoglobin autoxidizes faster than oxy hemoglobin 
(68,70) supports this proposal. 
Another possible explanation is that the crosslink 
causes tertiary structural changes at the heme environment 
enabling water molecules and other intermediates generated 
during the autoxidation, such as superoxide radical, 
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hydrogen peroxide, and hydroxy radical to enter and react 
with the iron. The study of mutant sperm whale myoglobins 
in which the distal histidine was replaced demonstrates 
that these mutant myoglobins autoxidize faster than normal 
myoglobin, and that the heme environment was more 
accessible to ligands to get into the heme pocket (80). As 
stated above, in the deoxyhemoglobin the F helix moves 
clockwise with respect to the heme axis, the CD corner 
moves away from the heme, but the E helix moves closer to 
it. These displacements cause the Phe CDl, Leu F7 and His 
F8 to move farther away from the heme, but His E7, Val Ell 
and Leu FG3 move closer to it. During the crosslinking 
reaction of a99XLHb A the hemoglobin was in the deoxy 
state, thus, these changes must have occurred. After 
reoxygenation of the deoxy a99XLHb A, these displacements 
may not go back to their original positions in the oxy 
state due 
Therefore, 
to structural constraints of the crosslink. 
it is expected that the crosslink will hold 
these displacements even after reoxygenation and may cause 
additional tertiary or secondary structural changes around 
the crosslink itself. 
The X-ray crystallographic structure of ,882XLHb A 
showed that the F helix and EF corner were displaced toward 
the bisphosphoglycerate binding cavity, but the overall 
tertiary structure of the hemoglobin does not change (29). 
The Lys 82,8 is located on the EF corner (EF6) and Lys 99a, 
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on the G helix (G6). The heme is covalently coordinated to 
His F8. In oxy hemoglobin the two Lys 82~'s are 6 A apart, 
and in deoxy hemoglobin the two Lys 99a's are separated by 
s.2 A. The fumarate crosslink has a span of 5 A. Thus the 
crosslink span is shorter than the inter-residue distance 
between the pairs of lysines. By crosslinking the two 
lysines are pulled toward each other. So, it is expected 
to cause local displacement of the F helix in ~82XLHb A and 
in a99XLHb A, of the G helix. Thus, these displacements by 
crosslinking may cause the heme to be displaced and the 
heme pocket to be opened up allowing ions to enter easily 
and react with the iron. In the T state it would seem that 
the His E7 and Val Ell would block the ligand pathway, but 
since the Phe CDl moves away from the heme it is possible 
that the ligand could enter from this channel. If the 
tertiary structure of oxy a99XLHb A resembles that of the 
deoxyhemoglobin then it would be autoxidized faster than Hb 
A or ~82XLHb A. A pseudo T conformation would most likely 
be oxidized to methemoglobin faster than one at the R state 
because during the oxidation process the ligand must be 
kicked off prior to oxidation. 
The evidence that a99XLHb A is held in the T state 
or pseudo T state and ~82XLHb A, in the R state, agrees 
with the finding that deoxy hemoglobin autoxidizes faster 
than oxy hemoglobin (68,70), and that the heme environments 
opened up more to allow ligands to come in and react at the 
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iron as suggested by Springer et al. (80). 
In the ~82XLHb A the crosslink took place when the 
hemoglobin was in the oxy state. Thus, it is believed that 
the crosslink holds the ~82XLHb A in the R state. Since 
the R state of oxy ~82XLHb A is essentially the same as oxy 
Hb A, except for the local perturbation around the 
crosslink, it should autoxidize at the same rate as oxy Hb 
A. Such a similarity in the autoxidation rate is confirmed 
for ~82XLHb A and Hb A (Table 16). Therefore, overall the 
faster rate of autoxidation of the crosslinked hemoglobins 
compared to uncross linked hemoglobin seems to be 
principally due to structural differences in the R and T 
states and local structural changes at the crosslink in the 
two crosslinked hemoglobins. 
C. THE EFFECT OF CATALASE AND SUPEROXIDE DISKUTASE ON 
THE AUTOXIDATION OF Hb A, a99XLHb A AND p82XLHb A 
The autoxidation of hemoglobin can be partially 
inhibited by either catalase or superoxide dismutase (Fig. 
35, 36 and 37). This is because 02 · - , HO· and H202 are 
generated during the autoxidation. As indicated above in 
the autoxidation reactions of hemoglobin, the 02· - , HO· and 
H202 are known to react with the Fe(II) at the heme center. 
Superoxide dismutase catalyzes the break down of 
The catalytic break down of 02·- to H202 by 
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SOD appears to be as follows (89): 
SOD-Cu(II) + 02·-
SOD-Cu(I) + 02·-
-+ 
-+ 
SOD-Cu(I) + 02 
SOD-Cu(II) +H202 
Thus, in the autoxidation reactions above SOD would inhibit 
the progress of the oxidation of Fe(II) -+ Fe(III) in 
reaction 5. Reaction 4 is a spontaneous dismutation 
reaction of 02 · - to form H202 and may occur independently 
of the presence of SOD. 
Catalase is present in the red cell and the 
cytoplasm of other cells. Its role is to catalyze the 
The decomposition of 
hydrogen peroxide by catalase is by means of two reactions. 
The first reaction involves the formation of a primary 
complex in which a molecule of H202 reacts with the Fe(III) 
in catalase (108): 
CAT-Fe(III)-OH + H202 = CAT-Fe(III)-OOH + H20 
The second reaction involves the primary complex reacting 
with a second molecule of H202 (108). 
CAT-Fe(III)-OOH + H202-+ CAT-Fe(III)-OH + H20 + 02 
catalase would prevent H202 from 
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reacting with the Fe(II) of the hemoglobin, thus, 
protecting the hemoglobin from oxidation. Therefore, the 
catalase would have acted to protect directly the progress 
of reactions 6 and 7, and indirectly reaction 10 since the 
HO· is one of the products of H202 reacting with the Fe(II) 
of hemoglobin. 
In both the crosslinked and uncrosslinked hemoglobins 
SOD and catalase inhibit the autoxidation partially. But 
when both are applied together the inhibition is increased 
(Fig. 35, 36 and 37). The catalase inhibits 11.1%/µM 
enzyme in the Hb A sample, 8.5%/µM in P8ZXLHb A and 9.7%/µM 
in a99XLHb A. The SOD inhibits Z%/µM enzyme in Hb A, 
1.9%/µM in P82XLHb A and 1.6%/µM in a99XLHb A (Table 16). 
The inhibition by catalase observed in both 
crosslinked and uncrosslinked hemoglobins was 49-64% and 
38-47% by SOD. Thus, the SOD inhibits autoxidation 
slightly less than catalase. This seems to suggest that 
either the amount of Hz02 generated in the autoxidation was 
higher than Oz·- or that certain dismutation reactions were 
responsible for the break down of 02 · - and thus, they are 
not intercepted by SOD. 
inhibition was 67-8Z%. 
When both enzymes were applied the 
Hence, not all the Oz·- and HzOz 
were intercepted by the enzymes. The inhibition of 
autoxidation by SOD and catalase is without doubt a proof 
of the 
effect 
generation of Oz· and Hz02 
of inhibition observed by 
in the react ion. The 
using SOD and catalase 
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should provide a clue to the protection of hemoglobin 
autoxidation. 
D. CROSSLINKED HEMOGLOBIN AS POTENTIAL BLOOD SUBSTITUTE 
The interest in using crosslinked hemoglobin as a 
blood substitute is being investigated quite extensively by 
several groups of scientists (18,27-30,33,34,40,49). Of 
the several required properties of a crosslinked hemoglobin 
as a potential blood substitute, the obvious ones are 
oxygen binding, structural stability and non-lability to 
oxidation. For a crosslinked hemoglobin to be considered 
as a potential blood substitute the oxygen affinity should 
not deviate significantly from that of whole blood, it must 
be cross linked between the like-subunits to prevent 
dissociation to a.f3 dimer, and it should be less labile to 
oxidation. 
Of all the crosslinked hemoglobins investigated so 
far, the most promising one is the o.99XLHb A. The o.99XLHb 
A has lower oxygen affinity, similar to that of whole blood 
(28), but the f382XLHb A has higher oxygen affinity (29). 
The o.99XLHb A, f382XLHb A, and their double crosslinked 
derivatives have the highest thermal stability (Table 13), 
which would imply the highest structural stability for 
these crosslinked proteins. The o.99XLHb A autoxidizes 
faster than f382XLHb A or Hb A, and f382XLHb A autoxidizes 
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slightly faster than Hb A (1.2 fold). Two important 
factors in making a blood substitute from modified 
hemoglobin lie in the autoxidation and stability. The 
stability of cross linked hemoglobin may increase the 
intravascular retention time of the hemoglobin in the body 
during circulation because 
toward the tetrameric form. 
the equilibrium is shifted 
Thereby, preventing renal 
elimination. With stable crosslinked protein, the solution 
could be sterilized at high temperature without causing 
denaturation. Also stabilized crosslinked hemoglobin could 
increase storage shelf-life and allow storage at room 
temperature. From this point of view, the crosslinking in 
both o and fJ crosslinked hemoglobins would satisfy these 
requirements. Since the autoxidation rate of o99XLHb A is 
faster than that of normal Hb A and f382XLHb A, it is not 
known if this rate would be acceptable. Snyder et al. (68) 
had proved that in Sprague-Dawley rats the methemoglobin 
reductase system was able to reduce the met o99XLHb A 
progressively from nearly 100% methemoglobin to 27% met 
hemoglobin within 5 hours. Based on this experiment the 
methemoglobin reductase system should be able to slow down 
the rate of autoxidation of the o99XLHb A in vivo. So, in 
vivo the rate of autoxidation at 0.0396 h-1 may not matter, 
but for storage purposes such hemoglobin would need 
protection from autoxidation by either antioxidants or 
enzyme systems. Such an effect was demonstrated by the 
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reduction of autoxidation of hemoglobins by SOD and 
catalase or both. 
During emergency in which a massive amount of blood 
substitute is needed to carry oxygen to the tissues in a 
short time the patient would need a fully oxygenated blood 
substitute. Any methemoglobin present in the blood 
substitute given to a patient may take a while for it to be 
reduced. Thus, the high autoxidation rate of a99XLHb A may 
present a problem in using it as a blood substitute. 
The thermal stability of Hb A-DMP, Hb A-TCEA, Hb A-
BCEA, a99XLHb A-DMP and ~82XLHb A-DMP is dependent on the 
amount of crosslink on them. The double crosslinked 
hemoglobins, a99XLHb A-DMP and ~82XLHb A-DMP, are the most 
stable ones, followed by Hb A-DMP (at 500:1 molar ratio) 
and Hb A-TCEA. The Hb A-BCEA has the same stability as Hb 
A. In regard to stability, some of these crosslinked 
hemoglobins (Hb A-DMP, a99XLHb A-DMP and ~82XLHb A-DMP) 
should also satisfy this requirement. However, this is 
questionable, since all the DMP treated hemoglobins exhibit 
low solubility in aqueous solution. Pennathur-Das et al. 
( 4 7) have shown that the oxygen affinity of DMA treated 
hemoglobin is increased. Thus, it is likely that DMP 
treated hemoglobins are also affected the same way. 
The nitrogen mustards are highly toxic compounds, so 
Hb A-TCEA and Hb A-BCEA are ruled out as potential blood 
substitutes. Furthermore their stability is low, but the 
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model of tri-functional crosslinking should provide a 
further search for such reagent with less toxicity. Roth 
et al. (42) have shown that the oxygen affinity of nitrogen 
mustard treated hemoglobin remains the same as Hb A. 
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APPENDIX 
19F LABELING ON HEMOGLOBIN 
PROCEDURES 
A. MODIFICATION REACTIONS OF HEMOGLOBIN WITH 3- BROM0-
1, l, l-TRIFLUOROPROPANONE 
The reaction of hemoglobin with 3-bromo-1,1,1-
trifluoropropanone (TFAB) was done according to the method 
of Huestis and Raftery (109). The labeling of 
oxyhemoglobin with was done in three different 
solvents, 0.2 M phosphate, 0.1 M NaCl, pH 7.2, 0.1 M MOPS, 
0.1 M NaCl, pH 7.2, and 0.01 M MOPS, pH 7.2. The mole 
ratio of TFAB to Cys ~93 was 2.5:1.0. TFAB was dissolved 
in the corresponding buffer, which the hemoglobin was in, 
or added neat directly to the hemoglobin solution. The pH 
of the solution tended to drop because of the acidity of 
the TFAB solution, hence, 5-20 µL of 0.2 M NaOH was added 
at a time to maintain the pH at 7.2. 
A 2 mL of 10.3% oxyhemoglobin A (103.4 mg/mL, 6.47 
mM heme, 1. 29 x lo- 5 mole heme, 6.45 x lo- 6 mole Cys ~93) 
in 0.01 M MOPS, 0.1 M NaCl, pH 7. 2' was reacted with 1. 8 µL 
of TFAB (d 1. 7 2 g/mL, 1. 61 x lo- 5 mole) at room temperature 
(22°C) for 30 minutes. The reaction was carried out in a 
small test tube with slow stirring by a mini stirring bar 
at the bottom and the pH was constantly monitored. If the 
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pH dropped below 7.0, the solution was adjusted with 0.2 M 
NaOH, 5-20 µL at a time. For reactions carried out in MOPS 
buffer the pH changed by 0.1-0.2 unit only, and therefore, 
pH adjustment was not needed. For different reactions the 
hemoglobin concentration was varied from 15-105 mg/mL, 
however most of the reactions had 50 mg/mL or 100 mg/mL. 
The molar ratio of TFAB to Cys ~93 was kept at 2.5:1 for 
most of the experiments, except for some of the initial 
experiments, which were 25:1. After the reaction was 
completed the hemoglobin solution was put in an ice cold 
bath for 10 minutes, centrifuged to remove any precipitates 
formed and passed through a G-25 column 
equilibrated with 0.01 M MOPS, 
Sephadex 
pH 7.0. The labeled 
hemoglobin (Hb-TFA) was concentrated by the pro-dicon in 
0.01 M MOPS, pH 7.0. The reactions of hemoglobin with TFAB 
were also done with CO deoxy and cyanomet hemoglobins in 
the same manner. The extent of modification at the 
cysteine residues was characterized by Ellman' s reagent, 
5,5'-dithiobis(2-nitrobenzoic acid) (110,111). 
B. NMR SAMPLE PREPARATION 
The hemoglobin solution for NMR studies consisted of 
20-100 mg/mL hemoglobin in 0.01 M MOPS, pH 7.0 and 10% D20. 
In the absence of guanidine three different buffers (0.01 M 
MOPS, pH 7.0; 0.1 M NaCl, pH 7.0; and 0.2 M phosphate, 0.1 
255 
M NaCl, pH 7 .0) were used, but most of the experiments 
established in the presence of guanidine were done in 0.01 
M MOPS, 10% 
concentration 
D20, pH 
(0.9-4.6 M). 
7.0 with various guanidine 
A 5 mm diameter NMR tube (from 
Wilmad Glass), fitted to a 0.7 mm diameter coaxial external 
reference capillary tube (from Wilmad Glass) was used. The 
external reference in the capillary tube contained 3 x 10- 3 
M of trifluoroacetic acid (TFA) in 0.01 M MOPS, pH 7.0. 
A protocol of an NMR sample preparation of 10% 
hemoglobin, 10% D20, and 1 M guanidine in 0. 01 M MOPS, pH 
7.0 would be as follows: 
A 233 µL of oxy HbA-TFA (257.5 mg/mL) in 0.01 M 
MOPS, pH 7.0 was mixed with 60 µL of D20, 
MOPS, pH 7.0, and 247 µL of 2.5 M guanidine 
pH 7.0. 
60 µL of 0.01 M 
in 0.01 M MOPS, 
The 19F NMR spectra were recorded using a Varian VXR 
300 MHz NMR spectrometer tuned to a frequency of 282.2 MHz 
(7.047 T). The probe was at room temperature (21± 0.5°C). 
The nucleus was set at 19.0. The acquisition time was 
0.296 second. The pulse width was 15 µsec. The spectral 
width was 8,000 Hz. The number of scans were between 
5,000-10,000. 
off. 
The 19F spectra were run with the decoupler 
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RESULTS 
In the hope of studying the hemoglobin conformation 
by NMR, the hemoglobin was labeled at Cys 93{3 with 19F. 
The reagent used for labeling was 3-bromo-1,1,1-
trifluoropropanone (TFA, F3CCOCH2Br). The labeling method 
was according to Huestis and Raftery (109,112,113). When a 
protein goes from one state to another it is likely that 
the environment at Cys 93{3 may change. This change might 
expose the 1 9 F on the Cys 93{3 to different environment and 
may cause a change in magnetic properties, such as chemical 
shift or relaxation time. It was hoped that the signal 
from 1 9 F could be use to probe the different states of the 
hemoglobin, such as the native or denatured state. 
Different chemical shifts have been observed for different 
ligated state of the hemoglobin (109' 112 '113). The 
denaturation state of the hemoglobin could be studied as a 
function of temperature or guanidine concentration. 
The spectra of different ligated TFA treated 
hemoglobin (Hb A-TFA) appear as broad singlets ranging from 
-8.4 to -8.9 ppm, with the met state being at higher field 
and cyanomet at lower field. Table 28 shows the chemical 
shifts observed by Huestis and Raftery compared to those 
from this research. Figure 42 shows the 19 F NMR signal 
from the Hb A-TFA. The chemical shifts observed by Huestis 
and Raftery (109,112,113) are at lower field than those 
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Table 28: 
The 19 F chemical shifts observed with 94.1 MHz at various 
ligand states in Hb A-TFA at pH 7.2 and 22°C relative to 
trifluroroacetic acid. The NMR samples contained 2.5-10% 
hemoglobin. 
Ligated state 5(ppm)a 5(ppm)b 
Cyanomet -4.89 -8.42 ± 0.04 
co -4.99 -8.56 ± 0.07 
Oxy -5.13 -8.62 ± 0.04 
Met -5.58 -8.94 ± 0.05 
Deoxy -5.68 -8.86 ± 0.06 
a Chemical shifts observed by Huestis and Raftery at 94.1 
MHz (109,112,113). 
b Chemical shifts observed in this research at 282.2 MHz. 
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Fig;ure 42: 
The 19F chemical shifts observed for different 
ligated states of hemoglobins 
7 . 2 ' at room temperature 
concentration was 10%. 
in 10% D20, 
(21°C). 
0.01 M MOPS, pH 
The hemoglobin 
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obtained in this research. 
in the reference used. 
This may be due to difference 
The reference, trifluoroacetic 
acid, used in this research was diluted in water and used 
externally; so it may have been dissociated to the anion 
form, since trifluoroacetic acid is a strong acid. Huestis 
and Raftery did not comment whether they diluted the 
trifluoroacetic acid in water or they used it neat. 
Nevertheless, the difference in chemical shift is the same 
in both results. 
It is possible to observe the hemoglobin in 
different ligated state in a sample. Figure 43 shows an 
oxy hemoglobin sample which a fraction of it has been 
oxidized to met hemoglobin. 
Probing the denatured state of hemoglobin using 
increasing guanidine concentration could not be realized 
because the Cys 93~ in the native state is on the surface 
of the hemoglobin molecule and in the denatured state it is 
also on the surface. So, the environment around the 19F 
probe is the same in both states, thus, no significant 
chemical shift was observed. Table 28 compares 
chemical shifts in hemoglobin in the presence or absence of 
guanidine. The F3CCOCH2Br in aqueous solution appears at-
8 .19 ± 0. 03 ppm from trifluoroacetic acid. The 19F in 
carb onmonoxyhemo g 1 ob in appears at - 8. 5 6 ppm, and that of 
met hemoglobin is at -8.94 ppm. This means that the 19F in 
carbonmonoxyhemoglobin is more exposed to the polar 
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Figure 43: 
Observation of different ligated states of 
hemoglobins in the same sample. The peak at - 8. 6 ppm is 
due to the oxy form, and at -9.1 ppm, the met form. 
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Table 29: 
The 19p chemical shifts 
presence or absence of 
in CO and met Hb A-TFA in the 
guanidine at room temperature 
(21°C). 
[Gdn] s of CO-Hb s of Met-Hb 
0.0 -8.56 ± 0.07 8.94 ± 0.05 
0.9 -8.70 -8.55 
1. 0 -8.65 ± 0.11 -8.61 
2.0 -8.75 ± 0.05 -8.68 
3.0 -8.71 -8.67 
3.6 -8.71 -8.70 
4.0 -8.71 
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solvent, water; therefore, it is in a more hydrophilic 
environment than in the met state. When Hb A-TFA is 
denatured in 3 M Gdn, the resonance appears at -8.70 
ppm. According to the results obtained, the Cys 93p in the 
denatured state of the protein would be in an intermediate 
environment between the met and CO hemoglobin states since 
its chemical shift is at -8. 70 ppm. 
hemoglobin is already denatured. 
At 3 M guanidine 
In the denatured state if the protein is in a random 
coil state, one would have expected the l9F probe to have, 
if not close to, the same chemical shift as the reagent 
itself (-8.2 ppm). The chemical shift would go from higher 
to lower field. In the met hemoglobin it appears to be so, 
but in the CO hemoglobin it is shifting upfield. Unless, 
at this concentration the CO state is changing to the met 
state, and its chemical shift is still shifting upfield and 
has not reached the state where it would go downfield. 
This could only be so if the CO and met hemoglobin have not 
denatured completely at 3 M Gdn. 
Three experiments in which hemoglobin was mixed with 
0. 9 M Gdn accompanied by raising the tempera tu re to 6 5 ° C 
showed the 19F shifted to -8.l ppm, which would agree with 
the interpretation that the 19 F probe would be in the same 
environment in the denatured state of the protein as the 
free reagent. But when the temperature was raised to 65°C 
the hemoglobin sample had already aggregated. Thus, it is 
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not certain whether this chemical shift represents the 
denatured state. It is also possible that temperature 
could effect such a chemical shift in the denatured 
protein. Aggregation is one of the reasons why the use of 
temperature to induce denaturation of hemoglobin was not 
very useful in NMR due to the ease of formation of 
aggregates at high hemoglobin concentration. Figure 44 
shows the effect of temperature on the 19 F chemical shift 
of hemoglobins. 
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Figure 44: 
The effect of temperature on the 19F chemical shift 
of Hb A-TFA; curves 1 and 2 are oxy Hb A-TFA; curve 3, oxy 
p82XLHb A-TFA; and curve 4, met Hb A-TFA. 
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SUMMARY 
Hemoglobin has been crosslinked using four different 
reagents: bis(3,5-dibromosalicyl) fumarate, dimethyl-
pimelimidate (DMP), tr is (,8-chloroethyl) amine (TCEA), and 
bis(,8-chloroethyl) methylamine (BCEA). The hemoglobins 
cross linked with imidoester and nitrogen mustard 
derivatives all produced heterogeneous species which were 
not resolved well enough to a single homogeneous 
crosslinked species. Increasing the molar ratio of 
nonspecific crosslinking reagents, TCEA, BCEA and DMP, to 
hemoglobin during reaction produced higher crosslinked 
species. Nonspecific crosslinking reagents can crosslink 
hemoglobin to form dimeric, trimeric, tetrameric, and 
polymeric species. The tri-functional reagent, TCEA, 
crosslinks hemoglobin to produce higher percentages of 
dimers and trimers compared to the bi-functional reagent, 
BCEA, whereby only dimers were predominant. Since the 
hemoglobin solution of the DMP, TCEA and BCEA treated 
hemoglobins were of heterogeneous nature, their thermal 
transition represents an average value of the crosslinked 
sample. 
All the crosslinked proteins have structural 
transitions at higher temperature than Hb A, except for Hb 
A-BCEA which is equal to Hb A. The specific crosslinker, 
bis(3,5-dibromosalicyl) fumarate, produces the highest 
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stability in the singly crosslinked protein. These are the 
~82XLHb A and a99XLHb A. The nonspecific crosslink 
reagents DMP, TCEA and BCEA stabilize hemoglobin by a 
lesser extent compared to the specific cross linker. 
However, the stability is still higher than normal Hb A by 
8-15°C. The Tm of these crosslinked hemoglobins from the 
Soret data are 41.3°C, Hb A-BCEA; 49.3°C, Hb A-TCEA; 
56.1°C, Hb A-DMP (500:1); 56.7°C, a99XLHb A· 
' 
56.6°C, 
~82XLHb A; 57.6°C, XLHb A; 58.7°C, a99XLHb A-DMP (500:1); 
and 60.4°C, ~82XLHb A-DMP (500:1). 
Since higher molecular weight crosslinked species 
are present in DMP, TCEA and BCEA treated hemoglobins, but 
their thermal transition is lower or only comparable to the 
a99XLHb A and ~82XLHb A at very high molar ratio of reagent 
to hemoglobin, the crosslinks in Hb A-DMP, Hb A-TCEA and Hb 
A-BCEA must have destabilized the proteins. So, not all 
crosslink will result in stabilizing the protein structure. 
The data from 280 nm and the Soret region indicate 
that the crosslinks stabilize some parts of the protein 
more than others. Double crosslinking of ~82XLHb A or 
a99XLHb A with DMP produces the highest change in 
stability, (60°C). The increase in stability due to the 
second reaction of DMP with crosslinked hemoglobin is much 
less than the stability due to the first reaction, 3°C 
compared to 16°C. Thus, the increase in Tm is not 
additive. 
The autoxidation rate of a99XLHb A is faster than 
those of the J982XLHb A and Hb A by 1.5 and 1.8 fold, 
respectively. The J982XLHb A and normal Hb A have nearly 
the same autoxidation rates within the limit of error. The 
apparent first order rate constant of autoxidation of 
hemoglobins are 2.20xlo-2 h-1, Hb A; 2.69xlo- 2 h-1, J982XLHb 
A; and 3.93xlo-2 h-1, a99XLHb A. The faster rate of 
autoxidation of the crosslinked hemoglobins is believed to 
be due to the tertiary structural change by the fumarate 
crosslink holding the oxy a99XLHb A in the T conformation 
and the J982XLHb A, in the R conformation. 
Superoxide dismutase and catalase are able to slow 
down the rate of autoxidation independently or together. 
The ability of SOD and CAT to protect hemoglobins from 
autoxidation is a further proof of the generation of Oz·-
and HzOz during autoxidation. This research emphasizes two 
important factors for the design of a blood substitute, 
stability and iron autoxidation. For a blood substitute, 
at least the modified hemoglobin is required to be 
stabilized by a crosslink and resistant to oxidation. 
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